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There are many aspects of life which, when viewed retrospectively,
fall into a pattern, although in their developing they seemed
but a random play of accident and circumstance.
Sir Macfariane Burnet, 1959.
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ABSTRACT:
Studies were undertaken to elucidate the in vivo immunochemical nature of the
antigen revealed when autologous erythrocytes are treated with the proteolytic enzyme,
bromelain. The primary aim of this thesis has been to identify the molecular form of
the BrMRBC antigen normally found in vivo either on bromelain-treated mouse
erythrocytes or in its naturally antigenically detectable form in the mouse
gastrointestinal tract.
Carbonic anhydrase (CA) from mouse erythrocyte membranes is recognised
and identified as an autoantigen in Western blotting experiments with FUB 1, a murine
IgM monoclonal antibody that has binding reactivity towards both phosphatidylcholine
and bromelain-treated mouse red blood cells (BrMRBC). Serum from mice stimulated
with lipopolysaccharide (LPS-serum) also recognises CA from erythrocytes and the
stomach. From SDS-PAGE and blotting experiments with whole mouse erythrocytes
we found two closely spaced glycoprotein bands were found in the 30 kD region that
reacted with both FUB 1 and LPS-serum; one of the molecular weight markers,
bovine carbonic anhydrase, which ran in the same 30 kD region also reacted with these
antibodies. Carbonic anhydrases from a range of mammalian species including rat,
rabbit, dog, human, horse, sheep, and cow were found to be cross-reactive with FUB
1 and LPS-serum by Western blotting, whereas human glycophorin A and human
asialoglycophorin were not recognised by the antibodies. A doublet band occurred for
mouse, rat and rabbit carbonic anhydrase, whereas a single band was evident for
human, sheep and horse erythrocyte carbonic anhydrase. FUB 1 specifically
recognises both native and denatured bovine carbonic anhydrase in ELISA assays. The
serological identity of the determinants on CA and BrMRBC was confirmed by
specific absorption of both FUB 1 and LPS-serum with BrMRBC and normal mouse
erythrocytes.
Carbonic anhydrase was purified from mouse stomach and shown to be
recognised by natural autoantibodies in western blotting experiments. In an attempt to
define epitopes present on carbonic anhydrase, the glycoprotein was treated with
specific enzymes to remove O-linked carbohydrates and was also treated with
proteases to cleave CA into defineable fragments.When these forms of carbonic
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anhydrase are western blotted, FUB 1 does not bind to deglycosylated carbonic
anhydrase suggesting that FUB 1 recognises O-linked carbohydrates on carbonic
anhydrase. In other preliminary experiments, where carbonic anhydrase has been
proteolytically cleaved, LPS serum is capable of recognising all cleavage fragments,
whereas FUB 1 appears to recognise a limited number of bands.
Thus, the autoantigenic epitope on erythrocytes that is revealed by the
proteolytic action of bromelain is associated, at least in part, with carbonic anhydrase.
The possible biological significance of natural autoantibodies binding to carbonic
anhydrase is examined and a model of the functional importance of this interaction is
presented.

CHA PTER ONE
IM M U N O CH EM ICA L CHARACTERISATION OF ERYTHROCYTE
ANTIGENS BY NATURAL AUTO ANTIBODIES

1.1. N A TU RA L A U TO A N TIB O D IES AND AU TO A N TIG EN S
Natural autoantibodies and the B lymphocytes from which they arise display
many unusual and unique properties which will be examined briefly in this review.
Natural antibodies are known to recognise a diverse range of autoantigens, of which a
selection will be examined (Section 1.1.2.). It is difficult to make a clear distinction
between pathological autoantibodies and natural non-pathogenic autoantibodies in
normal and autoimmune animals due to the complexity, diversity and multifactorial
nature of autoimmune disorders. Moreover, the function and origins of most natural
antibodies or autoantibodies have not yet been ascertained (Section 1.2.) and thus the
role of natural antibodies or autoantigens in the maintainence of self tolerance is
currently open to question . The very idea that natural autoantibodies exist raises
problems for how self tolerance and self recognition may operate, and the various
models of self tolerance are examined from this perspective (Section 1.2.1.).
Throughout this literature review particular emphasis will be placed upon the
determination of the in vivo immunochemical nature of a hidden autoantigen(s) on
autologous mouse red blood cells (RBC) that are recognised by natural
autoantibodies. In this model, a large proportion of the potential repertoire appears to
be primed to respond to hidden antigens on autologous red blood cells treated with
the proteolytic enzyme bromelain (BrMRBC; Cunningham 1974a, 1975,1976; Pages
and Bussard 1975; Bussard and Pages 1976; Steele and Cunningham 1978). These
studies and subsequent work by others on the elucidation of the BrMRBC-specific
autoantibodies, BrMRBC antigen(s) and the regulation of this response will be
reviewed (Sections 1.3. and 1.4.) and finally, vertebrate red blood cell antigens will
be examined briefly (Section 1.5.) in order to provide background information on
potential antigenic substances which may be involved in the BrMRBC epitope.
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1.1.1. N atural A utoantibodies
Natural antibodies have traditionally been defined as:
"any family o f molecules (probably always protein and, in mammals, probably always globulin)
which are present in the body fluids o f normal animals and which have the capacity to combine
specifically with potential antigens, but not with the immunologically acceptable molecules
normally present in body fluids." (Boy den 1965).

Natural antibodies were once thought to appear in the serum either due to
"unnoticed infections" with microorganisms or appear "spontaneously" with no
apparent antigenic stimulation (Wiener 1951). The definition must now be modified
to include the natural autoantibodies, principally of the IgM isotype, which display
specificity for many self-antigens or autoantigens. Apart from the anti-BrMRBC-type
of antibody, many natural autoantibodies have been demonstrated to occur in normal
animals and they can recognise many native and denatured autoantigens (Karsenti et
al. 1977; Guilbert et al. 1982; Dighiero etal. 1982, 1983,1985,1986,1987a 1987b).
They form the "background" level of immunoglobulin present in normal, healthy
animals but may be found in elevated levels in animals that have the genetic
predisposition to develop "spontaneous" autoimmune diseases, such as the
haemolytic anaemia which occurs in mice of the NZB inbred strain over the age of
nine months (Warner 1973). Natural antibodies can also be elevated in animals with
an increased antigenic load (Benner et al. 1982). Levels of natural antibody of the
IgM isotype tend to decrease as organisms age, with a corresponding increase in the
levels of autoantibodies of the IgG isotype (Kay and Makinodan 1976; Makinodan
and Kay 1980).
Some natural antibodies may display "high idiotypic connectivity" (Freitas et al.
1986; Holmberg et al. 1986) i.e. natural antibodies are capable of recognising the
idiotope of other natural antibodies. With hybridoma collections prepared from the
spleens of newborn mice, Holmberg et al. (1984a, 1984b, 1986) and Dighiero et al.
(1985) have shown that many IgM natural autoantibodies recognise the idiotypes of
other IgM natural autoantibodies. This high idiotypic connectivity is found to be
prevalent in hybridomas prepared from newborn mice, but is not found in collection
of hybridomas prepared from adult mice treated with B-cell mitogens. These highly
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connected natural autoantibodies appear to preferentially use two of the most
D-proximal Vjj-gene families 7183 and QUPC 52 (Holmberg 1987).
A nother feature o f some natural autoantibodies is that they display
cross-reactivity or "multispecificity" with many antigens and autoantigens (Dighiero
et al. 1982; Guilbert et al. 1982; Rubin et al. 1984; Prabhakar et al. 1984;
Underwood et al. 1985; Holmberg et al. 1986). In some of these studies it should
be noted that xenogenic proteins are used so one should be cautious about the
interpretations of cross-reactivity until it is demonstrated with targets prepared from
the same species or that a close relationship can be established between the foreign
and self antigen.
In the bromelain-m odified mouse red blood cell (BrMRBC) model of
autoreactivity, cross-reactivity has been demonstrated between the determinant on
BrMRBC and Sheep RBC (Pages and Bussard 1975), isologous IgG (Fc) (Cunliffe
and Cox 1980), and cross-reactivity between the BrMRBC determinant and
trimethylammonium-containing compounds (Serban et al. 1981; Cox and Hardy
1985) has also been established .
In normal strains of inbred mice which do not spontaneously develop
autoimmune diseases, such as CBA/H, high levels of natural autoantibodies to
erythrocyte antigens revealed by bromelain can be experimentally induced with
anti-lymphocyte serum (Cunningham 1975,1976) and polyclonal B-cell activators or
B-cell mitogens such as the lipopolysaccharides derived from many Gram negative
microorganisms (Cunningham 1974a, 1975). In such mice, a large fraction of the
potential Ig secreting repertoire (2% in spleen, 50-90% in peritoneum, 10% in bone
marrow, 66 % in pleural cells) has been shown to contain natural autoantibodies
specific for bromelain-treated autologous erythrocytes (Steele and Cunningham 1978;
Cunningham and Steele 1981). In a similar fashion, 35%-75% of the potential
repertoire has also been reported to display rheumatoid factor activity (Dresser 1978),
although Venn and Dresser (1987) have since detected an artefact in their haemolytic
plaque assay for detecting rheumatoid factor cells in that contamination of target IgG
by IgM results in the cross linking of target and effector IgM by the anti-IgM
developing agents. Venn and Dresser have not reassessed the percentage of the
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potential repertoire that may be involved in the production of RF, however, Steele
(1979) found that the level of anti-RF in cultured peritoneal cells was 1% when
developing serum was not used.
The parallels between rheumatoid factors and anti-BrMRBC responses are
striking (Table 1.1.). Cunliffe and Cox (1980) have demonstrated a cross-reaction
between BrMRBC and isologous Fc (RF) through inhibition of haemolysis assays
with isologous IgG (Fc) although the functional significance of this cross-reaction
remains to be elucidated. However, there are fundamental differences in the V region
genes employed in the anti-RF and anti-BrMRBC antibody responses (see Section
1.3.6.) suggesting that that the responses are not identical. Shlomchik et al. (1986,
1987a) examined the use of variable light chains used in the IgM anti-IgG response
and showed a highly restricted use of light chain germline genes especially in the
MRL-lprApr strain of mice where the rheumatoid factors appear to be a "monoclonal"
response ( Shlomchik et al. 1987b).

1.1.2. Natural Antibodies and Development
There is increasing evidence for the internal activation of B-cells by
self-antigens as first suggested by Jerne, in the context of idiotypic networks (Jeme
1971,1984; Steele 1979; Steele and Cunnigham 1980; Cunningham and Steele 1981;
Pereira et al. 1986; Portnoi et al. 1986), although a "spontaneous" appearance of
natural autoantibodies due to "preprogrammed genetic expression" during
development (Yancopoulous et al. 1984; Perlmutter et al. 1985) cannot be directly
discounted. Perlmutter (1987) after reviewing preliminary data, is of the view that the
develop mentally ordered expression of antibody V jj genes may be due to the
progressive activation from telomere to centromere of the V jj locus. These authors
however, have subsequently modified this idea of genetic predeterminantion in the
face of evidence that gene segments from all Vj j families are used in ontogney (Alt et
al.. 1987, Malynn et al. 1987). As with other problems in development concerning
ontogeny and phylogeny (Gould 1977), it is often difficult to determine the relative
contributions of genetic potential as opposed to antigenic stimulation from internal
and external environments.
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Table 1.1. The similarities between the anti-BrMRBC antibodies and
Rheumatoid factors
Shlomchik (1986,1987a,1987b) summarised some features o f rheumatoid factors:
1. They are not normally pathogenic (in contrast to IgG anti-IgG)
2. The production is regulated (with a peak in the response at d3 and a gradual subsidence in
l-2w ks.
3. The percentage o f B cells involved is high (3-15% o f LPS-induced hybridomas)
4. There is little evidence o f somatic mutation in IgM anti-IgG,
5. Rheumatoid factors may be induced in normal mice by either LPS or repeated protein (tetanus
toxin) injection but not by target IgG.

For anti-bromelain-treated mouse red blood cell antibodies:
1. N ot normally pathogenic (mainly IgM) (Cunningham 1976)
2. Regulated production (peak response in PFC occurs at days 3-4 after LPS stimulation, with
gradual subsidence by day 15; Cunningham 1975)
3. Percentage of B-cells involved is high (Steele and Cunningham 1978; or number of
anti-BrMRBC peritoneal cell precursors was 1 in every 150-200 peritoneal cells or 1 in 50 for
LPS-stimulated peritoneal cells (Cox et al. 1984)
4. N o reported IgG anti-BrM as a result of class switching in vivo or in vitro (Cunningham
1976) or almost always IgM except for IgG 3 (Bussard et al. 1 9 77). In the CH 12 lymphoma
line some isotype switching as w ell as simultaneous expression o f two isotypes has been
demonstrated to occur for IgA, IgG2b» IgG 3 . (Arnold et al. 1988 )
5. Can elevate anti-BrM levels in mice with LPS, xenogenic erythrocytes but not with injection of
NMRBC or BrMRBC (Cunningham 1974; Lord and Dutton 1975a; Cox et al 1977).
In addition, Heutz and Poncet (1989) have surveyed that anti-BrMRBC antibodies are of a
restricted idiotype

5
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Cunningham and Steele have raised the possibility that autoantigens may be
important educating in the development of immune diversity (Cunningham and Steele
1979; Steele and Cunningham 1979, 1980). With the BrM-antigen, which they also
found to occur at high levels in the gastrointestinal tract (Cunningham and Steele
1981), they describe a relationship between appearance of BrM antigen in the gut and
specific Ig-secreting cells in the spleen. Alternatively, natural autoantibodies may play
a role in the recognition of other types of internal antigens and thus be crucial in the
development of self tolerance (Avrameas 1986,1991).
The different views on how the antibody repertoire arises during development
may be resolved as more information becomes available on different sub-population
of lymphocytes in different immune system compartments. The Ly-1+ lymphocyte
population from which natural antibodies are thought to arise may be of a different
character to "conventional" B lymphocyte populations especially with regard to the
ways in which Ly-1+ and conventional B celf arise (examined in 1.3.4). Separate
pathways of development may operate for natural and acquired immunity and may
depend upon the microenvironment that the B cell finds itself in (Rajewsky et al.
1987; Kocks and Rajewsky 1989).
1.1.3. Natural Autoantibodies and Autoimmunity
Natural antibodies have been demonstrated to occur in normal animals and to
recognize autoantigens without rampant autoimmunity being evident. So what
distinguishes natural autoantibodies from pathological autoantibodies that occur in
autoimmune diseases ? There is a great diversity in the types of diseases classified as
autoimmune diseases, ranging from highly organ-specific thyroid disorders, such as
Hasimoto's thyroiditis and thyrotoxicosis, to the non-organ speci^c disorders such as
rheumatoid arthritis and systemic lupus erythematosus (reviewed in Roitt 1987;
Theofilopoulos 1987). It has been proposed that there is multifactorial etiology for
many autoimmune diseases (Table 1.2.) so it is feasible that natural antibodies may
exist in normal animals, but the role that these natural antibodies may play in health
and disease is not exactly clearcut (Smith and Steinberg 1983).
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The

m u ltip licity

of

factors

in volved

in

autoim m une

disorders

Genetic
Individual genes predispose to particular abnormalities
Diseases can be polygenic
Environmental Factors
Stimulate the immune system
Interfere with normal immune regulation
Hormonal Factors (modify disease manifestations)
Abnormal immune regulation
Disease results from quantitative abnormalities (e.g. amount of stem cell proliferation, amount of
autoantibody, quantity of immune complexes.)

Modified from Smith and Steinberg (1983)

In human studies, specific anti-tubulin, thyroglobulin, actin, myoglobin and
fetuin antibodies were found in a serum pool of 800 normal blood donors (Avrameas
et al. 1983). Patients with multiple sclerosis had higher levels of natural IgG against
myelin basic protein than normal controls or patients with other neurological diseases,
whereas all patients and normal controls reacted to a panel of antigens including actin,
myosin, tubulin, albumin, transferrin, peroxidase, thyroglobulin, DNA, prolactin,
TNP and myelin basic protein (Matsiota et al. 1988). Anti-sperm natural antibodies
have been demonstrated to occur in males and females aged 1 day to 40 years, but are
significantly absent in patients with AIDS or AIDS-related complex (Rodman et al.
1985,1986), although others have reported an overall increase in the levels of IgG,
IgM and IgA in patients with AIDS or AIDS-related complex (Matsiota et a l 1987).
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1.1.4. A utoantigens
Autoantigens may be defined and identified by reference to a corresponding
autoantibody, however, there seems to be an enormous range and diversity of
substances that could be defined as autoantigens (see Table 1.3). The table is not
comprehensive but aims to show the diversity of organs targeted or specific
molecules that have recently been identified in rodent and human studies. The
diversity of autoantigens raises many questions on what determines the antigenicity of
autoantigens, the role of autoantigens in the pathogenesis and etiology of autoimmune
disorders when compared to normal animals, and how do autoantigens, especially
ones that could be considered "internal" and normally sequestered from the immune
system by virtue of the cell membrane, become presented to the immune system ?
Autoantibodies can recognise many soluble autoantigens and cell-surface
antigens which are readily accessible to the immune system (reviewed in Smith and
Steinberg 1983), but they have also been found to recognise intracellular autoantigens
and antigens "buried" in cell membranes. In a comprehensive study of autoimmunity
in a human community, autoantibodies were found in 20% of the community (3492
subjects tested) directed against rheumatoid factor (RF), smooth muscle antibody,
nuclei, gastric parietal cells and thyroid epithelial cells in normal as well as humans
with autoimmune disorders (Hooper et al. 1972). In the

murine model of

autoreactivity towards bromelain-modified mouse erythrocytes (see Sections 1.3 and
1.4), a large proportion of natural autoantibodies have been found to be specific for
the "buried"

BrM autoantigen present on mouse erythrocytes and in the

gastrointestinal tract (Cunningham and Steele 1981). Currently there is strong
evidence that trim ethyl amm onium com pounds and more specifically
phosphatidylcholine is involved in the BrMRBC epitope (Serban et al. 1981; Pages et
al. 1982; Cox and Hardy 1985; Mercolino et al. 1986, 1988, 1989; Kawaguchi
1987b; Serban and Witz 1988) however, anti-BrM antibodies appear to recognise a
diverse range of other erythrocytes and antigens isolated from the stomach (examined
in detail in Section 1.4).
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by autoantibodies.

1. Rodent Studies (anti-BrM type)
Sheep RBC in carboxy-methyl-cellulose
Bussard 1966
Sheep RBC
Pages and Bussard 1975, Bussard et al 1977
Sheep RBC & anti HB antigen
DeHeer, Pages and Bussard, 1980
Human RBC, Rat RBC, Rabbit RBC
Pages and Arnaud 1980
Pigeon RBC
Pages and Arnaud 1980, Poncet et al. 1985
Mouse IgG(Fc)
Cunliffe and Cox 1980
Phosphoserine
Poncet étal. 1985
Trimethylammonium compounds
Serban et al 1981, Pages et al. 1982, Serban and Witz 1988
Low density lipoproteins, X and HB antigens
Linder and Edgington 1972,1973a,1973b
Low density lipoproteins (human and rat
Kawaguchi 1987b
but not chicken or mouse)
Phosphatidylcholine
Cox and Hardy 1985, Mercolino et al. 1986,1988,1989
Cholesterol particles coated with
Kaushik et al. 1986 (comment only, no data)
phosphatidylcholine
Thrombin treated platelets
Kawaguchi 1989
2. O ther R odent Studies
Ovarian glycolipids
Arend and Nijssen 1977
H-2 antigens
Cerny-Provaznik et al. 1985, 1986, Ivanyi et al. 1978
Thymocytes
Martin&Martin 1975, Sandberg&Steinvinkel 1988
De Maeyer-Guignard and De Maeyer 1986
Murine interferon-a & interferon-^
Dighiero et al. 1982,1983,19851986
Actin, tubulin,myosin,TNP-BSA
DNA (ds and ss)
Swartz, Jr et al. 1988
Cholesterol
Jacob et al 1986 Muso and Jacob 1987
DNA,cell surface proteins
from Raji cells (14,16,17,33 and 34kD)
Laing et al. 1987, 1988
Glycophorin
3. H um an studies
Steffanson et al. 1985
Neural tissue
Daar and Fabre 1981
Liver, heart and brain
Lutz and Wipf 1982; Lutz et al. 1984
RBC Integral membrane proteins
Winchester et al. 1975
Buried antigens on
lymphocytes and erythrocytes
Avrameas et.al. 1983; Dighiero et al.
Tubulin, actin, myoglobulin,
1982,1983; Guilbert et al. 1982
fetuin, transferrin, albumin,
cytochrome c and collagen
Tongio et al. 1985
HLA antigens
Wilson
et al. 1970.
Pepsin-digested IgA
Jackson
et al. 1987
Fab of IgA
Dighiero et al. 1987
Mitochondria
Caruso et al. 1988
Interferon IFN-y
Alvarez et al. 1987
Myosin
Rosenberg and Rogentine,Jr. 1972
Neuraminidase-treated lymphocytes
Alving et al. 1989
Cholesterol
Bucala
et al. 1987
Oestrogen
Logtenberg
et al. 1987
Calf thymus and cardiolipin, human
toxin
thyroglobulin, human IgG and tetanus
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ORIGIN

AN D

SIGNIFICANCE

OF

NATURAL

AUTOANTIBODIES IN THE CONTEXT OF SELF-NONSELF
D ISC RIM INA TIO N.
1.2.1. Theories of self tolerance and self recognition.
How does the immune system deal with the potentially endless array of
autoantigens and foreign antigens and still act in a non-aggresive way to the
constituents of the body? How do the various theories of self tolerance deal with the
existence of natural antibodies directed towards self antigens ? In this section, the aim
is to examine the main theories proposed on how the immune system copes with the
problem of self-recognition and tolerance in light of the fact that natural antibodies
exist and recognise autoantigens (see Table 1.4.).
One basic requirement of self-recognition that is often overlooked is that
self-antigen must be continually present, i.e. self-tolerance appears to be a learned or
acquired response. This has been demonstrated by Owen (1945) with acquired
tolerance to red blood cells in dizygotic cattle twins, by Triplett (1962) with Hyla
regilla pituitary transplants and more recently McCullagh (1989) has demonstrated
that self thyroid tissue needs to be present continuously for self tolerance to be
maintained in lambs. Triplett's work has been extended by Rollins-Smith and Cohen
(1982) in experiments where they show that allogeneic pituitary, but not self pituitary
is rejected in Rana pipens, suggesting that perhaps self may be accepted at some later
stage of development.There are many differences between these two amphibian
studies which require further investigation to determine the exact role of different
types of self antigens, and to determine if similar mechanisms operate in all animals.
In the clonal selection theory, Burnet provided a framework in which to view
the capacity of the immune system to respond to a wide range of foreign antigens and
yet not usually mount immune responses to tissues of the body. He proposed that
antigen interacted with unique "receptors" on a single cell, and stimulated a cell to
under go proliferation to produce descendants that preferentially produce one type of
receptor specific to the antigenic determinants (Bumet 1959; reviewed by Ada and
Nossal 1987; Steele 1991). The concept of clonal selection has remained intact,
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although it is now generally accepted that V-region diversification is completed after
rather than before antigenic stimulation (Cunningham 1974b, 1977; Rajewsky etal.
1987). Natural antibodies (e.g. red cell isoagglutinins such as anti-A , anti-B and the
T-agglutinin) were thought by Burnet (1959), to be an "accidental and irrelevant
circumstance" arising due to the purging of the appropriate clones by contact with
antigen in the neonate. Later, it became obvious that many diseases could be viewed
as an attack of the immune system on normal body constituents, and self reactive
clones could exist. While Burnet's basic precepts on clonal selection have stood the
test of time, his ideas of deletion of self reactive clones (1959) required modification
to account for autoimmune disorders. Burnet later viewed autoimmunity as a result of
the persistance of forbidden B-cell clones that had somehow escaped the purge of
forbidden clones early in an animals' life, or arising as a result of failure of immune
surveillance to deal with autoreactive clones that arise by somatic mutation (1961,
1972).
Following along the same lines, clonal abortion and clonal anergy (reviewed by
Nossal 1983) have been considered as mechanisms whereby tolerance is achieved by
downregulation or killing of antigen-reactive clones, however, like the idea of
forbidden self-reactive clones these methods of tolerance do not account for the
existence of any self-reactive clones that may produce natural autoantibodies. Clonal
deletion and anergy as models of tolerance are useful where large and frequent
injections of foreign antigens are involved, but are not easily applicable to concepts of
tolerance to self-antigens in normal animals. Evidence to support clonal anergy and
clonal deletion has arisen from studies with transgenic animals. Goodnow et al.
(1988, 1989,1990) have demonstrated in double-transgenic mice that "self-reactive"
B-cells specific for a new self-antigen, hen egg lysozyme, are present but incapable
of producing antibody suggesting some type of clonal anergy in operation. In another
study, Nemazee and Burki (1989) have demonstrated clonal deletion of anti-MHC
antibodies in transgenic mice.
In contrast to the theories of clonal anergy or deletion, the idea of effector cell
blockade (Nossal and Schrader 1975), where the presence of self antigen can block
membrane receptors for antigen, does not deny that self-reactive clones exist and may
help explain some aspects of the regulation of the natural autoantibody response
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against BrM RB C. The production of large number*of anti-BrMRBC peritoneal cells
in BrMRBC-free culture can be subsequently inhibited by the presence of BrMRBC
in culture (Lord and Dutton 1975). As part of the process of effector cell blockade,
natural autoantibodies may also act as blocking factors against cytotoxic lymphocytes
in the serum (Hellstrôm and Hellstrom 1972).
Other mechanisms of tolerance such as suppression or idiotype-anti-idiotype
regulation (Jeme 1984) may also have a role in the maintainence of self tolerance and
the regulation of the anti-BrMRBC response in mice. Suppression as originally
demonstrated by McCullagh (1970) and Gershon and Kondo (1971) may be an
effective means whereby self tolerance is normally maintained. Cunningham (1975,
1976) saw the regulation of self-reactive lymphoid cells specific for BrMRBC as a
balance of continual antigenic stimulation by self antigens held in check by continual
suppression. In normal CBA mice there was a 20-fold increase in anti-BrMRBC
plaque forming cells in mice that received anti-lymphocyte serum, a treatment that
specifically removes suppressor cells (Cunningham 1975). Thus, there is evidence
that this potential "anti-self" response against a hidden epitope on autologous
erythrocytes may be held in check by two different mechanisms of self-tolerance
involving antigen blockade and suppression. Given the importance of recognising
self antigens and maintaining self tolerance in different lymphoid compartments,
where T-cells are clonal deleted in the thymus and B-cells appear to be functionally
silenced (Basten 1989), it is highly likely that different mechanisms can operate
concurrently.
In general natural autoantibodies and the B lymphocytes from which they arise
do not fit neatly into theories of self tolerance involving deletion or anergy, but are
not seen as a challenge to these theories because "natural autoantibodies apparently
pose no threat to the host, presumably as a result of their low affinity and because
their polyspecific nature may ensure that they do not bind and concentrate
preferentially on any particular self-antigen target" (Goodnow 1989).
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Table 1.4. Theories of self tolerance and self recognition
Clonal Deletion

Burnet (1959)

Clonal Abortion

Burnet (1972) Nossal (1983)

Clonal Anergy

Nossal (1983)

Suppression

McCullagh (1970)
Gershon and Kondo (1971)

Effector cell blockade

Nossal and Schrader (1975)

Blocking factors

HeUstrom&Hellstrom (1972)

Antigen Blockade

Lord and Dutton (1975)

Network Interactions

Jeme (1971,1974,1984)

General references Theofilopoulos (1987) Roitt (1984)
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One model of self-recognition as postulated by Jerne (1971, 1974, 1984)
supports the presence of "autoantibodies" and contends that regulation of the immune
system is achieved via an idiotypic network.In this scheme, the V region of an
immunoglobulin or idiotype are immunogenic and may elicit other antibodies
(anti-idiotypes). The anti-idiotype may in turn elicit another anti-idiotype and so on to
form an idiotypic network. Evidence to support the importance of idiotypic networks
in autoimmunity is increasing (Male 1986; Coutinho 1980; Kearney and Vakil 1986;
Varela and Coutinho 1989; Pereira et al. 1986.). In one study of the role of idiotypic
interactions amongst natural autoantibodies, Kearney and Vakil (1986) showed that
idiotype-directed interactions during ontogeny play a major role in the establishment
of the adult B cell repertoire. Suppression and or the manipulation of idiotypic
networks may be achieved through injection of anti-idiotypic antibodies into neonate
or via the m aternal route. In agreement with Holmberg (1985) they found
cross-reactivity amongst their panel of neonatal liver and spleen monoclonal
antibodies. They state that anti- idiotype activity occurs mainly with lambda light
chains, and provide evidence for the regulation and appearance of certain families in
ontogeny. Idiotypic interactions between neonatal B cells appear to have a profound
effect on the adult B cell repertoire.
In another study (Lundkvist et al. 1989) injected as little as 10 ng of IgM natural
autoantibodies and showed chaotic perturbatuion of network interactions with each
individual mouse appeared to have its own characteristic pattern. If anti-idiotypic
antibodies are administered to newborn and pregnant mice, it has been found that the
effect is negligible; in normal BALB/c mice, but that there is evidence for idiotypic
suppression in autoimmune MRL-lpr/lpr mice and

specific decreases in anti-DNA

antibodies (Mahana et al. 1987). Neonatal animals appear to have the capacity to
respond to self antigens which they cannot make responses to later in development.
Neonatal mice can respond to syngeneic and xenogeneic actin and have higher
antibody titres than adult mice of the same strain, but the results cannot be extended to
other proteins such as myosin or albumin (Mahana et al. 1989). In a similar vein, if
neonatal mice are injected with either of two different IgMK polyspecific natural
autoantibodies the effect is that the adult mouse can produce altered amounts of IgG
specific for myosin (increased) andTNP (decreased) (Mahana et al. 1988).
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There is a considerable amount of activity that occurs in the functioning immune
systems of normal, and germ-free unmanipulated animals. In studies that examine the
recruitment of cells into B-cell pools of the mouse (Osmond 1984) and the sheep
(Reynolds 1987), it has been suggested that a percentage of these cells are recruited
by internal stimulation. Similarly, in germ-free mice fed on antigen-free diets, normal
levels of IgM may be maintained, although levels of IgG and IgA are decreased,
suggesting that the immune system may operate despite the lack of external
stimulation (Benner 1982). It has been demonstrated that antigenic challenge is
required for the development of the peripheral lymphoid tissue since lymph nodes
were not found to be present in antigen-free animals, however, there is considerable
internal activation in spite of this e.g. normal levels of activated and effector B cells,
and helper or suppressor T cells (Pereira et al. 1986).

1.2.2. Origins and Significance of Natural Autoantibodies.
It is difficult to discern how natural autoantibodies arise and what their exact
functional role is in the immune system. Amongst the complexities are: a) that they
are directed towards self-components; b) are found in normal as well as disease states
and; c) apparently are of little consequence to the maintainence of self tolerance
because of the low affinity for self antigens. Do these natural autoantibodies arise as a
result of some kind of polyclonal activation or as a result of antigen induction or by
some other process? Are they germ-line encoded or can they arise from somatic
mutation? If little is certain about how they may arise, their function is less clear.
Some of the proposed functions of natural autoantibodies have ranged from transport
molecules to the precursors of pathogenic autoantibodies (Boyden 1965; Grabar
1975, 1983).
Currently, there is evidence to support two main mechanisms for the appearance
of autoantibodies, polyclonal activation and antigen induction (Table 1.5), but these
mechanisms do not fully explain why autoantibodies should occur in normal animals
unless they were germline encoded and served a vital physiological function such as
increasing the clearance rate of antibody-antigen complexes by signalling to the
reticuloendothelial system.
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TA BLE 1.5. Com parison o f polyclonal activiation and antigen induction.

POLYCLONAL ACTIVATION

ANTIGEN INDUCTION

1. B cell hyperresponsiveness

1. Increase in specific autoantibodies

2. Poor response to further mitogenic
stimulation (activation of autoreactive clones)

compared to the rest of the serum
2. Recognition of specific epitopes

3. Normal animals mimic autoimmune

3. Some evidence of somatic mutation

states upon exposure to mitogens

implies antigen driven selection

4. B cell abnormalities
5. Germline encoded no real need for
further somatic hypermutation
or antigen driven selection
(identical in autoimmune and normal animals)
6. Polyclonal activation causes an
increased percentage of autoantibodies.

Table modified from points raised by Dziarski (1988)

Currently, there is much debate on the role of somatic mutation of germline
antibody sequences in autoimmunity. Autoantibodies are not thought to be derived
from genes committed exclusively to autoantibody production as some pathological
autoantibodies appear to use the same types of V-regions used in responses to
exogenous antigens (Davidson et al. 1987; Kofler et al. 1987) . Diamond and
collegues (Diamond and Scharff 1984; Davidson et al. 1986,1987) have
demonstrated that somatic mutation of germline sequences may result in the types of
pathological autoantibodies seen in autoimmune diseases i.e. the conversion of an
anti-bacterial antibody to an anti-DNA antibody. On the contrary, it has been shown
that germline encoded autoantibodies may ^mutate"upon antigenic stimulation to
recognise foreign antigens (Naparstek 1986). Carroll et al. (1985) have demonstrated
that bacterial phospholipid and whole bacteria (Streptococcus faecalis, Bacillus
cereuSy Staphylococcus aureus, and Escherichia c o li) were bound by autoantibodies
derived from MRL-lpr/lpr mice. It had previously been demonstrated that a narrow
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range of determinants, including cardiolipin, phosphatidic acid and double-stranded
DNA, were recognised by unimmunised mice that develop systemic lupus
erythematosus (Lafer et a l 1981). Phosphatidylserine, phosphatidylcholine and
phosphatidylethanolamine failed to inhibit these autoantibodies and it was concluded
that the common antigenic structure in the inhibitory molecules was the presence of
phosphodiester linkages separated by three carbons. Schwartz (1986) is of the view
that natural autoantibodies may serve no purpose and arise as the incidental
by-products of the mechanism responsible for the generation of antibody diversity.
Dighiero et a l . (1987a) have reviewed data on anti-BrMRBC responses in mice and
because these antibodies appear quite early in ontogeny and in germ-free mice, there
is evidence for a germline origin for anti-BrMRBC responses. Somatic mutation of
anti-BrMRBC antibodies has not been generally demonstrated to occur, although
IgG 3 has been demonstrated by one group (Bussard et al. 1977). In the CH 12
lymphoma line that recognises BrMRBC, variants expressing IgA, IgG2^ and IgG3
in addition to IgM, have been detected implying that some class switching and
maturation of the response may occur (Arnold et al. 1988). In general though,
anti-BrMRBC antibodies appear to be germline encoded (Reininger et al. 1987,1988;
Pennell et al. 1989; Poncet et al. 1989).
The functional significance of natural autoantibodies remains to be conclusively
demonstrated, although the patterns of cross-reactivity displayed by natural
autoantibodies suggest that they may play important roles in the functioning of the
immune system. It has been proposed that natural autoantibodies may function as
carriers of metabolites or may function as opsonins in promoting phagocytosis of
damaged cells (Boyden 1965; Grabar 1975,1983). Natural autoantibodies to
erythrocyte antigens may also be essential for the removal of effete red blood cells
from circulation (Cox , Baddams and Evans 1977), although this has been difficult to
demonstrate mainly due to the low percentage of aged red blood cells in circulation
(Cox and Cunliffe 1979).
It is known that red blood cells only have a limited lifespan (mouse 40-45 days;
Cox and Cunliffe 1979), but what is not known is the exact mechanism whereby
these cells are removed. Kay (1980) has shown that erythrophagocytosis of senescent
RBC by mononuclear phagocytes of the liver and spleen remove* IgG-coated
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autologous RBC rather than some sort of osmotic lysis of old RBC. Most
phagocytosis takes place in 1-2 hours after IgG attachment to RBC. The IgG that
recognises RBC can recognise either autologous or allogeneic RBC suggesting that
the antigenic site may be similar or identical for different individuals. The antigenic
site may have been blocked by steric hindrance of neighbouring molecules, or
alteration of "shielding" molecules with age (i.e. loss of subunits or loss of
membrane fluidity allowing molecular drift) resulting in the exposure of different
sugar, amino acids or a conformational change in structure.

1.3

NATURE

OF B-LYM PH O CYTES AND ANTIBODIES THAT

RECOGNISE BROMELAIN-TREATED MOUSE RED BLOOD CELLS.
In this section, different types of anti-BrMRBC B-cells and different ways of
raising anti-BrM antibodies will be reviewed as there appears to be subtle but
important differences between different populations of anti-mouse erythrocyte
antibodies raised by different methods from normal and autoimmune strains of mice.

1.3.1. The Peritoneal Cell Phenomenon
Bussard (1966) demonstrated the de novo synthesis of anti-sheep red blood
cell antibodies during the culture of peritoneal cells from non-immune mice in
carboxymethyl-cellulose gum. Peritoneal cells (5 x 10^ cells) isolated from 8 week
old CBA mice were cultured in 2.5.% carboxymethylcellulose containing 5 x 10^
sheep erythrocytes per ml and (10% fresh guinea pig semm) for three days at 37°C.
Haemolytic antibodies were thought to arise de novo by antigenic stimulation. These
antibody secreting cells were shown to be lymphocytes ( not macrophages) and to
also be present in cells isolated from the pleural cavity (Bendinelli and Wedderbum
1967). It was established that the peritoneal cell phenomenon could be demonstrated
in germ-free mice and that enhancement of the response could be demonstrated in
mice that had been pregnant (Nossal et al. 1970). Further, cell division was not
involved in the response (Nossal et al. 1970) and the phenomenon appeared to be
restricted principally to peritoneal cells (Bussard et al. 1970). This lack of cell
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division was later confirmed by Lord and Dutton (1975a) with a dramatic increase in
PFC between 2-4 days in culture, so that the high numbers of cells engaged in the
response do not arise due to enormous proliferation of a few autoreactive B-cells.
The in vitro phenomenon could also be induced in vivo . Thus Bussard and
colleagues (Bussard et al. 1970; Nossal et al. 1970; Boris et al 1970) found that
injections of sheep red blood cell could induce specific anti-SRBC lymphocytes but
that injection of an extract of mouse food had no effect on the plaque formation of
spleen cells against SRBC. These studies raised questions such as : What is the
nature of the cross-reacting antigen which primes peritoneal cells against SRBC?
What features of pregnancy cause the heightening of the phenomenon? Lord and
Dutton (1975a) showed that the anti-SRBC response displays distinctly different
kinetics to BrMRBC thus although the cross reactions between BrMRBC and Sheep
RBC are similar, they are not thought to be identical. In a similar fashion, although
injection of Rat RBC may elicit anti-BrMRBC the anti-Rat RBC response is not
identical to anti-BrMRBC responses (section 1.3.3).
Heutz and Poncet (1989) have characterised the cellular populations present in
the peritoneal cavity by FACS analysis and found that of the 3-7 x 10^ peritoneal
cells recovered from an adult B ALB/c mouse, 25-30% were myeloid cells and
65-70% were lymphoid cells. Of the lymphoid cells; 30-40% were Ly-1 B cells,
45-50% were conventional B-cells and 5-15% were T cells. In the Lord and Dutton
(1975a) study, they had difficulty in typing the cells responsible for plaques and
ended up classifying them as large mononuclear cells. Cunningham (1976) also
commented on these cells and classified them as basophillic mononuclear cells.
It was thought that these natural antibodies specific for sheep red blood cells
may appear in the peritoneum of mice due to some mechanical irritation of the
peritoneum or antigenic stimulation with foetal and placental antigens or due to an
unidentified cross-reacting-environmental antigen (Boris et al. 1970; Bussard et al.
1970; Nossal et al. 1970). These natural autoantibodies derived from peritoneal cells
were later shown to recognise antigens revealed on mouse erythrocytes that had been
pretreated with proteolytic enzymes (Section 1.4). The peritoneal cell phenomenon,
therefore, appeared to represent a “spontaneous lifting of the natural tolerance
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towards self-antigens" (Bussard and Pages 1976).
In studies on the formation of antibodies produced by peritoneal cells and
peritoneal cell hybridomas specific for sheep RBC and bromelain-treated mouse
erythrocytes, a high number of peritoneal cells (up to 10% of PFC both anti-SRBC
and anti-BrMRBCj with still higher numbers detected in NZB mice or retired breeder
CB A) produced IgM and IgG 3 antibodies that recognised a cross-reactive determinant
on BrMRBC and SRBC (Bussard et al. 1977; Pages and Bussard 1978). BrMRBC
ghosts could inhibit peritoneal cells in these assays suggesting that a specific epitope
was present on the red blood cell membrane.
In the Steele and Cunningham (1978) study, the level of BrM plaque forming
cells in the peritoneal cell population of CB A/H mice (pooled results from a number
of studies with 1.5-5 month old male and female mice) in the absence of LPS was
found to be approximately 15% of Ig-secreting cells, however, the potential
anti-BrMRBC repertoire in the peritoneal cavity as revealed by LPS was found to
increase to between 40% (6 week old female) and 95% (retired breeder female).
Using the data from this study, if the numbers of anti-BrMRBC are reexpressed as
numbers of anti-BrM per total PFC

and numbers of anti-BrMRBC PFC per

Ig-secreting cells (Table 1.6.) an estimate of the "precursor frequency" may be
derived. The numbers of peritoneal cells secreting BrMRBC antibodies from the pool
of male and female mice aged from 1.5-5 months is found to be 1 in 23809 (of total
PFC) or 1 in 6 (of Ig-secreting PFC) for unstimulated peritoneal cells. Similarly, the
numbers are found to be : 1 in 166 (of total PFC) or 1 in 3 (of Ig secreting PFC) for
LPS-stimulated cells in 6 week old mice a n d ; 1 in 26 cells (of total PFC) and almost
all of the Ig secreting cells for retired breeder females. Similar "precursor
frequencies" may be obtained from the Cunningham and Steele (1981) study for cells
before and after culture in LPS derived from 6-7 week old male mice.
Cox et al. (1984) have estimated the numbers of autoantibody precursors from
untreated C3H mice by limiting dilution analysis because one criticism of the Steele
and Cunningham (1978) data would be that spurious results may arise from relatively
high cell densities of lofywell. In the Cox (1984) study, they could detect one
autoantibody precursor for every 150-200 peritoneal cells cultured, and this could be
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increased to 1 in 50 in the presence of LPS or dextran sulphate. Thus, in the Steele
and Cunningham study (1978) there may be an underestimation of the numbers of
anti-BrMRBC secreting peritoneal cells in unstimulated mice due to the culture
conditons, whereas the level of antibody precursors after LPS stimulation would
appear to be in agreement
These limiting dilution analysis studies have been extended (Enington and Cox
1986) to show that peritoneal cells cultured from mice less than 3 weeks old had few
or no precursors but that adult levels were attained by 6 weeks of age. There was
however a difference detected between males and females with females having a
slightly elevated capacity for autoantibody producing precursors. This study hints that
other cell populations (non-B, nonadherent) may be required for the anti-BrMRBC
response. It has also been shown that cytokines may augment the levels of
autoantibody precursors although it was found that B-cell growth factor may not be
required since cell division was minimal (Cox et al. 1984). Autoantibody precursors
may also be increased by irradiation, presumably because radiosensitive suppressor
T cells are removed (Errington and Cox 1987). Accessory cells such as macrophages
and cytokines may be essential for autoantibody production by peritoneal cells in vivo
as they have been shown to be important in in vitro assays (Cox et al. 1984; Daenke
and Cox 1986; Kawaguchi 1986).
In a study on the number of splenic precursors specific for either BrMRBC or
sheep RBC in normal mice (Portnoi et al. 1986), it was found that most of the
autoreactive clonal precursor B cells are more frequently found in large rather than
small spleen cells, with the absolute frequencies of anti-BrMRBC for large and small
cells stated as 1 in 150 and 1 in 1400 respectively as compared to the anti-sheep
response of 1 in 33 (Large) and 1 in 230 (Small). For LPS stimulated mice, the anti
BRMRBC response was 1 in 10 (Large) and 1 in 18 (Small) and the anti-SRBC
response 1 in 30 (Large) and 1 in 15 (Small). In the Steele and Cunningham study
(1978), it may be seen that the splenic levels are 1 in 11494 (anti-BrMRBC PFC per
total cultured cells) or 1 in 66 (anti-BrM PFC per Ig-secreting cell) for unstimulated
spleen cells or between 1 in 2000 (anti-BrMRBC PFC per total cultured cells) or 1 in
130 (anti-BrM PFC per Ig-secreting cell) in 6 week old mice to 1 in 490
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Table 1.6. Re-evaluation of the levels of BrM plaque forming cells and determination of precusor frequencies
from data presented by Steele and Cunningham (1978) and Cunningham and Steele (1981).
1. U nstim ulated Mice - Pooled d ata from 1.5-5 m onths old male & female CBA/H
Data from T^ble 1 (Steele and Cunningham 1978)
PFC per 10° cells
Reexpressed data to determine"precursor frequency".
Ig
BrM
%BrM
BrM/PFC
BrM/Ig
Peritoneal cells
Spleen cells

250
5700

42
87

15
1.6

42/10° = 1 in 23810
87/106 = 1 in 11494

42/250 = 1 in 6
87/5700 = 1 in 65

2. Cells cultured in presence of 10|ig LPS from female CBA mice of different ages
Data from Table 2 (Steele and Cunningham 1978)
PFC per 10° <:ells
Reexpressed data
Ig
BrM
%BrM
BrM/PFC
BrM/Ig
a) 6 week old
Peritoneal cells
15000 6000
Spleen cells
65000 500
b) 1lweek old
Peritoneal cells
21000 15900
Spleen cells
36900 580
c) 14 week old
Peritoneal cells
28200 24400
Pleural cells
25600 1600
d) Retired breeder female
Peritoneal cells
39140 37060
Spleen cells
105600 2040

40
0.8

6000/106 = 1 in 166
500/106 = 1 in 2000

6000/15000 = 1 in 2.5
500/65000 = 1 in 130

75.4
1.6

15900/106 = 1 in 63
580/106 = 1 in 1724

15900/21000 = 1 in 1.3
580/36900 = 1 in 63.6

86.5
66.4

24400/106 = 1 in 41
1600/106 = 1 in 625

24400/28200 = 1 in 1.2
1600/25600 = 1 in 16

94.7
1.9

37060/106 = 1 in 27
2040/106 = 1 in 490

37060/39140 = 1 in 1
2040/105600 = 1 in 52

3. Cells before and after culture in presence of 50p.g LPS from 6-7 week old CBA mice
Data from Table 1 (Cunningham and Steele 1981)
PFC per organ
Reexpressed data
Ig
BrM
BrM/Ig
a)Day 0 results
Peritoneal cells
uncultured
cultured
Spleen cells
b) Day 3 culture
Peritoneal cells
uncultured
cultured
Spleen cells

70
20000
220000

120
19000
2900

1 in 1
1 in 1
l i n 75

2500
9200
1100000

1800
2900
17400

1 in 1.3
1 in 3
1 in 63
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(anti-BrMRBC PFC per total cultured cells) or 1 in 52 (anti-BrM PFC per
Ig-secreting cell) in retired breeder females in cultures containing LPS. Different mice
also have different capabilities to respond to BrMRBC, with high responders
{CBA/J, NZB, Biozzi (H), C3H, BXSB and C57BL/6} and low responders
{BALB/c, DBA 2 , SJL/J, CBA/N and Biozzi (L) mice} (Kaushik et al. 1986). The
major point of these studies on the levels of anti-BrMRBC lymphocytes found in
different immune compartments of mice of different ages and sex is that a large
proportion of the immune system appears to be capable of responding to BrMRBC.

1.3.2. Lipopolysaccharide Stim ulated Serum.
The actions of lipopolysaccharide isolated from the cell wall of many strains of
bacteria on the immune system are numerous. In a recent review (Jacobs 1982), LPS
acts as a T-independent antigen, B-cell mitogen and polyclonal B-cell activator and
immunological adjuvant. The Lipid A portion of LPS is thought to account for most
of its biological action. In normal mice, Cunningham (1974a) found that the spleen
contained large numbers of plaque forming cells specific for components revealed on
autologous erythrocytes that had been treated with bromelain. The level of plaques
was elevated two to three days after injections with 50 jig lipopolysaccharide from
Escherichia coli, whereas injections of the following did not increase PFC; injection
of allogeneic red blood cells or spleen cells, injection of isologous erythrocytes in
CFA, or a single injection of 10^ rat RBC (Cunningham 1974a) or injections of
bromelain-treated mouse erythrocytes (Cunningham 1975). Levels of anti-BrMRBC
were increased two to four days after injection o f anti-lymphocyte serum
(Cunningham 1975), thus it would appear that self tolerance may be a balance
between continual antigenic stimulation and suppression because anti-lymphocyte
serum was thought to remove suppressor cells. Further, Cunningham (1976)
established that similar levels of anti-BrMRBC autoantibodies could be found in germ
free mice, "specific pathogen free mice" and conventionally reared inbred mice.
Peritoneal cells from unimmunized mice where shown to produce in vitro,
antibodies that recognised both sheep red blood cells and bromelain-modified mouse
erythrocytes (Pages and Bussard 1975; Bussard and Pages 1976: Bussard, Vinit and

CHAPTER ONE

24

Pages 1977), thus providing a link between the peritoneal cell phenomenon and the
BrMRBC model of autoreactivity as demonstrated by Cunningham in the spleen. It
appeared that some form of derepression occurred during in vitro culture of B-cells
from non-im m unized m ice (Pages and B ussard

1975), thus releasing

autoantibody-producing lymphocytes that were normally suppressed in vivo.
There have been a number of studies with LPS-stimulated cells that demonstrate
a capacity of the immune system to react with autologous cells and proteins.
Hammerstrom et al. (1976) used LPS to induce autoantibodies from cultured bovine
spleen cells that could recognize untreated autologous red blood cells and Primi et a l
(1977) also demonstrated that LPS-activated mouse B cells are capable of specifically
recognising autologous spleen cells and autologous serum proteins. Ragimbeau and
■ fTrOtvx

Avram eas (1987) found natural autoantibodyAhybridomas prepared from
LPS-stimulated mice specifically bound to DNA, TNP and cytoskeletal proteins (actin
and tubulin). Single B cells producing these natural autoantibodies are polyspecific in
that they react with more than a single autoantigen (20% of TNP reactive clones also
react with actin, 14% with tubulin and 12% react with both actin and tubulin).

The age and sex of mice (Meredith, Kristie and Walford 1979; Errington and
Cox 1986) also appears to have a significant influence on the levels of natural
autoantibodies to erythrocyte antigens. Meredith and collegues (Meredith et al. 1979)
have shown that 24 month old mice have 3-4 times the number of LPS plaque
forming cells to autologous erythrocytes than 6 month old mice, but that the level of
autoreactive cells in young mice approach* that of the old mice with the use of low
doses of cyclophosphamide to selectively deplete suppressor cells.

1.3.3. Anti-rat Red Blood Cell Serum
Playfair and Marshall-Clarke (1973) were the first to demonstrate a loss of
tolerance to autologous red blood cells in mice that had recieved repeated injections of
rat RBC. The antigen was required continually (weekly intervals) for the mice to
remain direct Coomb’s positive and anaemic (Cox and Keast 1973) and the type of

CHAPTER ONE

25

anaemia induced was similar to the "warm-type" autoimmune haemolytic anaemia of
humans (Cox and Keast 1974a; Cox and Howies 1981).
In a recent review on human autoimmune haemolytic anaemias (Gibson 1988)
the main targets in warm-type autoimmune haemolytic anaemia are the blood group
antigen systems Rh and hi, but these have not been directly demonstrated as targets in
the mouse. There is, however, evidence for a cross reacting antigen on rat RBC able
to break tolerance in the mouse that required whole rat RBC. The anti-MRBC
response could not be induced with rat erythrocyte ghosts , heart, muscle, teste, brain
or foetal material (Keast and Calegro 1977). Haemolytic anaemia induced by injection
of rat RBC produces an anaemia in normal strains of mice which is self limiting
(Cooke et al 1978).They found suppressive activity in cell transfer experiments in a
population of cells derived from the spleen that had been B-cell depleted. Mice that
have been treated with cyclosporin A do not develop anaemia associated with
injections of Rat RBC and thi s shows unequivocally that T cells are involved in the
response to rat RBC (Cox et al. 1983). Memory B cells as well as suppressor T cells
have also been implicated in the regulation of the anaemia induced in mice to
autologous RBC (Watt et al. 1986)
Different patterns of anti-Rat RBC and anti-Mouse RBC antibodies may be
elicited with different immunisation protocols (Walker et al. 1987). In a protocol
designed to promote T supressor cells (3x weekly injections of Rat RBC, 2 months
rest,then 2x weekly injections of rat RBC) about 87% of the anti-Rat RBC
monoclonal antibodies react with Rat RBC exclusively with 12% cross-reactive for
mouse RBC, but in a protocol designed to promote T helper cells (5x weekly
injections of Rat RBC) 96% of the anti-Rat RBC monoclonal antibodies are
cross-reactive with only about 4% specifically anti-Rat RBC.
Recent studies have demonstrated that sialoglycophorins are recognised by
mouse anti-rat RBC serum and hybridomas on Western blots (Laing et al. 1987,1988)
They show that the major differences between rat and mouse RBC membranes
resides in the sialoglycophorins.They have assumed that the antigen revealed on
mouse and rat RBC is the same and that it is only present on the membrane and have
demonstrated that mouse anti-Rat RBC serum and monoclonal antibodies recognise
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two major rat RBC glycoprotein bands at 81kD and 38kD, with a number of minor
bands at 56kD, 31kD, 29kD and 23kD. These antibodies do not recognise mouse
erythrocyte membranes, but this is not so surprising as the membrane profiles that
they show for mouse and rat ghosts are different (i.e. mouse is missing many of the
molecular weight bands below 45kD; Laing et al. 1987 Figure 6). Four of the six
monoclonal antibodies specific for RRBC failed to react with rat membrane antigens
(Laing et al. 1988) i.e. they may have recognised some component that had been
removed during ghost preparation or alternatively epitopes that had been altered or
destroyed during membrane preparation or western blotting. The other two
monoclonal antibodies had reactivity resembling that of mouse anti rat RBC
described in Laing et al. (1987) against the 38 and 81kD autoantigens. The minor
bands were not characterised, however this group argued that because the two major
bands were glycophorins, the minor bands must also be glycophorins. The reactivity
of mouse anti-rat RBC serum or specific mouse anti-ratRBC hybridomas have not
been assessed against phosphatidylcholine, nor have the V-regions that are used by
these antibodies been characterised, so it is difficult to determine if antibodies used in
the anti-Rat RBC and anti-BrM responses are identical.

1.3.4. L y -1 + B -cells
Ly-1+ B cells are a unique subpopulation of lymphocytes from which natural
autoantibodies are thought to arise. They differ from conventional B cell populations
in the surface markers expressed, the types of antigens recognised, the high levels
expressed in the peritoneal cavity and the pathway of B cell differentiation followed
(reviewed in Herzenberg et al. 1986; Stall et al. 1986; Kocks and Rajewsky 1989;
Hayakawa and Hardy 1988). Hayakawa and colleagues (1983,1984,1985,1986)
have shown that a subpopulation of B-cells delineated by the Ly-1 surface marker is
present at high frequencies in NZB mice and is responsible for the high amounts of
anti-erythrocyte autoantibodies produced. The Ly-1+ B-cell marker, which appears
early in ontogeny, is also present in normal strains of mice and athymic mice
(Hayakawa etal. 1983,1986a, 1986b; Hayakawa and Hardy 1988) but is absent from
the im m unodeficient xid strains of mice (Stall et al. 1986). Ly-1+ B cells are
characterised by FACS as being high IgM, low-intermediate IgD and they
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spontaneously secrete IgM in vitro in the absence of mitogens or antigens (Hayakawa
et al. 1983). Injection of Sheep RBC does not increase the level of Ly-1+ B-cells
(Hayakawa et al. 1983). Of the peritoneal B cell population, Ly-1+ B cells comprise
30-60% whereas the level expressed in the spleen is about 2% (Hayakawa et al.
1985,1986a, 1986b, Hayakawa and Hardy 1988 ). In humans, there is an equivalent
type of B-cell known as Leu-1 or more correctly CD 5 B cells and these too form a
major percentage of the B cells in humans that appear early in ontogeny, especially in
foetal spleen and cord blood (reviewed by Kipps, 1989). Leu-1+ B cells secrete
rheumatoid factor after stimulation with Staphylococcus aureus (Hardy et a l 1987)
and antibodies to single-stranded DNA and rheumatoid factor after stimulation with
Epstein-Barr virus (Casali et al. 1987).
Ly-1+ B cells from normal mice are responsible for most of the anti-BrMRBC
response, whereas Ly-1*B cells from NZB mice also recognise DNA and thymocyte
cell surface antigens, but have only m inim al resonses to sheep RBC,
2,4,6-trinitrophenyl-KLH and TNP-Ficoll (Hayakawa et al. 1984). The peritoneal
cavity is an interesting lymphoid compartment because there is no identified organ
that gives rise to Ly-1+ B cells, and it has been suggested that these cells may be
"free-living" in the peritoneal cavity (Hayakawa et al. 1985).
Various organs have beji assessed for their ability to reconstitute the Ly-1 B cell
lineage in lethally irradiated mice (Hayakawa et al. 1985). Adult allotype-congenic
bone marrow and spleen are unable to reconstitue any Ly-1+ B lymphocytes,
whereas adult peritoneal cells alone may reconstitute Ly-1 B cell populations. If
however, adult peritoneal and bone marrow cells are transfered all B cell populations
are restored. In contrast, bone marrow, spleen and liver from young mice are capable
of restoring the Ly-1+ B cell population. Subsequently, it has been demonstrated that
for reconstitution to occur, the Ly-1+ B cell populations must express surface IgM
(Hayakawa et al. 1986b).
It has also been shown that many of the IgA secreting Ly-1+ B cells present in
the lamina propria of murine gut are derived from Ly-1+ B cells in the peritoneal
cavity (Kroese et al. 1989). IgM-, IgG- and IgA-secreting Ly-1+ B cells in lymphoid
tissue and gut of lethally irradiated mice were derived from donor peritoneal B cells.
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About 50% of the IgA secreting B-cells found in the lamina propria are Ly-1+, with
only a small proportion (estimated at less than 1%) of peritoneal cells capable of IgA
secretion.
The similarity between Ly-1+ B-cells and those B-cells producing natural
anti-erythrocyte autoantibodies is supported by the fact that both recognise BrMRBC
(Hayakawa et al. 1984,1986a,1986b) and phosphatidylcholine (Mercolino et al.
1986). Some Ly-1+ B cells have also been shown to bind to bacterial polysaccharides
and haptens such as TNP-BSA, phosphorylcholine-BSA, BSA, dextran, type 3
pneumococcal polysaccharide and BrMRBC but the majorityAthe interactions were of
low affinty and multireactive (Lalor and Morahan 1990). In limiting dilution assays,
there was a high ffequencey of Ly-1+ peritoneal B cells reactive with TNP-BSA (1 in
8), phosphorylcholine-BSA (1 in 10) and BrMRBC (1 in 17). For germ-free mice,
these figures were TNP-BSA (1 in 7), phosphorylcholine-BSA (1 in 3) and
BrMRBC (1 in 5). Lalor and Morahan (1990) have shown that anti-BRMRBC
antibody producing B cells are present in conventional spleen and bone m arrow, but
at a reduced level (1 in 1700 spleen, 1 in 630 for Ly-1" spleen cells and 1 in 740 for
virgin B cells derived from bone marrow).
In recent studies, a minor splenic subpopulation of CD5-negative B cells (i.e.
similar characteristics to CD5 B cells but lack expression of CD5 molecule) from BW
and CBA mice has been shown by FACS analysis to produce anti-BrMRBC
antibodies (Andrew et al. 1990) and it has been demonstrated that Ly-1" cells may
arise from the same precursors that give rise to Ly-1+ cells (Palacios et al. 1989) so
there may be subtle differences between different populations of anti-BrMRBC B
lymphocytes that are still to be resolved.
While Ly-1+ B cells only form a minor part of the adult B cell population they
are prevalent early in development and may be responsible for nearly half of the
serum IgM (Forster and Rajewsky 1987). Donor peritoneal cells survived the transfer
into allotype-congenic newborn recipients whereas donor bone marrow cells did not.
At 20 weeks, donor-derived Ly-1"*" B-cells were found at a level of 2% in the spleen,
suggesting some type of migration from the peritoneal cavity to the spleen and there is
an increase in the number of donor cells after 20 weeks to 15 times greater than the
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level injected. It would appear that this lineage may be important in the establishment
of the repertoire during ontogeny.
The importance of subtle changes to the Ly-1+ B cell population in the neonate
and the subsequent effects on adult repertoires has been examined in companion
studies (Lalor et al. 1989a, 1989b). In the first study (Lalor et al. 1989a),
anti-allotype IgM antibodies have been used to selectively deplete the paternal allotype
of conventional and Ly-1 B cell lineages (i.e. half the population) in allotype
heterozygote mice. The conventional B cell lineage gradually replenishes itself ,
however, the Ly-1 lineage (Ly-1+ and its sister population) will not replenish itself
once the long-lived precursor cells are depleted. They also report that the level of
nucleated erythrocye precursor cells is elevated in treated mice (up to 50% from the
5%-10% normally found in control mice), however as they did not assess other
haematological parameters it is difficult to assess the significance of their observation
in relation to erythropoietic activity or haemolytic anaemia. In contrast, in the second
study (Lalor et al. 1989b), if allotype homozygous animals are used, all Ly-1 B cells
are depleted, but reappear after the treatment antibody disappears. This study shows
that there may be a feedback loop operating during development, because addition of
mature Ly-1 B cells appears to block the development of immature precursors.
In addition to these subtle changes that occur to Ly-1+B cells in the internal
mileu, Ogura (1989) has shown that Ly-1+ Bcells may also be sensitive to external
factors. In several strains of autoimmune-disease prone mice there was a reduction in
the numbers of Ly-1+ B cells when these animals were maintained on a chronic
energy-intake restriction diet (high carbohydrate, low fat). The nature of the
inhibitory factors elicited by dietary manipulation was not specificed.
Ly-1+ B cells also display a remarkable ability to withstand long periods of in
vitro culture (Braun et al. 1986; Citri et al. 1987). Spleen cultures were permitted to
establish growth over an extended period (up to three years culture) and after an initial
"crisis period" they gave rise to an immortal Ly-1+ B cell line. It has subsequently
been shown that an elevated level of c-myc oncogene expression occurs in these cell
lines (Citri et al. 1987) signifying an elevated potential for lymphoid neoplasia.
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It had been previously established that B cell lymphomas could be induced in
mice by hyperimmunisation with sheep erythrocytes (Lanier et al. 1978), but these
CH series of lymphomas have been subsequently been found to bear the Ly-1 B cell
m arker (Lanier et al 1981).The CH series of lymphomas bind specifically to
BrMRBC, Sheep RBC and Escherichia coli (Pennell et al. 1985; Haughton et al
1986) or phosphorylcholine (Mercolino 1986,1988). Recent studies on the V regions
of these cell lines are reviewed in section 1.3.6..
In recent work Haughton and coworkers (Mercolino et al. 1986, 1988,1989)
have em ployed liposom al probes of diasterolphosphatidyl choline or
diasterolphosphatidyl glycerol impregnated with fluorocein conjugates to allow
detection and isolation of BrMRBC specific peritoneal B cells using the fluorescence
activated cell sorter. In one study (Mercolino et al. 1986) it was demonstrated that
most of phosphatidylcholine-binding B cells could be classed as belonging to the
L y-1+ B cell lineage and that six CH lymphomas (CH12, CH27, CH28, CH32,
CH34 and CH35) that specifically bound to both SRBC and BRMRBC also bound to
phosphatidylcholine-containing liposomes. Two other anti-BRM specific CH
lymphomas (CH9 and C H I5) examined did not show binding to either SRBC or
liposomes.Originally, these cells were derived from the CH series of murine
lymphomas (Lanier et a l . 1978, 1981; Pennell 1985). In studies on the ontogeny of
cells that bind to PC-liposomes, none were found in 1 or 4 day liver or speen, while
at day 12 there is approx 4 xlO^ and adult levels are attained by 3 weeks (Mercolino
et a l . 1988).

1.3.5. Antibodies and hybridomas from unstimulated animals
Various groups have demonstrated in normal unimmunised animals the
occurrence of natural antibodies that bind to other natural antibodies (Holmberg et al.
1984a, 1984b, 1986; Lymberi et al. 1985) or to cytoskeletal proteins such as tubulin
(Karsenti et al. 1977) or actin, tubulin, myosin (reviewed in Dighiero et al. 1987a) or
intracellular components of mouse fibroblasts (Underwood et al. 1985) or
nuclear-reactive autoantibodies (Rizzatti and Underwood, 1990).
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Holmberg and colleages (1984a, 1984b) found specific binding between the
variable regions of 2 monoclonal IgM antibodies from the same mouse (untreated 6
day old BALB/c mice) as well as a number of positive low affinity binding reactions
against constant regions when nine monoclonal autoantibodies were tested against a
panel of 70 neonatal autoantibodies. This "connectivity" could not, however be
demonstrated amongst adult mitogen-reactive antibody repertoires (Holmberg et al.
1986).
Natural antibodies have been demonstrated to bind to a number of cytoskeletal
proteins in a number of studies. Dighiero and collegues (1982,1983,1985,1988) have
dem onstrated specific binding against actin, tubulin, myosin, TNP-BSA,
double-stranded DNA and single-stranded DNA in a collection of hybridomas
produced in 6 day old (CBA/N x BALB/c)Fl mice. In another study (Underwood et
al. 1985), hybridomas were

produced from normal BALB/c, nude BALB/c,

germ-free BALB/c and 8-day old BALB/c with between 4-17% of the hybridomas
(depending on the type of mouse) recognising intracellular components of mouse
fibroblast and mouse 3T3 cells that had been acetone-fixed, with none of these
antibodies recognising cell surface antigens of 3T3 cells, fibroblasts, RBC or
thymocytes. One monoclonal (out of 1020) from an 8 day old BALB/c reacted with a
cell surface antigen on syngeneic thymocytes. The majority of the autoreactive clones
were IgM secretors (43 out of 45 stable hybridoma lines). There is a wide range of
antigens recognised by this collection of hybridomas such as thyroglobulin,
p-galactosidase, cardiolipin, phosphatidylethanolamine, diptheria toxin, tetanus
toxin, DNP-ovalbumin, fluorescein-ovalbumin, cytochrome-c, myoglobin and
carbonic anhydrase (Rizzatti and Underwood 1990).
In other studies aimed at determining the extent of the antibody repertoire in
germ-free BALB/c mice (Bos et al. 1987) young suckling mice were allowed
mother's milk until about 15-18 days old and then fed a chemically defined
ultrafiltered diet to limit dietary antigens. They concluded that the specificity of the
splenic IgM repertoire is independent of exogenous antigenic or mitogenic
stimulation, but that environmental stimulation found amongst conventionally reared
BALB/c can

enhance the level and rate of development of background IgG and

IgA. In the germ-free mice, the levels of IgA were lower and they did not catch up to
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adult levels by 70 days after birth. Others have demonstrated a high level of natural
lymphocyte activation in the spleen lymphoid population (10-20% of lymphoid
population B and T cells) during the postnatal development of germ-free and
conventional specific pathogen-free BALB/c mice (Fomi et al. 1988). They suggest
that a second wave of activated B cells appear

at 6 weeks in specific pathogen-free

mice due to polyclonal activation via bacterial products.
Hybridomas produced from the peritoneal cells of unimmunised mice have been
found to bind to BrMRBC. Anti-BrMRBC peritoneal cell hybridomas produced from
NZB mice have been found to recognise RBC from a number of different species
(Pages and Amaud 1980; Poncet et al. 1985) or trimethylammonium compounds
(Serban et al. 1981; Pages et al 1982; Poncet et al. 1985) while hybridomas from
norm al mice bind to cholesterol particles coated with phosphatidylcholine
(Kawaguchi 1987b). Peritoneal cell hybridom as derived from NZB and
LPS-stimulated BALB/c mice have been shown to secrete antibodies to BrMRBC but
not to either DNA or cytoskeletal proteins, in contrast to splenic hybridomas that
secrete polyspecific antibodies that bind to DNA, cytoskeletal proteins (Kaushik et
al. 1988).

1.3.6. Y-genes and V-regions of natural autoantibodies.
Natural monoclonal anti-BrMRBC autoantibodies prepared from NZB and CBA
mice have similar V-region structures as determined by amino acid sequencing
(Poncet et al. 1985) and there is evidence to suggest that natural autoantibodies from a
number of strains of inbred mice may be structurally related (Kaushik, et al. 1986).
Serban and Witz (1988) also found that anti-BrMRBC antibodies share a common
idiotype. Other evidence for the high homology displayed by anti-BrMRBC
antibodies derived from peritoneal B cell populations comes from studies directed
tow ards defining the genes encoding the V region (Reininger et al.
1987,1988,1990a,1990b; Pennell et al. 1988,1989; Poncet et al. 1989,1990).
However, splenic populations of anti-BrMRBC appear to be able to use different Vpj
genes in addition to Vpj 11 (Conger et al. 1989; Hardy et al. 1989, Poncet et al.
1990; Kaushik et al. 1990).
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It has been shown that diversity in VH regions of peritoneal cell anti-BrMRBC
antibodies is limited or restricted and they appear to comprise

a new family ,

VH 11 (Reininger et al. 1987,1988). Similarly, VL appear to preferentially use VK9
(Reininger et al. 1987). VH 11 expression did not occur in NZB, BALB/c or
(CBA/N x BALB/c)Fl splenic hybridomas from new bom mice, and yet they were
found in peritoneal cell hybridomas that expressed anti-BrMRBC antibodies (Poncet
et al. 1989). In NZB mice three V j j gene families (J558, J606 and 3609) and five
V K groups (8, 9, 19, 21 and 28) were found to encode anti-BrMRBC antibodies
(Reininger et al. 1990). In studies with Ly-1+ B cells derived from CH lymphomas
(Pennell et a l . 1988,1989), it has been found that only two heavy chain and k chain
V-region gene combinations were used suggesting that they are germline encoded.
The CH27 lymphoma studied here appeaifto belong to another other unique V jj
group, whereas others belong to V j j 11 . The Vj^ region also appears to be highly
conserved with

and VK9 used by anti-BrMRBC antibodies. They suggest clonal

selection by antigen as a mechanism for the large number of highly homologous V
regions encoded by these antibodies and suggest that the selecting antigen " is either
endogenous or ubiquitous in the environment".
It has been confirmed that natural antibodies from peritoneal B cells use the
common Vj j region sequence (V

11) and a single common L chain VK 9 (VK BrM)

but diversity has been demonstrated in LPS-stimulated splenic B-cells with four Vjq
families utilised (Conger et al. 1989) . In the LPS-stimulated splenic population it
was found that one anti-BrM antibody did not bind to trimethylammonium, while 4
anti - (BrMRBC+SRBC) antibodies also reacted with trimethylammonium, and 8
clones reacted with trimethylammonium and BRMRBC, but not SRBC. These
results were supported by a study in which anti-BrMRBC antibodies originating in
the spleen were examined (Hardy et al. 1989). Most antibodies examined were from
the V j_j 11 family, while one hybridoma derived from an Ly “ B cell used S107Vjj
and another two anti-BrMRBC antibodies using the Vjq gene described by Pennell
that are used by the CH27 lymphoma (Pennell et al. 1988). Diversity was also noted
in the V

K

groups used by anti-BrMRBC antibodies derived from Xid mice, with

predominant pairing of V jj 11 and VK 9, and the occasional involvement of VK 1,10
and 19 (Kaushik et a l . 1990).
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Evidence to suggest an endogenous origin of antigen stimulation is suggested in
studies with adult germ-free mice raised on a chemically defined diet in antigen-free
conditions that established an adult pattern of J558 usage (Bos and Meeuwsen,1989).
These germ free adults retained the preferential u fo f PC7183 however, and when the
antigen binding specificities of hybridomas from LPS-stimulated splenic B cells from
adult germ-free BALB/c mice were compared to hybridomas derived from 5-day old
conventional BALB/c mice, neonatal mice had a large proportion of multireactive B
cells that recognized "autoantigens" (rat stomach,liver and kidney, acetylcholine
receptor from Torpedo California and mouse antiidiotypic antibodies) and bacterial
antigens. Similar patterns of reactivity were seen with adult antigen-deprived mice
(Bos etal. 1989).
Recent studies with murine rheumatoid factors (Shlomchik et al. 1986) and
natural autoantibodies to DNA (Naparstek et al. 1986) suggest that the V-regions
encoding these natural autoantibodies also belong to structurally-related families and
that there are a limited number of germline V region sequences encoding the
specificities.

1 .4 . B R O M E L A IN -T R E A T E D

M O U SE

RED

BLO O D

CELLS-

CHARACTERISATION OF A "HIDDEN” AUTO ANTIGEN.
The exact nature of the in vivo epitopes involved with BrMRBC are not known
with certainty. There is strong evidence that phosphatidylcholine forms part of this
epitope, but phosphatidylcholine alone as the BrM antigen cannot account for all of
the characteristics described for this epitope, such as the occurence, regulation, organ
distribution and possible functional significance. In this section, the regulation of
anti-BrMRBC responses will be examined briefly, followed by a comprehensive
examination of studies directed towards elucidating the BrMRBC antigen.
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1.4.1. R egulation o f the anti-BrM RBC response.
Regulation of the anti-BrMRBC response has been suggested to involve a
number of different mechanisms, viz., involving suppressor T cells, regulation by the
BrMRBC antigen itself and anti-idiotypic interactions. "Self’-tolerance or regulation
in the BrMRBC system could be most readily explained by an active suppression
mechanism (Cunningham 1975,1976) rather than the alternative explanation of the
appearance o f forbidden auto-reactive clones (Burnet 1959). There is growing
support for some type of immunoregulatory processes regulating the response to
autologous antigens rather than clonal deletion, especially as specific non-immune T
cells have been demonstrated to recognise autologous erythrocytes (Hooper 1987;
Hooper and Taylor 1987). There is also a progressive loss of functioning suppressor
T cells in aged NZB mice, which suggests that a breakdown in active suppression
due to factors associated with aging is partly responsible for the appearance of
autoantibodies to mouse erythrocytes (Moore and Calkins 1985; Miller and Calkins
1988). T-cell involvement in the control of autoantibody production in the BrMRBC
model was shown by Ramshaw and Eidinger (1977) when they demonstrated
delayed hypersensitivity to BrMRBC . In contrast to this, Cox, Baddams and Evans
(1977) established that there was no delayed hypersensitivity to BrMRBC, although
there was to BrSheepRBC and Sheep RBC, and no increase in the level of natural
autoantibodies when mice received injections of BrMRBC, although the protocols of
these experiments were different.
There appears to be a dichotomy of T cell dependence by peritoneal and spleen
cell-derived anti-BrMRBC producing cells (Huetz et al. 1988,1989). The peritoneal B
cell population was found to be T-cell independent, but there is evidence for
regulation of the splenic population by T cells. It was shown that 1 in 360 anti-BrM
precursors could be found in the spleen of BALB/c mice, but virtually none (1 in
9086) in the nude counterpart. However, in nude mice reconstitued with T cells the
level o f detectable precursors approaches that found in BALB/c (1 in 812),
suggesting a T-cell dependence on the generation and activation of anti-BrM B cells in
the spleen.
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Lord and Dutton (1975b) also demonstrated that the antibody production by
m ouse peritoneal cells in culture could be inhibited by co-culture with
bromelain-treated mouse erythrocytes, so that in addition to T-cell control of
autoantibody production, other mechanisms involving direct blocking of self-reactive
lymphocytes by antigen may be operative.As little as 2 to 5x 10^ BrMRBC per
culture caused 98% suppression of anti-BrMRBC response when compared to
control cultures. The same level of NMRBC had no suppressive effect, but the
BrMRBC had to be present at the beginnning of the culture for the suppressive effect
to occur. Recently,a monoclonal autoantibody specific for mouse RBC was derived
from an aged NZB mouse and found to be capable of inducing autoimmune
haemolytic disease in BALB/c mice (Caufield et al. 1989). This antibody could be
inhibited by mouse red blood cell sonicates used by these authors, however, although
this demonstrates suppression of an "anti-self’ response by antigen, this does not
really distinguish whether the antigenic substance occurred at the cell surface or if it is
a cytoplasmic antigen.
The regulation or inhibition of natural autoantibody responses to mouse
erythrocytes involves both T-cells and BrMRBC antigens. In one study (Cox et al.
1979), the number of BrM-specific plaque forming cells was found to increase if
RBC were lysed with ammmonium chloride before culture, and significantly decrease
if co-cultutred with NMRBC or BrMRBC. An increase was also noted if cultures of
peritoneal cells were pre-treated with complement and anti-0, suggesting that T-cells
are crucial to regulation of the response. In addition, Wieties and Moticka (1986)
have shown that autoantibody secretion may be partially controlled by anti-idiotypic
regulation, and there is suggestive evidence that a non-complement fixing IgM may
be involved with the regulation of the autoantibody response (Jablonska 1977).
Regulation of the anti-BrMRBC response may be complicated because there is
evidence from studies with germ free-mice that the anti-BrMRBC response may arise
from endogenous stimulation rather than some kind of external stimulation .
Germ-free BALB/c spleens contained 1400 PFC per 108 nucleated cells against
bromelain-treated mouse RBC, whereas even nude mice (nu/nu) had an average of
560 PFC per 108 nucleated cells (Cunningham 1974a). Forty eight hours after a 50
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p.g i.p. injection of LPS, CBA mice had 206,000 anti-BrMRBC PFC per 10^
nucleated cells, when compared to 5,320 PFC found in unstimulated CBA mice. PFC
capacity against BrMRBC occurs in strains of germ free, specific pathogen free and
nude mice, indicating perhaps the thymus independence of this response
(Cunningham (1976) although regulation may be achieved by different mechanisms
given the capacity for antigen to inhibit peritoneal cells directly (Lord and Dutton
1975b).

1 .4 .2 .C h aracterisation

of

the

hidden

autoan tigen

on

autologous

eryth rocytes.
In the search for the identity of the BrMRBC epitope, cross-reactions have been
demonstrated against erythrocytes from different species (Pages and Bussard 1975;
Pages and Arnaud 1980 ), isologous mouse IgG (Fc) (Cunliffe and Cox 1980),
trimethylammonium compounds (especially phosphatidylcholine) and lipids (Serban
et al. 1981; Poncet et al. 1985; Cox and Hardy 1985; Mercolino et al. 1986,
1988,1989 ; K aw aguchi et a l 1987b,1988b; Serban and W itz 1988), and
autoantigens expressed principally in the gastrointestinal tract (Cunningham and Steele
1981). These different types of antigens will be reviewed with a view to establishing
the true in vivo nature of the BrMRBC antigen.
In earlier studies, autoantibodies to erythrocytes were reported to occur in
normal strains of mice and at elevated levels in NZB mice (Wilson, Warner and
Holmes 1971; Lord and Dutton 1975a). In normal mice, intact erythrocytes are not
normally antigenic unless they are treated with proteolytic enzymes, such as
bromelain or papain, and to a lesser effect, trypsin (Cunningham 1974a, 1976).
Linder and Edgington (1972) had demonstrated the presence of two antigens, X and
HB, on the erythrocytes of the autoimmune NZB strain of mice. The X antigen was
present on the surface of the red cell membrane, while the HB antigen was exposed
only after proteolytic treatment of erythrocytes with bromelain. Bromelain-treated
RBC, however, could remove both X and HB activity from sera. Large numbers of
autoantibody-secreting cells in NZB mice were found to be specific for both the X
and HB antigens (Linder and Edgington 1972, DeHeer and Edgington 1974; DeHeer
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et al. 1978). Both the HB and X antigens could be purified from mouse plasma
(Linder and Edgington 1973a, 1973b) and used to specifically inhibit anti-X or
anti-HB antibodies purified from NZB erythrocytes. In addition, it was found that
bromelain-treated stroma could inhibit 85% of anti-HB plaque forming cells, whereas
intact stroma could inhibit 90% of anti-X plaque forming cells (DeHeer and
Edgington 1974).
Peritoneal cells in culture were found to be able to secrete antibodies that
specifically bound to Sheep RBC and BrMRBC, but not NMRBC, thus establishing
a link between the peritoneal cell phenomenon and a hidden autologous erythrocyte
antigen (Pages and Bussard 1975). In addition to sheep RBC, anti-BrMRBC
antibodies derived from peritoneal cells of NZB mice were found to bind to intact
pigeon and human RBC, whereas horse and sheep RBC were found to be negative :
BrMRBC (highly stained) >Human A and 0>Pigeon RBC>Rat RBC>Human B>
rabbit>chicken RBC>untreated mouse RBC>Goat, sheep, horse (unstained) (Pages
and Amaud 1980). It is interesting that no activity could be demonstrated against
Sheep RBC suggesting that, in this case , the anti-BrMRBC antibodies were not
cross-reactive as had been demonstrated previously for peritoneal cell cultures (Pages
and Bussard 1978). Similarly, monoclonal anti-BrMRBC antibodies may bind to
BrMRBC, BrRat RBC, Sheep and Br-Sheep RBC, Br-Horse RBC , chicken RBC
and Br-Chicken RBC and Br- Frog RBC, but not to MRBC, rat RBC, horse RBC or
frog RBC to different degrees in haemolytic assays (Kawaguchi 1986). The fact that
there is some kind of hierarchy of binding may suggest a fundamental difference in
the presentation of surface antigens in the topology of different RBC from different
species.
What is the nature of the cross reactive epitope on sheep RBC ? In an unusual
study, a water soluble fraction of sheep RBC devoid of all membrane that contained a
highly immunogenic protein fraction called FI was produced (Seman et al. 1971). FI
and FII was prepared from sheep RBC lysate, FI was the main protein fraction in the
void volume of a Sephadex G 100 column. FII consisted of haemoglobin. Mice
injected with FI had a strong response, but some membrane components were found
to be required for the full expression of antigenicity of this protein.The protein,
although abundant, was not further purified or characterised.
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The effect of the proteolytic enzyme bromelain on mouse red blood cells is to
reveal a previously hidden epitope. Bromelain removes only Band 3 , an integral
membrane protein involved in anion transport, from the membrane and even after
extensive bromelain digestion only an additional two spectrin bands are removed
(Cunliffe and Cox 1979).Thus membrane proteins would appear to be fairly resistant
to proteolytic degradation, and it is not thought that bromelain directly acts upon the
BrMRBC epitope, because anti-BrMRBC antibodies may be raised in rats by
injection of intact mouse erythrocytes (Cunningham 1974a). This suggests that
bromelain reveals an epitope that is normally hidden. That the two responses were
made by different populations o f rat antibodies was shown by absorption
experiments. Absorption of rat anti-mouse RBC semm with NMRBC could remove
only slight reactivity against BrMRBC, and the converse was also found to be true.
If, in contrast, BrMRBC are injected into mice, the number of antibody-producing
cells does not increase from a background level of 5,500-10,000 found in
unimmunised mice (Cox et al. 1977). BrMRBC had similar levels of resistance to
osmotic lysis as NMRBC suggesting that bromelain treatment did not grossly deform
RBC and that therewereno recognisable neo-antigens created on BrMRBC that could
stimulate a response above the background levels displayed.
Strong evidence has accumulated to support trimethylammonium compounds
(specifically phosphatidylcholine) as being involved in the BrMRBC antigenic
determinants. Bussard and colleagues using anti-BrMRBC IgM monoclonal
antibodies derived from peritoneal B-cells from NZB mice found that they recognised
trimethylammonium compounds (choline) (Serban et al. 1981; Pages et al. 1982;
Poncet et al. 1985; Serban and Witz 1988). Compounds such as choline chloride,
phosphorylcholine, betaine and betaine hydroxide at concentrations of between
12.5mM and lOOmM were found to be capable of specifically inhibiting the
complement-dependent lysis of BrMRBC by natural autoantibodies (Serban et al.
1981) and direct binding to trimethylammonium by anti-BrMRBC antibodies has
been demonstrated in radioimmunoassasys (Serban and Witz 1988).The ability for
these compounds to inhibit the plaque-forming capacity of peritoneal cells has also
been dem onstrated (Pages et al. 1982). Phosphoserine and phenyltrimethylammonium as well as ghosts prepared from NMRBC also have the ability to inhibit
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anti-BrM RBC antibodies (Poncet et al. 1985) suggesting that a membrane
phospholipid or an integral membrane protein may be recognised. Serban and Witz
(1988) have shown the presence of natural autoantibodies in murine sera at a level of
13.8|ig/ml, with an increase in the presence of a trimethylammonium-binding
idiotype with age or with certain autoimmune strains [69.3pg/ml for (NZB x NZW)
FI bearing the 141 lymphoma]. Also, they found that the BrM-epitope was revealed
after bromelain-treatment of mouse, rat, sheep , rabbit, human and chicken RBC (and
Normal CRBC), and that this could be inhibited with trimethylammonium.
Cox and Hardy (1985) showed that anti-BrMRBC antibodies displayed strong
crossreactivity with the polar headgroup of the ubiquitous membrane phospholipid,
phosphatidylcholine. Inhibition of anti-BrMRBC antibodies could be achieved at
low er levels (2qg/m l) than those required to demonstrate inhibition with
trimethylammonium compounds. Phosphatidyl dimethyl ethanolamine dipalmitoyl, a
closely related phospholipid was found to have no inhibitory effect on anti-BrMRBC,
thus showing that the polar head group is important, however, the entire
phosphatidylcholine molecule is required for maximum inhibition of haemolysis. It
must be noted that the effects of inhbition are diminished by several orders of
m agnitude (10-1000 tim es) when m ixed liposom es, containing either
phosphotidylinositol or phosphatidic acid were used in conjunction with
phosphatidylcholine.This can be attributed to a charge effect of negative
phospholipids on the polar headgroup of phosphatidylcholine. Mercolino and
collegues have found that phosphatidylcholine in liposomes is recognised specifically
by Ly-1+ lymphomas ( Mercolino et al. 1986) and also that peritoneal Ly-1+ B cells
isolated from normal mice also bind specifically to phosphatidylcholine (Mercolino et
a l 1988).
In a recent study, Hardy and Cox (1990) provided evidence for a
phopholipase-sensitive structure on mouse red blood cells recognised by mouse
peritoneal cells. This is good evidence to show the importance of phosphatidylcholine
in the BrMRBC epitope, however, at best only a 40% reduction in binding of
peritoneal cells to these cells can be achieved, suggesting that some other structure
may still be recognised. In addition, second enzyme treatments are employed to
further digest any protein epitopes, with no further effect on the binding of
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anti-BrMRBC antibodies. In the "second enzyme" digestion, cells that have been
bromelain-treated are subjected to further proteolytic degradation with bromelain or
other proteolytic enzymes. This may not be the correct approach to take if N- or
O-linked carbohydrates are involved in the epitope, especially if they were attached to
some cytoplasmic protein as a second enzyme digestion may not be able to effectively
digest intracellular proteins. Further, the second enzymes used may not further cleave
peripheral erythrocyte proteins after the bromelain-sensitive proteins have been
removed. Cunningham (1974a) has shown by raising anti-BrMRBC antibodies in
rats by the injection of NMRBC, that the epitopes revealed by bromelain are not
modified by bromelain but are hidden structures on NMRBC. The study with second
enzymes and their effect would have been clearer to assess if SDS-PAGE had been
conducted to determine what, if anything, was removed from the whole cell, so these
studies do not rule out a complex epitope involving perhaps protein, glycoprotein or
carbohydrate.
Kawaguchi (1987b) has demonstrated that anti-BrMRBC antibodies , in
addition to recognising phosphatidylcholine, bind to human and chicken low density
lipoproteins (LDL), but not mouse or rat LDL. Four of the IgM monoclonal
antibodies were found to bind differently to different "natural" or animal derived
liposomes and to synthetic liposomes. One did not bind to liposomes, another could
bind to liposom es containing dipalm itoyl, distearoyl and diarrachidoyl
phosphatidylcholine, and the remaining two could bind to the same but could not to
phosphatidylcholine liposomes with unsaturated fatty acids or short chain fatty acids
(less than 10 C chains). It was suggested that phosphatidylcholine may be spaced
apart at the wrong distance for the antibodies to bind. Further, it was shown that there
were differences in the fine specificity of antigen binding for phosphatidylcholine
among different idiotypic groups of anti-BrMRBC monoclonals. In a related study,
Kawaguchi (1988) found that anti-BrM antibodies that were similar to those induced
by LPS stimulation could be obtained by injection of chicken egg LDL emulsified in
Incomplete Freund's adjuvant.
It is not known if the cross-reactive determinant on sheep RBC contains
phosphatidylcholine, but there is some evidence to the contrary. Studies on the lipid
composition o f sheep and mouse erythrocytes have found that sheep RBC do not
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contain phosphatidylcholine (Saito et al. 1983, Nelson 1967). Mouse erythrocyte
lipids contain phosphatidylcholine and show a similar type and percentage of lipids to
rat erythrocytes (as measured by Nelson), with two strains, C57BL/6 and C3H/He
showing minor variation in percentage of lipids. There is also evidence that lipids by
themselves are poor immunogens, however, they may enhance the immunogenicity
of protein antigens (Marcus and Schwarting 1976; Marcus 1984). Thus, although
phosphatidylcholine may be bound by natural antibodies and form a portion of the
BrMRBC epitope, there is a question as to whether they may by themselves stimulate
the anti-BrMRBC lymphocytes to secrete anti-BrMRBC antibodies.
Huetz and Poncet (1989) have provided arguments to suggest that
anti-phosphorylcholine

antibodies

are not identical to anti-BrM RBC

(phosphatidylcholine) antibodies. Thus, conventional anti-phosphorylcholine
antibodies do not lyse BrMRBC in conventional lysis assays; the affinity of
anti-BRMRBC for phosphorylcholine is low; mice use

different V-genes for

phosphorylcholine and BrMRBC and lastly, no antiphosphorylcholine idiotype
recognises anti-BrM idiotypes.
The exact identity in vivo of the responsible stimulating determinants is
unknown. There is evidence that blood group substances isolated from the murine
gut are recognised by anti-BrMRBC antibodies and that gut-derived antigens may be
responsible for the initial high level of anti-BrM lymphocytes early in ontogeny
(Cunningham and Steele 1981). Whether blood group substances are involved in the
BrMRBC autoantigen(s) requires further investigation, bearing in mind that blood
group carbohydrates may be bound to either proteins or lipids on red blood cells or
expressed predominantly on proteins in the gastrointestinal tract (Kabat 1956,Watkins
1974, Feizi and Childs 1985, Feizi 1990). In humans, Moore and collègues (1982)
have demonstrated that phospholipid is an important component of the human Rh
antigen, but that a protein (as yet unidentified apart from molecular weight 28.5 kD)
is also involved in the epitope recognised as the Rh antigen.
In studies using antigen inhibition and/or antigen absorption of the complement
mediated lytic assay, BrMRBC-like antigens (BrM-antigens) were found in the
gastrointestinal tracts of normal inbred CBA/J mice (Cunningham and Steele 1981)
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and germ-free outbred Swiss mice (Steele and Cunningham, 1979). In addition,
complement-dependent lysis of antibody-sensitized BrMRBC could be specifically
inhibited with a partially purified "blood-group-like" substance extracted from mouse
stomachs (Cunningham and Steele 1981) following the methods of Kabat (1956).
The gastrointestinal distribution and emergence of the BrMRBC antigen early in
ontogeny and the subsequent appearance of specific natural autoantibodies in one
week old mice, suggest that the BrMRBC antigen may act as an important stimulator
of large numbers of potential autoantibody-secreting B-cells (Steele and Cunningham
1978,1979; Cunningham and Steele 1981). It was established that both the capacity
to synthesise BrMRBC specific IgM antibody and the natural form of the BrMRBC
antigen appeared by the end of the first week of life and reached adult levels by the
third week.
The BrMRBC antigen is not normally detectable in a wide range of tissues
including foetal gut, but appears at high levels in gut tissue shortly after birth
(Cunningham and Steele 1981). Tissues from the stomach and upper small intestine
were a rich source of antigenic material, capable of specifically absorbing the IgM
anti-BrMRBC antibody, whereas the salivary glands, liver and kidney were found to
be variably positive (lung, brain, spleen, bone marrow, thymus, peritoneal cells,
foetal intestine, food pellets, testes and ovaries were negative). If foetal stomach and
intestine had been pretreated with pepsin at pH 4, it behaved like adult stomach in its
ability to remove anti-BrM RBC antibodies from serum. Further, it was shown that
complement-dependent lysis of antibody-sensitized BrMRBC could be specifically
inhibited with a blood group like substance extracted from mouse stomachs.
The restricted distribution of the BrMRBC antigen has been demonstrated
independently in studies by Garzelli and collegues (1987). They examined the
reactivity^anti-BrMRB C antibodies and the tissue distribution of the antigen by direct
immunofluorescence on frozen tissue sections. Anti-BrMRBC antibodies were said to
be "polyspecifc" since they react with multiple organs, however, this does not
exclude that the same antigenic epitopes may occur in different tissues. Anti-BrM
reacted with cellsclose to the lumen of the seminiferous tubules of the testis, the
A

s

.

lamina propria of gastric mucosae, the cytoplasm of cel^ in the salivary glands,
scattered cells in the thymus and lymph node, and the cytoplasm of about 20% of
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nucleated cells in the bone marrow. BrM-antigen has also been found on erythocytes,
platelets, thymus,bone m arrow and spleen cells after proteolytic treatment
(Kawaguchi 1988a). Platelets were also found to react with anti-BrMRBC antibodies
at 0°C but not at 37°C. Stronger reactivity can be demonstrated with thrombin-treated
platelets (Kawaguchi 1989).

1.5. RED BLOOD CELL ANTIGENS
Erythrocytes play a central role in mammals in the transport of oxygen to
tissues and removal of carbon dioxide (Schmidt-Nielsen 1983). The cell membrane of
erythrocytes is a complex structure with many different proteins, glycoproteins,
phospholipids and carbohydrate moieties present in a lipid bilayer (for reviews see
Bretscher 1973; Steck 1974; Surgenor 1974; Marchesi and Furthmayr 1976). The
outer part of the human erythrocyte lipid bilayer mainly contains phospholipids with
choline moieties (Zwaal, et al. 1973) and the principal components of the membrane
skeleton of human red blood cells are actin, spectrin, ankyrin, Band 3, Band 4.1,
tropomyosin and myosin (Table 1.7.; Bennett 1985).
The ABO blood group antigens and the naturally-occuring isohaemagglutinins
in humans are of primary importance in the practice of blood transfusion, and hence,
much is known of the structure and composition of the blood group antigens (Kabat
1956; Watkins 1966,1974). Many environmental antigens, such as food substances,
dust, blood group substances from other species, simple sugars and microorganisms
are cross-reactive with human ABO blood group substances and natural antibodies to
blood group antigens have traditionally thought to be due to antigenic stimulation with
these environmental antigens (Kabat 1956).
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Table 1.7. Erythrocyte membrane proteins (Modified from Bennett, 1985)
Peripheral proteins
Spectrin
Ankyrin
Band 4.1
Band 4.2
Band 4.9
Actin
Glyceraldehyde
3-Phosphosdehydrogenase
Band 7
Band 8
Tropomyosin

S u b u n it M w t
a = 260,000
b = 225,000
215,000
78,000
72,000
45,000
43,000
35,000
29,000
23,000
29,000

Integral proteins
Band 3
Glycophorin A
Glycophorin B
Glycophorin C

Subunit M w t
89,000
31,000
23,000
29,000
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Natural antibodies also recognise minor blood group antigens. In many
species, there is a developmental change in the expression of carbohydrate antigens
on the surface of the erythrocyte (Feizi and Childs 1985) i.e. with the human Ii
blood group there is a switch from the expression of foetal i antigens to mature I
antigens. Natural antibodies to the Ii blood groups are usually abundant in certain
types of autoimmune haemolytic anaemia but are also present in normal individuals
(Hakomori 1981). These natural antibodies can also recognise tumour-associated
antigens of gastric carcinomas (Feizi and Childs 1985) and antigens expressed by
foetal intestinal glycoproteins (Feizi 1985).Carbohydrate antigens comprise the
major allogeneic antigens (Blood group antigens in man), Forssman antigen and
differentiation markers such as SSEA-1 (Solter and Knowles 1978). Forssman
antigens are carbohydrate structures that are attached to lipids and occur on the
erythrocytes of certain animals (Hakomori and Kannagi 1983, 1986).Forssman
antigen positive animals are guinea pig, horse , cat, dog, sheep, goat, mice, pigeon,
chicken and turtle.Forssman negative animals are rabbit, rat, cow, pig, human,
monkey and frog.
There are other glycoprotein and protein structures present in red blood cell
membranes, such as MHC antigens (Spackjr. and Edidin 1986; Nakashima et al.
1986), LPS receptors (Springer et al. 1973, 1974) and other receptors or
transporters, which are potentially capable of acting as autoantigens. However, as
well as the wide range of cell surface antigens, it is also known that some "buried"
antigens or intracellular components from red blood cells may also react with
natural antibodies (as outlined above). In human erythrocytes, a buried region of
Band 3 has also been identified as an autoantigenic target for IgG in autoimmune
haemolytic anaemia (Lutz 1983).
Erythrocytes only have a limited lifespan in circulation, in the human it is said
to be 120 days (Dacie and Lewis 1976) whereas in the mouse it has been measured
at about 40-45 days (Cox and Cunliffe 1979). It is pertinent to ask why these cells
are removed from circulation, how and what happens in the breakdown of RBC ?
With human erythrocytes, it has been suggested that haemoglobin may become
denatured to form Heinz bodies which complex with the anion channel to form
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autoantigenic epitopes signalling that the cell can no longer function as a transporter
of oxygen (Schluter and Drenckhahn 1986), but haemoglobin is presumably
enclosed within a membrane - how does it signal to the immune system that it is
aging and requires removal ?
Thus in addition to membrane lipids, there are a number of potential targets
that have been briefly mentioned here that could be recognised as antigenic on
erythrocytes. Most of these structures are "surface" antigens, and it must be borne
in mind that erythrocytes normally have a coating of erythroglycan which normally
protect the intact cell from interactions with IgM or IgG (Jamefelts et al.
1978,1982). Bromelain treatment removes Band 3, a major component of the anion
channel, (Cunliffe and Cox 1979), thus certain cytoplasmic proteins and/or lipids
may become exposed to reveal BrMRBC autoantigens.
1.6. AIMS OF THE STUDY
Several facts emerge when these studies are viewed together. There is high
potential for anti-BrMRBC available in the potential murine Ig repertoire (Steele and
Cunningham 1978), and there is a demarcation of anti-BrMRBC activity to the
peritoneal cavity and the pleural cavity, and the distribution of the BrM-antigen is
restricted to specific sites and specific organs (Cunningham and Steele 1981). Does
this indicate a high local level of stimulating autoantigen at these sites? Is there a
possibility that another autoantigen apart from phosp hatidyl choline may be
involved in the BrMRBC autoantigen (s) ? What is the nature of autoantigenic
epitopes in the gut and are they related to the BrM-antigens expressed on
erythrocytes?
The principal aim of this thesis is to examine mouse red blood cells and the
murine stomach, isolate and characterise the epitopes expressed in vivo.

CHAPTER TWO
MATERIALS AND METHODS
2.1. ANIM ALS
2 .1 .1 . M ice
Retired female breeder CBA/H £ an mice (10-19 weeks old) were obtained
from the Animal Breeding Establishment of the John Curtin School of Medical
Research, Canberra, Australia, and housed at the Animal House, University of
Wollongong until required. Occasionally, Balb/c and CBA/H cross C57B/6 from
the same source were used for antibody absorption.
2.1.2. R abbits
Rabbits were immunised to make specific high titre IgG anti-BrMRBC
antibodies (Chapter 3, Table 3.2) or left unimmunised as sources of complement.
One outbred male rabbit died during immunisation with BrMRBC. One NZW male
rabbit that was used to produce anti-BrMRBC antibodies became ill during
immunisation with BrMRBC with stomach lesions evident upon autopsy. Vetlar
(Ketamine Hydrochloride, Parke Davis; anesthetic) was administered i.m. at
25mg/kg to produce anesthesia in conjunction with 3mg/kg Rompun (Xylazine,
Bayer, muscle relaxant & sedative) and the rabbit was bled from the heart. NZW
rabbits obtained from New South Wales University from the Psychology
Department, and housed at the Animal House, University of Wollongong, were
used as sources of complement for haemolysis assays.
2.2. ANTIBODIES AND COMPLEMENT
2.2.1. LPS stimulated serum and normal mouse serum
CBA/H mice, received lipopolysaccharide (LPS) from Escherichia coli strain
0127:B8 (Phenol extract, Sigma no L-3129, Sigma Chemical Co. St.
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Louis,MO,US A) 50 |ig intraperitoneally (i.p.) in 0.1 ml of sterile physiological
saline . LPS-stimulated serum (LPS-serum) from a group of mice was collected
and pooled 7 days after injectionAstored in small lots at -20°C until use. Several
batches of LPS serum were produced over a number of years (Chapter 4 Table
4.1.).
Normal mouse serum was collected freshly from individual CBA/H retired
female breeder mice as required. The levels of IgM present in LPS stimulated
serum and normal mouse serum were quantified by radial immunodiffussion in
agar (Section 2.2.3.).

2.2.2 M onoclonal antibody culture
FUB 1 is an IgM monoclonal antibody produced by fusion of an LPS
stimulated C3H mouse spleen with P3.653 . The monoclonal was selected for its
ability to specifically lyse BrMRBC and not NMRBC in standard haemolysis
assays and specifically binds to phosphatidylcholine micelles (K.O.Cox, S.Hardy,
P.Kenny, unpublished manuscript). FUB 1 was originally produced in Professor
Cox's laboratory by Peter Kenny and the B-cell hybridomas (FUB 1, FUB 3 and
FUB 4) arrived by post from Dr. Paul Lalor of the Walter and Eliza Hall Institute
(WEHI) , University of Melbourne who had them in culture in June 1988. FUB 3
is crossreactive with BrMRBC and Rat RBC, while FUB 4 is specific for Rat
R B C only (Table 2.1.).
The three hybridoma lines, FUB 1, FUB 3 and FUB 4 (see Table 2.1) each
containing approximately 5x10^ cells from log phase cultures arrived and the
volume was adjusted to 6ml with C-DM EM . Five millilitres was cultured initally
in a 25cm^ flask and 1ml as a backup cultured in a 25 well cluster plate (Sterilin,
Middlesex, England).
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Table 2.1. Background inform ation on m onoclonal hybridom as.

FUB 1

LPS injected into C3H; spleen fused with P3.653;
IgM anti-BrMRBC, anti-phosphatidylcholine

FUB 3

Rat RBC injected into C3H; spleen fused with P3.653; IgM anti-BrMRBC,
anti-RtRBC

FUB 4

Rat RBC injected into C3H; spleen fused with P3.653; IgG anti-RtRBC

Cell viability was determ ined by mixing one volume o f hybridoma
suspension with one volume of 0.1% trypan blue (Sigma,T-0887) in sterile
phosphate buffered saline (PBS) and counting healthy yellow cells and dead blue
cells under a phase contrast microscope (Olympus C011) with a haemocytometer.
Viability of hybridomas expressed as a percentage was determined as the number
of viable cells divided by the total number of cells x 100, and this was used as an
indication of the health of the culture or if feeding or subculturing was required.
All cell lines sent from WEHI were screened for mycoplasma contamination
with a Mycotrim kit (Hana Media Inc., California T500-000) by aseptically
removing 1.0 ml of hybridoma culture medium containing 10^ to 10^ cells and
incubating this in a flask containing agar to support mycoplasma growth. This
flask is incubated for 4-7 days and examined for the growth of colonies and if
negative, the agar reinoculated by tilting the broth over the agar surface again and
incubated with the agar side up. All cell lines were negative for mycoplasma.
The hybridomas were maintained in 25 cm^ sterile flasks with canted neck
(Lux scientific corporation, 5350) or 75 cm^ sterile tissue culture flasks (Coming,
25110) with complete Dulbecco's Modification of Eagle's Medium (DMEM) in a
water-jacketed 5% CO 2 incubator (Forma Scientific). Each flask was flushed with
5% CO 2 in air through a 0.2 |im Acrodisc filter (Gelman Sciences, 4-192).
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One litre o f DMEM powder (FlowLaboratories 10-331-20 powder) was
reconstituted by the addition of 3.7 g/L sodium bicarbonate and 5 x 10"^ M
2-mercaptoethanol in 1 Litre of autoclaved glass distilled water and the pH adjusted
to 7.2 with sterile HC1 and NaOH. The medium was divided into 90ml aliqouts
and stored at 4°C until required. To make complete DMEM (C-DMEM), 10%
foetal calf serum (FCS) and antibiotics ( 5.0 IU/ml Penicillin and 5mg/ml
streptom ycin, Flow Laboratories, 16-700-49) were added to 90ml DMEM prior to
use. Foetal calf serum (Flow Laboratories, 29-101-49) was complement
inactivated by incubating in a water bath for 30 minutes at 56°C.
After storage at 4°C for 15 days C-DMEM was further supplemented with
584 mg/L filter sterilised L-glutamine (Flow Laboratories, 15-801-13). Medium
was sterilised by filtration through 0.22jim membranes (Millipore, type GS)
connected to a suction filtration unit (Millipore, X X I104700). All glass and plastic
disposable items were sterilised by autoclaving for 15-20 minutes at 115-120°C if
they had not previously been sterilised by gamma irradiation , and all hybridoma
work was conducted in a laminar flow cabinet (Gelman Science,CF 435).
Monoclonal antibodies were tested for anti-BrMRBC activity by suspension
c-ELISA with BrMRBC and NMRBC, harvested from culture supernatants and
stored at -80° C (long term storage) or -20°C (short term storage). The moifclonals
were used in various ELISA and immunoblotting experiments. IgM concentrations
of FUB 1 and FUB 3 monoclonal antibodies were quantified by immunodiffusion
in agar (see Section 2.2.3)
For freezing down cell lines, hybridomas were placed in liquid nitrogen
when actively dividing cells covered approximately 80% of the surface area of the
flasks. The cell suspensions were counted and centrifuged in sterile 25 ml
centrifuge tubes for 2500 rpm for 10 minutes. The supernatant was removed, and
the pellet resuspended in ice cold sterile FCS 40% + C-DMEM 60% and an equal
volum e o f dim ethyl sulphoxide (DMSO) 20%+C-DMEM 80% was added
dropwise with stirring for a final cell concentration of 1-5 x 10^ cells /ml. The final
ratio

of DMSO: FCS: C-DMEM in the freezing medium is 1:2: 8. One to
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two millilitres of cell suspensions were then placed in freezing vials (Sterilin,506)
held on ice, transferred to a -80°C freezer overnight and then placed in liquid
nitrogen the following morning.
Hybridomas were thawed by removing vials from liquid nitrogen and
swirling the vials in a 37°C water bath. The cell suspension was transferred to a
25ml centrifuge tube containing 15 ml of ice cold growth medium in C-DMEM
centrifuged at 2500 rpm for 10 minutes. The growth medium consisted of 20%
foetal calf serum in hypoxanthine thymidine medium (2% of 50 x HT stock
solution , Flow Laboratories 16-809-49). Cells were washed twice by this
procedure, resuspended in 7ml of growth medium and transferred to a 50 ml flask.
Depending upon the viability of the cells, supplements of 2-3ml of growth
medium were added to cultures from 2 to 5 days.

2.2.3. Q uantitation o f IgM from LPS-serum , normal mouse serum
and mouse monoclonal antibodies.
i

'

Several antibodies were quantised for the level of IgM present using a radial
immunodiffusion kit from The Binding Site (R.N. 278.2). Plates were removed
from storage at 4° C and allowed to equilibrate to room temperature. LPS-semm
was diluted 10-fold so that it would fall into the recommended assay range and
applied to the wells with a Hamilton syringe. Normal mouse serum was diluted 1:2
and the concentration of the monoclonal antibodies was doubled by two fills of the
wells over 30 minutes. The endpoint method for reading the results was adopted
because the calibrators could not be located, thus the minimum time required for
diffusion of IgM is 100 hours. The diameter of the rings was measured at 76,100
and 120 hours to determine the maximum ring diameter and the concentration of
IgM determined by reference to a table supplied with the kit.
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M ouse IgM M yeloma

Serban et al. (1981) have previously used MOPC 104E as a negative control
antibody for BrMRBC. It is an IgM myeloma protein with a specificity for
a - 1,3,linked dextran (Potter 1972). MOPC 104E was obtained as clarified
ascities from Sigma (M 2521).

2.2.5. Preparation and purification of

immune rabbit serum

IgG.

Rabbits were bled from the marginal ear vein into sterile containers. The
blood was allowed to clot overnight at 4°C and the serum removed the following
morning. In a 40ml polypropylene centrifuge tube, 1 volume of ice cold saturated
ammonium sulphate (BDH 45206) was added to one volume of immune rabbit
serum dropwise with stirring and left for 2 hours on ice before centrifuging in a
refrigerated centrifuge at 0°C for 20 minutes at 10,000 rpm. The pellet was washed
once in 50% ice-cold ammonium sulphate , dissolved in one volume of sterile
saline and dialysed overnight against several changes of physiological saline and
then distilled water. Small aliqots were stored at -20°C before use.
2.2.6.

Preparation and purification of rabbit complement

For the preparation of complement, rabbits were bled from the marginal ear
vein into sterile 50ml containers and immediately placed on ice. Blood was allowed
to clot on ice for 30 minutes and then centrifuged at 2000 rpm for 10 minutes in a
prechilled centrifuge (0°C, Sorvall RC 5B fitted with a HB-4 swing out rotor).
Serum was removed and absorbed on ice 3 times with 0.5 volumes of packed cold
MRBC, and 3 times with 0.5 volumes of BrMRBC. Absorbed rabbit serum for
use in complement dependent lysis assays was then stored at -80°C until required.
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2.2.7. Sources of other antibodies
Other commercial sources o f second antibody conjugates obtained from
Sigma were used in ELISA and blotting procedures, including goat a-mouse IgM
(p-chain specific)-alkaline phosphatase conjugate (A 7784), goat a-mouse IgM
(p-chain specific)-biotin conjugate (B 9265), streptavidin-alkaline phosphatase
(Dakopatt D 396) and goat a-Rabbit IgG-alkaline phosphatase conjugate (A 7539).

2.2.8. P reabsorp tion o f prim ary and secondary antibodies with
ery th ro cy tes.
Commercial second antibody preparations used for immunoblotting and
ELISA were routinely absorbed to remove a-BrMRBC and a-NMRBC antibodies
and later a-carbonic anhydrase antibodies. Second antibody (20 |il of stock diluted
10-fold in 1% Bovine serum albumin in PBS) was absorbed on ice three times
with 500 pi of packed NMRBC and then an additional three times with 500 pi of
packed BrMRBC.
For the pre-absorption of FUB 1 and LPS-serum, a 20% (v/v) packed pellet
of either BrMRBC or NMRBC was added for 60 minutes on ice then centrifuged
and the absorbed serum added to another packed erythrocyte pellet. This step was
repeated for a total of three rounds of absorptions .

2.2.9. R eduction o f IgM to m onom ers with 2-M ercaptoethanol,
2-m ercaptoethylam ine and Dithiothreitol.
For certain ELISA experiments, IgM monomers were produced to determine
if inhibition of binding to BrMRBC by carbonic anhydrase could be achieved more
effectively with monomers than experiments where IgM remains intact. Three
different m ethods o f reduction were attempted using 2-mercaptoethanol,
2-mercatoethylamine and dithiothreitol.
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One m illilitre of FUB 1 or 1:10 LPS was treated with either 0.01 M
2-mercaptoethylamine (Sigma M 9768) at 37°C for 75 minutes (Nisonoff et a l
1960), or treated with lOmM 2-mercaptoethanol at 37°C for 90 minutes or 0.02M
dithiothreitol at room temperature for 30 minutes (Stanworth and Turner, 1986).
The preparations were alkylated at room temperature with 50% molar excess of
iodoacetamide (Sigma I 6125) with the pH held between 7 and 8 with Tris-HCl
buffer. Reducing agents and iodoacetamide were removed by either dialysis or by
passage over a Sephadex G-25 column and the preparations returned to their initial
volumes by treatment with Aquacide.
2.3.E R Y T H R O C Y T E S
2.3.1. M ouse erythrocytes
Red blood cells were collected under ether anaesthesia from adult female
CBA/H mice , placed into Alsever's solution and used on the day of collection.
Erythrocytes were washed three times in phosphate-buffered saline (PBS, pH 7.4)
before use, carefully removing the buffy coat after each centrifugation step.
Bromelain-treated mouse red blood cells (BrMRBC) were prepared as described
by Cunningham (1974). One volume (0.5-1.0 ml) of packed RBC was treated
with one volume of 10 mg/ml bromelain (EC 3.4.22.4 , Sigma no. B 2252) in
PBS for 30 minutes at 37 °C. BrMRBC were washed an additional three to five
times in 10 ml volumes of PBS before use.
2.3.2. M ouse erythrocytes ghosts
Mouse erythrocyte ghosts were prepared basically as outlined by Dodge et al.
(1963). Mouse red blood cells were collected, pooled and washed in PBS. Some
cells were treated with bromelain and washed in PBS as outlined above (Section
2.2.2) and referred to in subsequent steps as BrM-ghosts as opposed to ghosts
created from normal mouse erythrocytes. A 50% (v/v) suspension of RBC was
made in isotonic PBS and to every 2ml of this suspension, 28ml of ice-cold 20
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m illiosm ole hypotonic phosphate buffer , pH 7.4, was added. Ghosts were
pelletted by centrifuging in 40 ml polypropylene centrifuge tubes at 12,000 rpm
for 1 hour (20,000g) in a Sorvall RC-5B refrigerated centrifuge set at 4°C and
fitted with a HB-4 swing out rotor The supernatant is carefully decanted and the
pellet resuspended in hypo tonic lysis buffer and washed a further three times.
The washed ghost pellet was finally resuspended overnight in 0.1 N KOH at
room temperature to prepare protein-free ghosts as outlined by Dodge et al.
(1963). Small aliqouts were washed in isotonic PBS to remove KOH before use.
Protein-free ghosts were used in initial experiments, but in later experiments
ghosts were finally resuspended in isotonic PBS instead of KOH and stored at 4°C
for immediate use or -20°C for longer term storage.
Ghosts prepared from NMRBC form a pearly white p e lle t. It was noted
however, after hypotonic lysis (under identical conditions in a number of different
experiments) that BrM-ghosts were still slightly pinkish, possibly indicating that
not all o f the haemoglobin could be removed from BrM-ghosts. Protein was
determ ined by a m icro-Lowry assay using Bovine serum albumin (BSA;
Boehringer Mannheim 775860 Fraction V) as a standard (Section 2.7.1.), the
number of ghosts/ml were counted using a haemocytometer, and dry weight/ml
determined by drying and weighing aliquots of ghost suspensions.
2.3.3. Erythrocytes from other species.
Blood from a range of species including CBA/H mice, NZW rabbits, and
young W istar Rats- was obtained by standard methods of either ear bleeding or
heart puncture into Alsever's solution from animals housed at the University of
Wollongong. Defibrinated sheep and horse red blood cells were obtained from
Filtron Pty Ltd, Brooklyn Victoria. Human group O blood was supplied by the
author into Alsever's solution. All red blood cells were tested for A and B blood
group substances by direct agglutination with typing sera obtained from
Commonwealth Serum Laboratories, Victoria (Anti-A
01021001).

01011001 & anti-B
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2.4. ASSAYS FOR BROM ELAIN-TREATED MOUSE RED BLOOD
CELLS
2.4.1 H aem olytic assay
The technique of Cunningham and Steele (1981) was used. Serial dilutions
of LPS-serumwere made in 50 jil vol of Hank's balanced salt solution containing
5% BSA, 25 pi of Rabbit complement (as in Section 2.2.6 above), followed by
25 |il of either 1% NMRBC or 1% BrMRBC. The endpoint of titration was read as
approximately 50% lysis after lhr.
2 .4 .2 .

S u sp en sion

C ellu lar

E n zym e-lin k ed

Im m unoassays

For

E rythrocytes
A suspension c-ELISA was used to detect BrMRBC-specific antibodies
because fixatives such as Poly-L-Lysine and glutaraldehyde, as well as the process
of adsorption of normal erythrocytes to plastic microtitre plates, exposes
neo-antigens on normal red blood cells (Jonusys and Steele, 1988). Microtitre
plates were blocked overnight at room temperature with IO O jllI of 1% BSA in PBS.
Plates were aspirated and serial two- or three-fold dilution of antibody were made
in 1% BSA. Fifty microlitres of a 2% suspension of RBC in PBS were added and
allowed to incubate for 90 minutes at room temperature.
Erythrocytes were pelleted in microtitre plates by centrifugation at 2,000 rpm
for 5 m inutes and washed three times with 100pl of 1% BSA in PBS.
Subsequently, centrifugation at 1,000 rpm for 5 minutes was found to be sufficient
to pellet RBC without excessive lysis occurring and was used in later experiments.
RBC were transferred to another microtitre plate that had been blocked overnight
with 1% BSA in PBS and 50pl of second antibody applied. The transfer steps
were found to be essential to remove background due to antibodies and complexes
of antibody and lysed red blood cells binding to plastic microtitre wells that are a
source of background in conventional ELISA with erythrocytes (Jonusys and
Steele, 1988).
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a -m o u s e IgM second

antibodies were used, the incubation was allowed to proceed for 1 hour before a
further round o f washing and substrate application. In some

later ELISA

experiments, a biotinylated second antibody was used in conjunction with
streptavidin alkaline phosphatase. Fifty microlitres of 1:5000 biotinylated goat
a-mouse IgM second antibody added to each well and left for 3 hours. Plates were
centrifuged and aspirated, then 50|il of 1:2000 streptavidin-alkaline phosphatase
added and left for 1 hour. The replicate error between duplicate titrations in ELISA
assays expressed as a percentage varies between 2-10%.
A method published by Klinman and Steinberg (1988) using fixed RBC to
evaluate anti-BrM spleen cells was found to be unsuitable for serum antibodies and
monoclonals. In this method, 0.1% RBC are allowed to form a monolayer and
adhered to microtitre wells by the addition of 0.15% gluteraldehyde in PBS for 5
minutes. The plates are washed with PBS and air-idriedL for 3 hours before
blocking in 1% BSA and the assay continued as for a conventional ELISA assay
by titrating antibodies instead of spleen cells. When this method of attaching
erythrocytes to microtitre wells was adapted to ELISA assay conditions rather than
an ELISA-Spot assay, high binding titres were noted against both BrMRBC and
NMRBC. Thus, this method of attaching NMRBC to ELISA plates was found to
be unsuitable and therefore not routinely used.

2.4.3. Direct agglutination of mouse erythrocytes

(Direct Coomb's

test)
Rabbit anti-BrM serum that has been extensively absorbed with NMRBC to
remove cross reactive antibodies was titrated against BrMRBC and NMRBC in
two or three fold steps from neat in 50 |il of 1% BSA for measurement of total
specific immunoglobulin. For the measurement of IgG, serum was titrated in the
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presence o f 1:70 2-m ercaptoethanol (BDH 44143) and incubated at room
temperature in a fume hood for 1 hour. Fifty microlitres of a 2% RBC suspension
was added to each well and incubated at 30°C.
2.4.4. Direct Binding ELISA for erythrocyte ghosts.
Ghosts were allowed to bind to microtitre plates for two hours, centrifuged
for 15 minutes at 1,000 rpm and washed twice in 1% BSA in PBS. Plates were
blocked in 1% BS A in PBS for 90 minutes. First antibodies were applied, then the
plates were treated in the same manner as descibed for the suspension assay from
this step onward.

2.5.BLO O D GROUP SUBSTANCES AND SEROLOGICAL TESTS
FOR RBC.
2.5.1. Preparation of blood group substances.
Blood group substances were prepared from a pool of 90 CBA/H retired
breeder female mice and a separate pool of 71 mice according to the Kabat method
(Kabat 1956). Mice were given water but food pellets were removed the night
before the collection o f stomachs. Stomachs were removed and flushed with
approximately 1ml of sterile PBS (gut washings), then the stomach open ed and
the mucosal surface was gently scrap ed with the handle of a scalpel blade into
approximately 2ml of sterile PBS (gut scrapings).
Gut washings and scrapings were digested separately with pepsin (Sigma,
Porcine stomach mucosae P6887) in 0.5 M citrate-HCl buffer , pH 2.3, and
incubated at 37 °C with the addition of 1ml of toluene to maintain sterility. The pH
was checked daily and adjusted with HC1 if required. On day 12, the digest was
filtered , brought to pH above 5 with solid sodium acetate and blood group
substances were precipitated overnight with 3 volumes of ice-cold absolute
alcohol. The precipitates were washed twice with absolute ethanol, dried and used
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at concentrations of lm g solid/ml diluent without further purification or evaluation
in dot blot experiments.
Occasionally, an extract of fresh gut was prepared from 1-2 mice by scraping
the mucosae into sterile saline , centrifuging the solids and evaluating the proteins
in the supernatant by SDS-PAGE or immunoblotting.

2.5.2. Treatm ent o f erythrocytes with AET and periodate.
One way to determine if blood group antigens are involved in unknown
erythrocyte epitopes is to use substances that are known to destroy these antigens
specifically on hum an red blood cells. A 6% aqueous solution of
2-aminoethylisothiouronium bromide (AET, Sigma A 5879) destroys antigens that
are part of the Kell blood group system. Incubation of NMRBC or BrMRBC in
aqueous solutions of AET results in lysis, so AET was also dissolved in PBS, pH
7.2. Four millilitres of 6% AET is added to 1ml of washed and packed RBC and
incubated for 20 minutes. The treated RBC are then washed three times in PBS
before use (American Association of Blood Banks Technical manual 1985).
Aqueous solutions of sodium meta-periodate have been used to destroy
human A, B, O, H, P, M, N, D and Lea

human blood group antigens

(Kabat,1956). Periodate solutions were prepared at 0.005M pH 4 and 0.001 M pH
5 and were used in a 1:1 ratio with packed NMRBC and BrMRBC for 15 minutes
at room temperature in a foil-covered test tube. Cel^were washed three times m
PBS before use.
2.6. PREPARATION OF AFFINITY COLUMNS
A ffin ity

ch ro m atography

gels

w ere

p repared

w ith

cyanogen

bromide-activated Sepharose 4B according to manufacturer’s recommendations
(Pharmacia Fine Chemicals, North Ryde, Australia; Affinity Chromatography
principles and methods, 1979). An appropraite amount of cyanogen-bromide
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activated Sepharose was weighed and regenerated in ImM HC1 for 15 minutes.
The gel was then washed three times with 200ml/g Sepharose of 1 mM HC1 on a
sintered glass filter attached to a Buchner flask and vacuum pump. The gel is then
washed with coupling buffer, 0.1 M NaHCC>3 containing 0.5 M NaCl, pH 8.3,
and transfered to a sterile centrifuge tube containing the ligand to be coupled to the
gel at 5-10 mg protein per ml. Three types of ligand were coupled to Sepharose,
namely BrM-ghosts, Rabbit a-BrMRBC serum and bovine carbonic anhydrase.
Coupling was allowed to take place on an end-over-end rotator overnight at
4°C. Coupling efficiency was determined by measuring the amount of protein in
the original sample and the amount of protein remaining in the supernatant after
conjugation by measuring the optical density in quartz cuvettes at 280nm. The
coupling efficiency is determined b y :
Coupling efficiency - Protein before conjugation - protein after conjugation x jqo
Protein before conjugation

Reactive groups were blocked for 2 hours at room temperature with 1M
ethanolamine, pH 8.0, and the gel was washed in alternating cycles of coupling
buffer and acetate buffer (0.1M acetate containing 0.5M NaCl, pH 4). The gel was
stored at 4°C in PBS-0.1% sodium azide.
2.7.PURIFIED ANTIGENS AND CHEMICALS
2.7.1. Purified proteins and protein assay
A number of purified proteins were purchased from Sigma and assessed by
western blotting including glycophorin A ( G 5017), human asiaologlycophorin (A
9791), carbonic anhydrase from bovine(C 7500), human (C 6892), rabbit (C
1266) and dog (C 3513) erythrocytes. Fetuin (F 2379) and asialofetuin (A 1908)
were purchased from Sigma and used as controls to assess the removal of sialic
acid by neuraminidase and O-linked carbohydrates by O-glycanase.
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Lowry protein asays (Lowry et a l 1951) were scaled down so that they
could be conducted in eppendorf tubes and processed in microtitre plates.
Standards were prepared from a stock solution of 500jig/ml BSA in 200|il
volumes. Protein samples were diluted so that the amounts of protein were within
the same range as the standards. Lowry reagents were made up on the day of use
and consisted of : Reagent A - Na2CC>3

w/y) in 0.1M NaOH; Reagent B -

lm l of C uS04. 5H20 (1% w/v) and 1 ml potassium tartrate (2% w/v); Reagent C
- 2ml of Reagent B and 48ml of Reagent A; Reagent D - 1:1 ratio of Folin &
Ciocalteu’s phenol reagent and distilled water.
To each 200|il sample or standard, 1 ml of reagent C was added and allowed
to incubate at room temperature for 15 minutes. Reagent D is then added at 0.1ml
per tube, mixed by inversion and allowed to incubate for 30 minutes. A 200 jxl
aliquot from each tube was transferred to the wells of a microtitre plate and the
optical density measured at 630 nm. The amount of protein in the sample was
determined by reference to a standard curve and the line of best f it.

2.7.2.

B uffers

Alsever's solution was obtained as a filter sterilised solution from the John
Curtin School of Medical Research. Sterile saline was prepared by autoclaving a
0.85% (w/v) NaCl solution. Phosphate buffered saline consisted of 0.85%(w/v)
NaCl, 0.107% (w/v) Na2H P 0 4, 0.39% (w/v) Na H2P 0 4 and 0.2% (w/v) NaN3,
pH 7.2.
Bovine serum albumin was prepared as a 1% or 3% (w/v) solution in PBS
with 0.1% (w/v) NaN3 from a 10% (w/v) stock solution of BSA in water. Gelatin
was prepared as a 0.5%(w/v) solution, with 0.5%(v/v) NaCl and 0.5%(v/v)
polyoxyethylene monolaurate (Tween 20).
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2.8. POLYACRYLAM IDE
2 .8 .1 .S D S

GEL

ELECTROPHORESIS (PAGE)

-PA G E

The discontinuous SDS-PAGE method of Laemmli (1970) with 4-6%T
stacking gel and 15-20%T separating gel was used in a minigel system (Biorad
Mini Protean II) at 200V constant for approximately 55 mins for 0.75x 10 x 7 cm
gels .

M inigels were poured from a 30% total acrylamide (%T), 2.67%

crosslinked (%C) stock, diluted to 10%T, 12.5%T, 15%T or 20%T as indicated.
Acrylamide solutions were made 0.1% with respect to SDS and polymerisation
initiated with N,N,N,N,-tetramethylethylenediamine (TEMED, Biorad 161-0800)
and catalysed with ammonium persulphate (Biorad 161-0700). The separating gel
was cast and overlayed with water saturated butan-l-ol to exclude oxygen and
allow polymerisation to proceed uninhibited. Before the stacking gel was poured,
butanol and any unpolymerised acrylamide are washed off with distilled water and
a litde unpolymerised stacking gel solution. Stacking gels were poured with the
appropriate combs.The composition of the upper and lower gel buffers is given in
Table 2.2:

T ab le 2.2. G el com position
Composition of gels(ml)
Total (10ml)

Stacking gels
4% T
6% T

6.1
Distilled water (autoclaved Milli-Q)
Lower gel buffer (1.5M Tris-HCl,pH8.8) Upper Gel Buffer (1.5M Tris-HCl, pH6.8) 2.5
0.1
10% SDS
Acrylamde/bis acrylamide (30% stock)
1.3
0.05
10% Ammonium persulphate
0.01
TEMED

5.4
2.5
0.1
2.0
0.05
0.01

Separating gels
15%
10% 12%
4.02
2.5
-

0.1
3.33
0.05
0.005

3.19
2.5
-

0.1
4.16
0.05
0.005

2.35
2.5
0.1
5.0
0.05
0.005

20%
0.68
2.5
-

0.1
6.67
0.05
0.005
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Samples were diluted in either 2x or 5x sample buffer either with or without
2-mercaptoethanol as a reducing agent, and either boiled at 100°C for 5-10mins or
allowed to remain at room temperature before loading onto gels. Sample buffer (5x)
consisted o f 4 ml o f distilled water, 1 ml of 0.1M tris-HCl, pH 6.8, 0.8ml of
glycerol, 1.6ml of 10% stock SDS, 0.4ml of 2-mercaptoethanol and 0.2ml of 0.05%
bromophenol blue. Sample loads were adjusted depending upon the staining
method to be used, since Coomassie Blue will stain approximately lp g of protein
and silver stain lng. Minigels were electrophoresed at 200V constant for 30-50
minutes or 100V constant for 60 minutes depending upon the migration of the
bromophenol blue tracking dye.
After electrophoresis, gel^were stained or electroblotted or photgraphed as
appropriate, and stored in sealed plastic bags with either 7% acetic acid or distilled
water-0.1% sodium azide. Molecular weight markers were purchased from Biorad
(Low range 161 0304 and High range 161 0303 ) and prestained molecular weight
markers from Sigma Chemical Co. (SDS-7B) were used to ensure transmission of
protein to nitrocellulose in pilot western blotting experiments (Table 2.3). Standard
proteins o f known pi were purchased from Biorad (161 0310) for use in IEF
experiments.

2.8.2 Staining m ethods for proteins and glycoproteins
Gels were stained for proteins using either Coommassie Blue, collodial
Coomassie Blue for detecting nanogram amounts of proteins in gels (Neuhoff et al.
1988) or silver staining and for glycoproteins by Alcian Blue or periodic acid-Schiff
Base stain. The composition of the stains is presented in the following Tables. Silver
staining was conducted according to the method of Merril et al. 1981 using a kit
from Biorad (Table 2.5) and occasionally gels were double stained with Coomassie
Blue and silverstained following the methods of Dzandu (Dzandu et al. 1984,1985a
&b; Deh etal. 1985).
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The Alcian Blue (Wardi and Michos 1972) and Periodic acid-Schiff methods
(Sam s and Palade 1979) were used to stain gels for glycoproteins. Alcian Blue is
used in histology to stain acid mucopolysaccharides, sulphated mucopolysaccarides
and sialic-acid containing compounds (Kieman 1981). Gels are soaked overnight in
40% methanol/10% Glacial acetic acid, stained in Alcian Blue (0.5%w/v Alcian Bue,
3%v/v glacial acetic acid to 100ml with distilled H^O; filter and add a crystal of
thymol) for 10-30 min and rinsed in running distilled water until the background is
clear.
For Schiff s staining for carbohydrates, gels were fixed in 40% methanol/10%
glacial acetic acid overnight and reswollen in 7% acetic acid. Gels were oxidised
with 1% periodic acid in 7% acetic acid for 1 hour in the dark at 4°C and washed
several times with 7% acetic acid over 24 hours. Schiff s Acid Fuschin (Sigma S
5133) was used to stain the gels for 1 hour at 4°C and then destained in either 10%
acetic acid or 1% sodium metabisulphite in 1% HC1.
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and IEF m olecular w eight m arkers

Mwt (Daltons)

Phycocyanin
Myosin (rabbit muscle)
Alpha 2 macroglobulin
(human plasma)
Beta-galactosidase E .coli,
Phosphorylase B
(rabbit muscle)
Fructose-6-Phosphate Kinase
(rabbit muscle)
Bovine serum albumin
Haemoglobin A (human)
Haemoglobin C(human)
Pyruvate Kinase (chicken muscle)
Lentil lectin (Three bands)
Fumerase (Porcine heart)
Ovalbumin
Lactate dehydrogenase
(Rabbit muscle)
Carbonic anhydrase
(Bovine erythrocyte)
Human Carbonic anhydrase
Trióse Phosphate isomerase
(Rabbit muscle)
Soybean Trypsin inhibitor
Beta-Lactoglobulin B
Myoglobin (Equine)
Lysozyme
Cytochrome c

H igh*

232,000
200,000
180,000

•

116,000
97,400

•
•

Low

31,000

•
♦
♦

•
•

•
(7.10)
(7.50)
•
(7.8,8.0, 8.2)
•

•

•
♦

(6.00)

•

(6.50)

28,000
26,600
21,500
18,400
17,500
14,400
12,200

IEF(pI)

(4.65)

84,000
66,200
64,500
64,500
58,000
49,000
48,500
45,000
36,500

Prestained

•
♦
(5.10)
(7.00)
♦
(9.60)

* High molecular weight markers; Low molecular weight markers; Prestained markers
with Coomassie Blue attached to allow direct visualisation of separation of proteins
during an electrophoresis run and visualisation of blotting efficiency; IEF -isoelectric
focussing markers and corresponding pi.
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T able 2.4. Coom assie Blue stains for pro tein s.
Coomassie Blue R-250 stains for proteins
Conventional

Neuhoff et al. 1988

Fixative

40% Methanol,10% Acetic acid 1 hr

12% Trichloroacetic acid, 1hr

Stain composition

0.1% CBB R-250 in fixative.

6% w/v ammonium sulphate
0.1% w/v CBB R-250
2.0% w/v phosphoric acid
20% v/vmethanol

Destain

40% Methanol, 10% Acetic acid
(1-3 hours,overnight)
Hg

No destaining required,

Range

ng

T able 2.5. Silver stain in g protocol.
Fixative 140%Methanol/10%HoAc(v/v)
Fixative II 10%Ethanol/5% HoAc (v/v)
Oxidizer (potassium dicromate/nitric acid)
Deionized water
Silver reagent (silver nitrate)
Deionized water
Developer (sodium carbonate/paraformaldehyde)
Stop 5% acetic acid

30 min
2 x 15 min
5 min
2 x 5 min
20 min
1 min
30 sec, then 2 x 5min
5 min
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2.9. IM M UNO BLO TTING TECH NIQ UES
2.9.1. W estern B lotting
W estern blotting is a pow erful technique to separate and visualise
immunoreactive protein components of cells or mixtures of proteins (Towbin et a l
1979; Burnette 1981; Gershoni and Palade 1983; Beisiegel 1986). Western blotting
onto nitrocellulose was conducted according to the principles of Towbin et a l (1979)
using a mini-transfer system (Biorad Mini Trans-blot) and a 25 mM Tris-192 mM
glycine, 20% (v/v) m ethanol buffer, pH 8.3 for 1 hour at 100V constant
(250-260mA). Blots were dried at room temperature, blocked with 3% BSA in PBS
overnight at room temperature on a ro ck er, and washed extensively with 20 ml PBS
containing 0.1% Tween 20 during all washing steps. Various times of incubation
and concentrations of primary antibody were used and have been indicated in the
appropriate sections.

The biotinylated goat a-mouse IgM antibodies (Sigma B 9265) used at 1:2500 or
1:5000 to develop the blots, were routinely preabsorbed with NMRBC and
BrMRBC to remove antibodies that were capable of directly binding to carbonic
anhydrase-associated determinants on mouse erythrocytes. An alkaline phosphatase
detection system (Leary et al. 1983) involving 1:2000 or 1:2500 streptavidin-alkaline
phosphatase (Dakopatts D396), nitroblue tetrazolium (Sigma N6876) and
5-brom o-4-chloro-3-indolyl phosphate, p-toluidine salt (B 8503 Sigma)
(NBT/BCIP) in diethanolamine/HCl buffer pH 9.2 was used. For 100ml of
diethanolamine buffer, 0.033g NBT in 440 p.1 of 70% dimethylformamide and
0.0165g BCIP into 330jil of 100% dimethylformamide are used. NBT and BCIP
are added to diethanolam ine im m ediatlely before use and the reaction on
nitrocellulose blots was allowed to proceed for 15-30 minutes. The reaction may be
terminated by washing each blot extensively with running deionized water then
drying with a hair dryer.
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In earlier western blotting experiments, including most of the dot blots, Fast Red
was used as a substrate for alkaline phosphatase. Napthol ASBI phosphate (Sigma
No N 2250) was dissolved in 0.1M T ris-H C l buffer containing lOOmg/L
M gC l 2 7 H 2 O. Fast Red (Sigma No F I 500) was added to the Napthol solution at
lm g/m l, mixed vigourously, filtered and adjusted to pH 9.2 before use.
Some blots were stained for total protein using Amido Black 10B (Syu and
Kahan 1987).

Blots were placed in 0.1% (w/v) Amido Black in 45% (v/v)

methanol, 10% (v/v) acetic acid for lOmins and destained with 90% (v/v) methanol,
2% (v/v) acetic acid.
2.9.2. L ipid im m unoblotting
Two methods of lipid immunoblotting have been published (Buehler and Macher
1986; Towbin et al. 1984). Following the basic procedure of Buehler and Machler
(1986), 20jal o f fresh gut and NMRBC were spotted on Silica gel 60 thin layer
chromatography microslides (Analtech) and allowed to dry at room temperature. The
slid es

w ere p lac ed

into

chrom otography

tanks preeq u ilib rated with

chloroform:methanol:water (60:35:8), and allowed to run until the solvent front was
0.5cm from the top of the slide. M icroslides were removed from the tank and
allowed to dry for 1 hour in a fume hood. The TLC plate was sprayed with
isopropanol:water (2:1) from an atomiser until damp, and nitrocellulose layed over
the plate with pressure applied with a 1-2 kg weight for 2 hours. Nitrocellulose was
rem oved and allowed to dry, then blocked with 1% gelatin and treated with LPS
serum (1:40), goat anti-mouse IgM-alkaline phosphatase conjugate (1:1000) and
Fast Red substrate.
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F O C U S S IN G

AN D

T W O -D IM E N SIO N A L

M APS OF M OUSE ERYTHROCYTES
2 .10.1 Iso electic focu ssin g
The aim of conducting isoelectric focussing experiments was two-fold, to
establish if the immunoreactive bands on SDS-PAGE were due to one type of
protein only and to determine the isoelectric points of these bands. Isoelectric
focussing has been used by several groups to determine 2-D maps of human
erythrocyte membranes (O'Farrell, 1975) or whole red cell lysates (Edwards et al.
1979).
Isoelectric focussing was conducted in capillary tubes using a Miniprotean II
tube cell ( B io rad ) according to the method of O'Farrell (1975). The composition
of the gel monomer and sample buffers is summarised in Tables 2.6, 2.7 and 2.8.
Capillary tubes were filled with monomer solution and allowed to polymerise.

T able 2.6. Tube gel m onom er solution (10m l)

9.2M urea

5.5g

4% acrylamide

1.3ml stock acrylamide/bis (30%T/5.4%C)

2% Triton X-100

2.0ml of 10% deionized Triton X-100

1.6% Biolyte 5/7 ampholyte

0.400ml 5-7 ampholyte

0.4% Biolyte 3/10 ampholyte

0.100ml 3-10 ampholyte

Distilled water

1.97ml

0.01% ammonium persulphate

lOpl 10% ammonium persulphate

0.1% TEMED

10pl
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T able 2.7 F irs t dim ension sam ple b u ffer (10ml):

9.5M urea

5.7g

2% Triton X-100

2.0ml of 10% deionized Triton X-100

5% p-Mercaptoethanol

0.5ml

1.6% Biolyte 5/7 ampholyte

0.400ml 5-7 ampholyte

0.4% Biolyte 3/10 ampholyte

0.100ml 3-10 ampholyte

Distilled water

to 10ml

Store at -80°C in 0.5ml aliquots

T able 2.8. F irs t d im ension sam ple o verlay b u ffer (10ml):

9.0M urea

5.41g

0.8% Biolyte 5/7 ampholyte

0.200ml 5-7 ampholyte

0.2% Biolyte 3/10 ampholyte

0.050ml 3-10 ampholyte

bromophenol blue

0.050ml of 0.05% stock solution

Distilled water

to 10ml

Store at -80°C in 0.5ml aliquots

The tube gels were pre-electrophoresed using either a Pharmacia 2000/2.0 or an
LKB 2197 power supply at 200V for lOmins, 300V for 15 mins and 400V for 15
mins with degassed 20mM NaOH present in the upper chamber and lOmM H 3PO 4
in the lower chamber. Protein samples dissolved in first dimension sample buffer
were then loaded , overlayed with overlay buffer and electrophoresed at 500V for
lOmins, then 750V for 3.5 hours. IEF gels were removed from the capillary tubes
and either stained directly for protein or soaked for 10 minutes in SDS equilibration
buffer (Table 2.9) prior to layering the gel onto a second dimension SDS-PAGE.
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For staining proteins in IEF gels, the gel was fixed in 5% sulphosalicylic acid
(M erck 1194746) and 10% trichloroacetic acid (TCA, Ajax chemicals,558) for 1
hour. Ampholytes were removed by methanol:acetic acid:water (3:1:6) and then
stained with 0.2% Coomassie Blue R-250 in the ampholyte removal buffer or
silverstained (Table 2.5.). Gels were fixed with 30% methanol,10% TCA, 3.5%
sulfosalicyclic acid for 1 hour and rinsed several times over 2 hours with 30%
methanol/10% TCA to remove the carrier ampholytes before silver staining.

2.10.2.

Two dim ensional electrophoresis of red blood cell lysates.

Isoelectric focussing in the first dimension was performed as outlined in the
previous section. Tube gels were extruded from the capillary tubes and equilibrated
in SDS sample buffer (Table 2.9.), then placed onto the top of a conventional
SDS-PAGE gel and electrophoresed in a standard way (Section 2.8.1.). Two
dimensional protein maps are useful for determining if a single band in SDS-PAGE
gels is composed of one or more proteins, or determining if some protein component
of cells is altered in disease states (O’Farrell 1975; Edwards et aL 1979; Dunbar
1987.). Low m olecular weight m arkers were electrophoresed in the second
dimension in a separate well to assist in locating the murine carbonic anhydrase
bands on two dimensional maps.
Table 2.9. SDS sam ple equilibration buffer

0.0625 M Tris-HCl,pH6.8

12.5ml of 0.5M Tris, pH6.8

2.3% (w/v) SDS

23ml 10% (w/v)SDS

5% (v/v) p-mercaptoethanol

5ml

10%glycerol(w/v)

8ml

Bromophenol Blue

2.5ml of 0.05% (w/v) stock

Distilled water

to 100ml
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IM M U N O A SSA Y S

FO R

CA RBO NIC

A N H Y D R A SE.
2.11.1. D irect binding assays for carbonic anhydrase
For the measurement of antibody titres against carbonic anhydrase, the inner 60
wells of a glastic microtitre plate were coated overnight at room temperature with
50jil of a QrS- mg/ml solution of bovine carbonic anhydrase that had been either left
untreated (dissolved in phosphate-buffered saline) or denatured in various ways.
Carbonic anhydrase was denatured by the following treatments: Acid treatmentlm M HC1, pH 2.4 ; Heat- 60°C for 15 mins in phosphate-buffered saline; SDS +
Heat- Heat in 10% SDS (Laurylsulfate, sodium salt L 4509) for 15 mins at 60°C;
Urea - 10M urea (Sigma U 5378); Gu-HCl - 8M guanidine-HCl (Sigma G 4505).
Concentrations of urea and guanidine-HCl used here are above the concentrations
known to produce random coils of purified human carbonic anhydrase (Carlsson et
al 1973).
W ells were aspirated and then blocked with lOOjil of 1% bovine serum albumin
for 90 mins at room temperature. FUB 1 was titrated in three-fold steps and allowed
to incubate for 90 mins. Plates were washed three times with lOOjil/well of 1% BSA
and then coated with 50jil of 1:5000 Biotinylated Goat a-mouse IgM for 3 hours.
Plates were aspirated and 50jil of 1:2000 Streptavidin-alkaline phosphatase allowed
to bind for 1 hour. After three more washes,lOOjil of p-nitrophenylphosphate
substrate in diethanolamine/HCl buffer, pH 9.2, was applied to each well and
absorbance read at 410nm at 30 and 60 minutes. Endpoint titres were defined as the
reciprocal of the dilution of FUB 1 at an OD cutoff point of 0 .2 at 30 minutes.
2.11.2 Competitive inhibition assays for carbonic anhydrase
In competitive inhibition assays with carbonic anhydrase, plates were coated
overnight with 50|il of 500p.g/ml bovine carbonic anhydrase. Wells were blocked
for 90 mins with lOOpl of 1% BSA in PBS. FUB 1 was titrated in the presence of
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200jj,g/ml carbonic anhydrase with the remainder of the procedure the same as a

standard ELISA from the second antibody step onward.

2.12

M URINE CARBONIC ANHYDRASE

2.12.1. M ouse stom ach carbonic anhydrase
The method of Carter and Parsons (1970) for the separation and purification of
guinea pig gastric mucosae carbonic anhydrase was followed. 30 CBA/H retired
breeder female mice were exsanginated under ether anaesthesia. Blood was collected
as before, and the stomach was removed. The contents were washed out with
ice-cold sterile PBS, and the mucosae removed with a glass slide that had been
swabbed with 70% ethanol. The pooled mucosae was homogenized (6.2g wet
weight) with 10ml of 0.3 mol/L sucrose in sodium phosphate buffer 30m mol/L, pH
7.2 at 0°C, using a glass homogenizer and teflon-coated plunger (10ml capacity, 50
(vJ/vz )

return strokes). Excess protein was precipitated with 55% ammonium sulphate
(326g solid/L supernatant). Concentrate supernatant with Aquacide if required before
fractionation on Sephadex G-75. Running and eluting buffer for run 0.1 mol/L
solution o f Na 2 SC>4 containing sodium phosphate buffer (0.05mol/L) pH 7.2.
Fractions tested for protein by the micro-Lowry method, and positive fractions mn
on SDS-Page and western blots.
2.12.2.

M ouse erythrocyte carbonic anhydrase

Erythrocytes were collected from the same 30 mice, pooled and washed in PBS.
One volume of packed RBC were lysed with 2 volumes of ice-cold distilled water
(u / v )

_

and fractionated with solid ammonium sulphate (45%ftof final volume). The pH was
m onitored and maintained at pH 7.2 by the addition of NH 3 solution while the
solution was stirred on a magnetic stirrer for 1-2 hour at 2-4°C. The precipitate
containing most of the haemoglobin was removed by centrifugation at 10,000 rpm
for 1 hour at 0-4°C. The supernatant was retained and fractionated on DEAE
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-Sephacyl (Pharmacia) with 8mmol/L Triethanolamine-HCl (Sigma T1502), pH 7.8
and 25 mmol/L Triethanolamine-HCl, pH 4.6. Protein-containing fractions were
analysed by SDS-PAGE.

2.13. EPITOPE ANALYSIS OF CARBONIC ANHYDRASE
2.13.1. C arbohydrate epitopes
Exam ination o f the mouse carbonic anhydrase II sequence obtained from
examination o f DNA suggests that possible sites of glycosylation (Ser , Thr and
Asn) are located at the N-terminal end. On the basis of the molecular weights of the
constituent amino acids of carbonic anhydrase, between 3-6% of the molecule may
be accounted for by post-translational modifications such as carbohydrates. From the
mouse CA II sequence, any carbohydrate linkages are likely to be of the O-linked
type, with linkages on Ser and Thr only, because there is no sequence of tripeptides
that follows the m otif for N-linked carbohydrates i.e. Asn-X-Ser(Thr) (Spiro
1973). At this stage it was considered superfluous to use additional enzymes to
rem ove N-linked carbohydrates when the possibility of them occurring seemed
improbable. Two main methods of deglycosylation were attempted. In one method,
carbonic anhydrase was deglycosylated with specific enzymes to remove O-linked
carbohydrates and in the other method sodium meta-periodate was employed. The
enzym e that specifically rem oves O -linked carbohydrates is endo-alphaN-acetyl-D-galactosam inidase from Diplococcus pneumoniae

(O-glycosidase

Boehringer Mannheim Cat No 1012 142 or O-glycanase EC 3.2.1.97 pH 6-7 Mwt
160,000).T his enzym e has been shown to specifically rem ove O-linked
oligosaccharides attached to either Ser and Thr (Umemoto et al 1977). It is known
that sialic acid may interfere with this reaction, thus the glycoprotein must be treated
with neuraminidase prior to endoglycosidase treatment.
In experiments where carbonic anhydrase was deglycosylated with enzymes, the
reaction mixture (total final volume 40fil) containing 10jil of lmg/m l protein
(lOOjig) was prepared in 20mmol/l sodium cacodylate buffer. Control proteins
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included fetuin to check for the effectiveness o f the neuraminidase digestion, and
asialofetuin as a control protein for O-glycosidase digestion. Ten milliunits of
neuraminidase i.e. 10|il (1U, Boehringer) was added to the protein and incubated at
37°C for 19 hours. 2.5 mU of O-glycosidase i.e.

5 jli1,

from Diplococcuspneumoniae

was then added and incubated at 37 °C for 24 hours. The reaction was quenched by
addition of IOjllI of 5X reducing sample buffer.
In some preliminary experiments, mouse carbonic anhydrase bands were excised
from SD S-PAGE gels or whole m ouse erythrocytes were digested with
neuraminidase and O-glycanase and electrophoresed on a second SDS-PAGE gel.
These conditions that digested an aqueous solution of protein were not optimum for
digestion o f carbohydrates from w hole cells or proteins imm obilised in
polyacrylamide gels.
Periodate oxidation was conducted according to the method of Spiro (1966).
BCA was dissolved at 5mg/ml in 0.05M sodium acetate buffer, pH 4.5. Sodium
metaperiodate in sodium acetate buffer was added at final concentrations of 0.01M
and 0.08M, due to the unknown amount of carbohydrate present and the unknown
consumption of periodate. The reaction took place at 4°C in the dark overnight. The
solutions are then place in dialysis bags and dialysed extensively against 3x 0.15M
NaCl x 3L, then 3x d ^ O x 3L. The volume is reduced back to the original volume
with Aquacide.
2.13.2. P rotein analysis
One approach to defining the sites on carbonic anhydrase that are recognised by
LPS serum and FUB 1 would involve proteolytic cleavage of the protein at certain
restricted sites to give a limited number of cleavage products (Cleveland et al. 1977,
Cleveland 1983). Upon electrophoresis and immunoblotting, the antigenic portions
of the molecule may then be determined or defined. From examination of the mouse
C A II sequences available derived from the nucleotide sequence, mouse C A II has a
73%-81% homology to CA from other species (Curtis et a l . 1983). It contains 34
amino acids unique to mouse CA II including an additional Arg in position 171, with
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a corresponding lack o f Arg at position 57 in an area that is considered to be an
invariant portion of the molecule for other species.
A number of proteolytic enzymes, including trypsin, chymotrypsin and chemical
cleavage agents such as cyanogen bromide and hydroxylamine were considered, but
they would have resulted in too many cleavage sites per carbonic anhydrase molecule
and it would have been difficult to resolve the antigenicity of these smaller
fragments. Thus endoproteinase Arg-C and papain were selected because a limited
number of larger fragments would result. Once a larger fragment was recognised by
immunoblotting techniques, the fragment could be further digested to determine the
amino acids involved.
Endoproteinase Arg-C EC 3.4.21.40 is a serine protease isolated from mouse
submaxillary gland that specifically cleaves proteins on the carboxylic side of
arginine (Levy et al. 1970, Schenkein et al. 1981, Bousfield and Ward 1988.). The
expected cleavage sites of endoproteinase Arg-C for mouse carbonic anhydrase II are
indicated in Figure 5.1. in Chapter 5.
Peptide mapping in one dimension was conducted for carbonic anhydrase
(Cleveland 1970). Initially this method was attempted with gel slices from a
polyacrylamide gel preequilibrated in gel slice equilibration buffer/protease dilution
solution, but these experiments resulted in protein smears. In a second method
rec ommended for soluble protein , 5jig of carbonic anhydrase in 5jil of sample
buffer was applied to each well and the lOjil of protease solution containing 5.6ng of
endoproteinase Arg-C was carefully layered over the top (100:1 ratio of protein to
enzyme). The protease dilution solution consisted of 2.5ml of stacking gel buffer,
0.1 ml o f 10% SDS, 1.0ml o f glycerol, 20 *il of 0.5M EDTA, 30|il of
2-mercaptoethanol, 6.3 ml of distilled water and a trace of bromophenol blue. The
overlay solution consisted of 2.5 ml of stacking gel solution, 0.1ml of 10% SDS,
2.0ml o f glycerol, 20jil of 0.5 M EDTA,

3 0 jj,1 of

2 -mercaptoethanol and 5.4 ml of

distilled water. Electrophoresis through the stacking gel was conducted at a lowered
voltage of 100V to allow digestion of the protein to occur and then the voltage was
increased to 200V during migration of the fragments through the separating gel.

C H A PT ER T H R EE
ANALYSIS O F RED BLOOD C ELL MEMBRANES , GUT
M A TE R IA L AND SP E C IFIC AN TI-BrM RBC ANTIBODIES.

3.1. P R E A M B L E
In order to resolve the immunochemical nature of the BrMRBC-type of
antigens which occur in vivo , the initial aim of these experiments was to obtain a
purified form of the aqueous-type of BrM antigen from mouse stomach that had
been demonstrated by Cunningham and Steele (1981) . Blood group substances
have been prepared from a number of different tissues from a variety of different
animals (Kabat 1956), but little work has been done with rodents species, except to
type H-2 antigens on mouse erythrocytes (Gorer 1936, Spack and Edidin 1986) or
to identify the Ii blood group system (Fezi and Childs 1985). Initially, the aim was
to prepare blood group substances from the gut because this is a more concentrated
site for blood group substances than on erythrocytes (Kabat 1956). After this
material had been purified by the use of various affinity columns, the aim was then
to return to purifying the BrM antigen from erythrocytes . To purify the material
from the gastointestinal tract the steps envis

ged were to : 1) prepare and purify

hyperimmune Rabbit anti-BrM serum 2) prepare affinity columns of BrMRBC
treated ghosts to obtain a highly specific Rb anti-BrM IgG from the hyperimmune
rabbit serum, and 3) prepare another affinity column coupled with purified Rabbit
anti-BrMRBC and use this to extract an aqueous antigen (blood group substances)
prepared from a mouse gastric mucosae suspension. However, there were several
negative results and problems with this approach that can be contemplated in
hindsight, and the problem of the identity of the aqueous BrM antigen was
approached from a completely different direction (Chapter 4).
Here the aims were to examine the erythrocyte membrane and material from
the stomach mucosae for the presence of the BrMRBC-type of antigen, and to
isolate

and characterise the antigen(s). Another aim was to prepare specific

anti-BrMRBC antibodies such as rabbit anti-BrMRBC hyperimmune serum in
addition to LPS-stimulated serum from mice. Finally a number of serological tests
were employed to characterise mouse blood group antigens.
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3.2. PREPARATION OF RED BLOOD CELL MEMBRANES
3.2.1. Preparation and characterization of protein-free and
protein-containing ghosts
Protein-depleted cell membranes (or ghosts) were prepared from normal or
brom elain-treated mouse erythrocytes by the method of Dodge et al. (1963)
(Chapter 2 , Section 2.3.2.). In that paper, the optimum conditions of osmolarity
and pH are described for preparing ghosts from human erythrocytes in which
"essentially all the lipid is recovered but some non-haemoglobin nitrogen containing
substance may be lost". The final stage in the method is to transfer the membrane
pellet to a volumetric flask containg 0. IN KOH and stand overnight at room
temperature to form a homogeneous ghost preparation. In later experiments (Tables
3.1.& 3.3, Figure 3.1) , this alkali solubilisation step was ommitted because
protein-free ghosts were not effective in inhibition tests and gave low titres when
tested against LPS serum.
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T ab le 3.1 P reparation and ch aracterisation o f different batches of
g h o s ts
Protein* ± SEM

ghosts/ml#

Dry weight

Comment

BrMRBC

8 .92fig/m l ± 1 .3
(n= 6)

1 3 .2 8 x l 0 7

nd 1I

N M RBC

3 .1 5 |ig /m l ± 0.2
(n= 6)

8 .6 6 x l0 7

ND

BrM still retain stubborn Hb
after sam e number o f washes as
NMRBC
T h ese gh osts w ere so lu b ilised
(from a p o o l o f 19 m ice) in
0.1N K O H

Type
B atch 1

B atch 2
BrM RBC

1720p g/m l + 1 1 .8 6 4 . 2 2 x l 0 8
(n= 4)

8 .5 5 m g /m l

G h o sts
p rep a re d
fro m
30
retired breeder m ice.G hosts not
treated with 0.1N KOH

B atch 3
BrMRBC

2408jig/m l ± 4 .9 7
(n= 4)

8 .2 x l0 8

1 2 .5 5 m g /m l

G h o sts
p rep a re d
fro m
50
retired breeder m ice. Ghosts not
treated with 0.1N KOH

S ee Table 4.3

ND

ND

Ghosts prepared from
25 retired breeder m ice. U sed in
SDS-PAGE experiments in Chapter
4. (Table 4.3).

B atch 4
BrMRBC
NMRBC

*Protein determined by a microLowry method, using BSA as standard . The protein in the ghost
samples was determined from substituting the OD into the equation of the line of best fit (e.g.
Batch 1, y=0.0012x+0.0039; correlation coefficient r=0.99, where y= Optical Density,4 lOnm &
x= \xg protein {BSA standard}), and expressed as jig/ml average of duplicate determinations. The
lines of best fit for each experiment are: Batch 2 y= 0.0023 =0.0056x; Batch 3 y=0.0039 =
0.0012x; Batch 4 y=0.0036 = 0.0014x.
# ghosts/ml determined as "intact" ghosts after staining with methylene blue in sterile saline,
f Not determined
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3.3. IM M UNISATION OF RABBITS W ITH BrMRBC.
3.3.1. Preparation o f im m une rabbit serum
One aim was to raise high titre anti-BrMRBC in rabbits for use in the
purification of the erythrocyte and gut BrM antigens (see Table 3.2), Titres of the
collected serum w ere determ ined by direct Coomb's test (Table 3.2).
p-mercaptoethanol (2-ME) was used to dissociate IgM so that levels of IgG
specific for BrMRBC could be determined.
Certain problems were experienced in obtaining enough suitable serum from
this method including : 1) the fact that the rabbits were of undetermined age and
background, 2) antibodies were probably raised against other mouse erythrocyte
antigens and 3) the time taken to raise high titre antibodies was fairly lengthy and
occasionally the anti-BrMRBC titre would decrease upon repeated immunisation.
Given the problems experienced it no longer became economical to dwell on
producing rabbit immune serum and the design of other experiments that would
give clearcut results took priority.
3.3.2. T esting o f the ability o f Rabbit serum to be inhibited by
B rM -gh osts
In an experiment to test whether the '’BrM-ghosts" had retained the
BrMRBC epitopes, an attempt was made to inhibit the binding of Rabbit P day 51
serum to BrMRBC in direct agglutination assays with either 2.72|ig protein/well,
5.44|ig protein/well or 13.6p.g protein /well BrM ghosts . Rabbit serum was
titrated in three-fold steps in duplicate from an initial dilution of 1 in 3 , and the
endpoint occurred at 1 in 2187 for all wells (results not shown), regardless of the
presence of BrM ghosts as inhibitory particles. This may be due, in part, to the
ghosts participating in an agglutination lattice or being used at too low a
concentration to achieve inhibition..
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Immunisation

schedules

for

Rabbits

BW

and

P

1. Rabbit BW
D ay 0

0.1m l 10% BrM in sterile saline (no azide used in washing steps) i.v marginal ear vein

D ay 28 0.6m l

10% BrM in sterile saline (no azide used in washing steps) intradermally (0.2m l/ each

leg, 0.2m l in neck fat fold); D ay 36

B leed from marginal ear vein, allow to clot overnight. Absorb

1.5ml Rb serum 4x 20% packed NM RBC (30 mins rt, 30m ins ice) Test by direct Coombs test using 1%
B S A as a diluent. Reciprocal o f the endpoint o f the titrations is presented in these table.
----------------------------------- NM absorbed

unabsorbed

Rb antiB

512

1024

Rb anti-B 2-M E

256

512

Rb anti NM RBC

64

Rb anti N 2ME

128

64

128

D ay 48 B oost as for d28;d52 Rabbit taken to a ’veterinary surgeon and put down
2. Rabbit P
D ay 0

0.1m l BrMRBC i.v. in left marginal ear vein; D ay 21 B oost 0.1m l BrMRBC i.v. in left

m arginal ear vein; D ay 4 4 B oost 0.6m l, 0 .2 m l to each hind leg, 0.2m l to the scruff o f then neck;
D ay 51 collected 30m l o f blood from ear vein and thus 12 m l sera, absorb 4x with 20% NMRBC
________________ *NM absorbed_______ unabsorbed
Rb antiB

6561

19683

Rb anti-B 2-M E

6561

19683

Rb anti NM RBC

243

Rb anti N 2ME

729

87

729

Ammonium sulphate
anti-BrM

2187

anti-NMRBC

D ay 91, D ay

3

101 collected blood from m arginal ear vein (only a weak anti BrM repsonse.) and

pooled serum .

Rb antiBrM
Rb anti NM RBC

NMabsorbed

27

2187

0

81

unabsorbed

D ay 105 B oost ala 0.6m l id; D ay 133 B oost 0.6m l i.d.; D ay 140 T est bleed (2m l blood)
D ay 144 Rabbit in com a by lunchtime. Terminal bleed from the heart under anesthesia (Rompon and
Ketamine)

*N M absorbed refers to rabbit serum that has been preabsorbed with packed NM RBC to remove
anti-NM RBC antibodies, and unabsorbed refers to serum that has not been preabsorbed before use.
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P R E P A R A T IO N

F IR S T

STEP

IN

OF

G H O ST

THE

A F F IN IT Y

P U R IF IC A T IO N

CO LUM NS AS A
OF

SP E C IF C

A N T I-B rM R B C A N T IB O D IE S.
3.4.1. T esting the binding titres o f LPS serum against BrM -ghosts
in ELISA

In prelim inary experiments with LPS stimulated serum, the suitability of
ghost m aterial was tested in ELISA . In a direct binding c-ELISA, wells of an
ELISA plate were coated with 2% NMRBC, 2% BrMRBC and BrM ghosts
resuspended from a stock solution at concentrations of 1.36 jig/well {lx}, 2.72
M-g/well {2x} and 6.8 p,g/well {5x} . LPS stimulated serum was titrated in 3-fold
steps from 1:10 (Figure 3.1a) and the binding titres expressed in Table 3.3. LPS
serum bound to BrMRBC and BrM ghosts used at 6.8|ig/ml {5x BrM ghosts} at a
higher titre than BrM RBC ghosts used at lower concentrations per well or
NMRBC.
In a repeat experim ents (Figure 3.1b and 3.1c), the basic pattern was
repeated but the titres obtained under similar conditions were elevated. LPS serum
bound to BrMRBC and BrMRBC ghosts but not to NMRBC in these experiments.
The only significant change made was that different batches o f BrM ghosts
containing more protein were used, with a resulting higher titre. It would appear
that not all protein was removed from ghosts left in PBS as opposed to ghosts left
overnight in 0.1N KOH. On the basis of these results, BrM ghost columns were
made with protein-containing ghosts (Section 3.4.2.), although the negative results
obtained with the columns prompted a reexamination of BrM-ghosts in ELISA and
their ability to inhibit binding against BrMRBC in competitive-inhibition ELISA
assays was then evaluated ( Section 3.4.3).
These results demonstrate that when BrMRBC ghosts are allowed to adhere
overnight to plastic microtitre plates antigenic sites are presented that LPS serum is
capable o f binding to in ELISA experiments. The binding titre of LPS serum may
be increased if the BrM ghosts are not pretreated with KOH to produce protein-free
membranes, because the titre of LPS appears to correlate to the amount of protein
coated.
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T able 3.3.

Binding titr e s i o f LPS serum against BrM ghosts , NMRBC and

BRM RBC

Expedient 1
Alkali-treated

x BrM ghosts (jig protein/well)**

(1.36)

Experiment 2

Experiment 3

Batch #2

Batch # 3

(13.6)

(120.4)

11000

lx BrM ghosts*

180

2040

2x BrMghosts {2.72jig/well}

190

nd

nd

5x BrMghosts {6.8jj.g/well}

660

nd

nd

BrMRBC

265

475

1358

NMRBC

23

12

50

$ Reciprocal of binding titre
* Protein measured by microLowry, ghosts washed in PBS before use and resuspended in PBS to
give a higher concentration of protein/ml than the original samples in Table 3.1. Note that the
concentration of lx ghosts is vastly different in each separate experiment.
* In experiment 1, ghosts from the same batch were washed with PBS and then resuspended at
either 1.36 jug protein/ well or 2.72 pg protein/well or 6.8 jig protein/well, hence lx, 2x and 5x
BrM ghosts respectively.
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Figure 3.1. Titration of LPS stim ulated serum against BrM-ghosts in
susp en sion c-ELISA .
a) Experiment 1: LPS-serum was titrated in 3-fold steps from 1:10, second
antibody at 1:500, OD read at 30 mins. Ghosts from Batch 1 Table 3.1.
Target antigens: 2% BrMRBC ( • ), 2% NMRBC ( O ), lx BrM-ghosts(B ), 2x
BrM-ghosts ( □ ) , 5x BrM-ghosts (A ).
b) Experiment 2: Suspension c-ELISA conditions as above, but different batch of
ghosts (see Table 3.2 Batch 2) Target antigens: 2% BrMRBC ( • ) , 2% NMRBC
( O ), lx B rM -ghosts(B ).
c) Experiment 3: Suspension c-ELISA conditions as above, but different batch of
ghosts(seee Table 3.2, Batch 3) Target antigens: 2% BrMRBC ( • ) , 2% NMRBC
( O ), lx BrM -ghosts(B )•

Optical

Density,410nm

Optical

Density, 410nm

Optical

density,410nm
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Figure 3.1

Figure 3.1b

Figure 3.1.c
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3.4.2. The preparation o f BrM ghost affinity columns and attempts
to purify anti-BrM antibodies from LPS serum.
A ffin ity

colum ns

w ere p repared

by

attaching B rM -ghosts to

cyanogen-brom ide activated Sepharose, and used to purify anti-BrM ghost
an tib o d ies

from

L P S -stim u lated

serum .

F ollow ing

m anufacturer's

recom mendations on the optim um levels o f protein that can be attached to
CN-Bromide Sepharose, 10 ml of freshly prepared and resuspended BrM ghosts
(not alkali treated) from the batch of 50 mice containing approximately 20 mg/ml of
protein were coupled with a coupling efficiency of 95.8% . These ghosts had been
tested for reactivity with LPS-serum in suspension ELISA (Experiment 3 in Table
3.1 and Figure 3.1c.).
In a preliminary experiment three ml of LPS serum was loaded onto the
column, the effluent

was collected and the column washed with 20ml of PBS.

Antibodies were eluted from the column with 3M sodium thiocyanate and 1ml
fractions collected; the optical density at 280nm measured with protein-containing
fractions pooled and dialysed overnight against phosphate-buffered saline and
adjusted back to the original volume with Aquacide.
LPS serum, the collected fall through and the anti-BrM eluate were tested for
anti-BrM activity and anti-NMRBC activity in a suspension ELISA (Table 3.4).
The column did not bind all anti-BrM antibodies in LPS-serum as shown by the
anti-BrM activity present in the fall through, however the theoretically remaining
anti-BrM activity cannot be accounted for in the anti-BrM eluate. Perhaps activity
in the anti-BrM eluate was lost during elution with sodium thiocyanate and
dialysis, or alternatively was still retained on the column and not dislodged by
thiocyanate elution. Other reasons for the failure of BrM-ghost affinity columns
will be discussed below in section 3.6.
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Table 3.4. Anti-BrMRBC and anti-NMRBC titres of LPS serum, column fall
through and eluted anti-BrMRBC antibodies.
NM RBC#

BrMRBC

Voi

anti-BrM Units*

% activity^

LPS serum

5.2

2000

3ml

6000

100%

Fall through

0

160

5ml

800

13%

anti-BrM eluate

0

3

3 ml

9

0.15%

* (volume x titre)
# average of duplicate titrations
Setting the initial LPS titre against BrMRBC as 100% activity, the fall through retains only 13 % of
the original activity and the anti-BrM eluate retains 0.15% activity.

3.4.3.

C om p etitive EL ISA

assays using BrM

ghosts to inhibit

binding o f LPS serum to BrMRBC
One concern about using solid phase supports and adhering agents with
p
erythrocytes (and presumably ghosts) is that binding to solid-phase sugorts
appears to create neo-antigens on normal red blood cells that confuse the situation
when one is trying to sort out the nature of the "hidden" BrM antigen (Jonusys and
Steele 1988). In theory this problem should not occur with suspension-type
ELISA assays, however, inhibition assays would appear to be ideal in bypassing
this problem because antibodies would bind to native antigens in solution.
In ghost inhibition assays, LPS serum was preincubated with various
concentrations of ghosts overnight at 4°C, the supernatant was retained after
centrifugation to sediment ghost-antibody complexes and used against NMRBC
and BrMRBC in a suspension-type ELISA. NMRBC ghosts were used as control
ghosts. In this series of experiments, NM-Ghosts or BrM ghosts did not inhibit
binding of LPS serum to BrMRBC (result not shown). This may be due to a
number of factors, namely the ghosts did not contain the BrM-antigen, or if the
BrM antigen was present it may have not been present in sufficient concentration to
achieve inhibition.
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3.5. SEROLOGICAL TESTS TO DETERMINE THE NATURE OF
MOUSE BLOOD GROUP ANTIGENS.
3.5.1. AET

and periodate treatm ent of NMRBC and BrMRBC.

Cunningham and Steele (1981) presented preliminary data that a blood-group
-like substance may possibly be involved in the BrM-determinant isolated from
mouse stomach. Thus, in order to demonstrate if blood group substances on
erythrocytes are involved in the BrM determinant, chemicals to destroy blood
group substances were employed. The aim was to destroy blood group substances
using sodium periodate and 2-aminoethylisothiouronium bromide (AET) and test
by direct agglutination with LPS-serum. A 6% aqueous solution of AET destroys
antigen o f the Kell blood group system, except Kx (AABB Tecnical
manual, 1988). 0.001M periodate at pH 5 for 15 minutes destroys M,N and D
antigens while A ,B ,0,H ,P and Lea receptors are not affected and 0.005M
periodate at pH 4 for 15 minutes is capable of destroying A,B, O, and H receptors
(Kabat 1956).
Both AET and periodate in aqueous solution lyse mouse erythrocytes so
these results were inconclusive, and when these tests were repeated with AET and
periodate in PBS lysis of mouse RBC still occurred. This would indicate that
further experimental conditions would need to be investigated to provide an
environment in which lysis did not occur in the presence of these reagents, or
changes may have to be made to the standard protocol for human red blood cell
with regard to the concentration of reagents, times and temperatures of incubation.

3.5.2. U se o f anti-A and anti-B typing reagents with vertebrate red
blood cells.
Mouse RBC and BrMRBC are not agglutinated with anti-A or anti-B typing
reagents.T he sam e result occurred with sheep and human RBC and
bromelain-treated SRBC and human group O RBC. Rat, rabbit and horse RBC
and the bromelain-treated equivalents were all agglutinated by anti-B typing
reagent. Thus, mouse red blood cells and bromelain-treated mouse red blood cells
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do not appear to carry A- or B-blood group substances, making these type of
blood group substance unlikely target antigens on BrMRBC.
3 .5 .3 .

P rep a ra tio n

of

B lood

G roup

Su bstances

from

m ouse

sto m a ch .
Blood group substances were prepared as outlined in Materials and methods,
however, due to the problems experienced in preparing and purifying specific
Rabbit anti-BrM antibodies, they could not be purified as originally planned and
were used in the next chapter in optimising conditions for dot-blotting.

3.6.

D ISC U SSIO N
Although the initial aims and approaches taken to purify the BrM antigen

were theoretically achievable, a number of setbacks and negative results prompted
a close examination of the problem and a new approach is outlined in the following
chapters. One question raised by the preparation and use of BrM ghosts is
whether protein-free ghosts actually contain the BrM epitope. The fact that lower
titres are demonstrated against protein-free ghosts ELISA (Table 3.3; Figure 3.1)
when compared to later batches of ghosts that contained significantly more protein
as determined by the Lowry method tends to support this idea. Others have
prepared BrM ghosts using the Dodge method with success to purify specifc
anti-BrM or to specifically inhibit anti-BrM plaque formation (Pages and Bussard
1978; Poncet et al. 1985). However, it was not exactly specificed in these papers if
the ghosts prepared were alkali-treated protein-free ghosts as specificed by Dodge
et al. (1963) or protein-containing ghosts and if so, the types of proteins have not
been shown by SDS-PAGE. In the demonstration of the effect of bromelain on
RBC mem branes, Cunliffe and Cox (1979) did not strip all protein from
membranes with alkali treatment and membrane proteins apart from Band 3 are
well represented in these ghosts.
The m ost significant observation here however is that the binding titre is
roughly dependent upon the protein content of the ghost membrane (Tables 3.1.
and 3.2 and Figure 3.1.) as protein deficient BrM-ghosts appear to bind less LPS
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serum than those that contain protein. This of course raises the question of what
types of proteins are present in BrM-ghosts and NMRBC ghosts that have not
been treated with strong alkali, and this will be examined by SDS-PAGE in the
next chapter.

The purification of in vivo forms of the BrM antigen from RBC and mouse
stomach is dependent upon the use of specific anti-BrMRBC reagents. Mouse
LPS-serum is easily prepared, but suffers from the disadvantage in deploying
methods that depend upon high affinity o f antibodies for a ligand in that most of
the anti-BrM activity is confined to IgM (Cunningham 1976), and the possiblity
that many antibodies with many different specificities may be present. Several
unsuccessful attempts were made to produce specific rabbit anti-BrM IgG and
alternative sources o f BrM-specific antibodies such as LPS-stimulated serum and
monoclonal antibodies were investigated and used for the rest of the project.
One of the major difficulties in using LPS stimulated serum to attempt to
purify BrM-type antigens is that the the exact binding specificities of antibodies
cannot be known with certainty. If LPS acts as a B lymphocyte mitogen, then
presumably all resting B cells (virgin and /or memory) must be stimulated to
produce antibodies. This is likely to result in a collection of high and low affinity
antibodies all with differing specificities, with the only certain factor being that a
high proportion o f the B-cells and the antibodies they produce appear to
specifically bind to unknown epitopes on autologous RBC that have been treated
with bromelain. Consequently, in order to determine the unknown in vivo
epitope(s), one must use at least one defined reagent of limited specificity, and
Professor Cox of Flinders University, Bedford Park, South Australia agreed to
allow me to use a monoclonal antibody, FUB 1, that had been selected for on the
basis o f reactivity to BrMRBC in complement dependent lysis assays. The use of
this BrMRBC-specific reagent clarified some of the problems encountered here and
allowed a fresh attack on the problem from a completely different approach, as will
be outlined in the next chapter.
On the basis of the binding observered in these c-ELISA experiments (Table
3.3 and Figure 3.1), a BrM-ghost affinity column was constructed. However,
when LPS serum was applied to the column and anti-BrM antibodies could not be
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eluted or recovered in total from the fall-through antibody fraction (Table 3.4),
this may be due to a number of reasons: 1) Antigen was altered in the coupling
procedure such that it was no longer recognized by autoantibodies; 2) The L P^
may not have been in contact with the column for sufficient time for binding to take
place, as seen in the relatively high titre of anti-BrM in the fall through fraction,
and yet sufficient LPS serum must have been bound for the decrease of anti-BrM
titre in the fall through when compared to LPS serum. Alternatively, 3) the loss in
anti-BrM activity in the eluate may have been due to inactiviation during
thiocyanate treatment and dialysis, or incomplete elution from the column.
The experiments conducted to destroy blood group substances by either AET
treat ment or periodate treatment were not conclusive because mouse red blood
cells were particularly sensitive to lysis by these agents whether they were used as
aqueous solutions or dissolved in phosphate-buffered saline. The results were
inconclusive because the endpoint of the direct agglutination assay is difficult to
determine when lysis occurs. Using human blood grouping reagents with RBC
from various species, mouse RBC do not agglutinate with either anti-A or anti-B
reagents. This suggests that mouse RBC or bromelain-treated mouse RBC do not
contain the terminal immunodominant sugars N-acetyl glucosamine or N-acetyl
galatosamine. Other blood group systems such as Ii have been shown to occur on
mouse RBC (Feizi 1988), but reagents to test for these blood groups are not
readil. y available . Crude blood group substances were prepared but could not be
purified by passage over a specific anti-BrMRBC affinity column.

CHAPTER FOUR
IMMUNOBLOTTING OF MOUSE RED BLOOD CELLS
4.1. PREAM BLE

The initial aim of the project was to characterise the in vivo forms of the BrM
RBC antigen(s), and the initial negative results obtained (Chapter 3) indicated that a
completely different approach was in order. Protocols to determine the nature of the
BrM-antigen(s) could not be designed without at least knowing whether a protein, lipid
or carbohydrate or combination of these was involved in the epitope. Results obtained in
the last chapter with erythrocyte ghosts indicate that proteins may be involved in the BrM
antigen, and although the evidence supporting phosphatidylcholine is solid, it does not
rule out entirely another component contributing to the BrM epitope. SDS-PAGE
combined with W estern blotting techniques of whole BrMRBC and NMRBC could
either show or rule out if proteins were recognised by anti-BrM antibodies.
Alternatively, if this approach was not successful thin-layer chromatography combined
with lipid immunoblotting could possibly give insight to the types of molecules involved
in the BrM-epitope. After these avenues have been investigated, then the possible
involvment of attached carbohydrates could be assessed if the BrM-epitope was found to
be a glycoprotein or glycolipid.
Another problem of concern was that LPS serum that has been used previously
was probably polyclonal. Thus, a specific anti-BrMRBC hybridoma, FUB 1, that had
been produced by Prof. K. O. Cox's Laboratory at Flinder's University was obtained,
subcultured and used in dot blot and ELISA experiments. FUB 3 and FUB 4 , with
specific binding to BrMRBC/Rat RBC and Rat RBC respectively, were also cultured but
not used extensively in this study.
In preliminary dot blots, BrMRBC, NMRBC, BrM-ghosts, NM-ghosts, gut
washings and gut scrapings were evaluated with LPS serum and FUB 1 and FUB 3.
Different patterns of binding were established for LPS serum and the monoclonal
antibodies. However, background staining was a major problem and as a result all steps
in the immunoblotting procedure were evaluated and modified. Whole BrMRBC and
NM RBC were used in W estern Blotting experiments with LPS serum and FUB 1
m ainly because whole cell preparations are normally used for haemolysis and
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cellular-ELISA assays, and it is possible that some antigenic epitopes may be lost in the
preparation of erythrocyte ghosts. Immunoreactive bands were detected at approximately
30kD and the identitiy of these bands and relationship to the BrMRBC antigen(s) will be
established in this chapter.

4.2. OPTIM ISING CONDITIONS FOR DOT BLOTTING .
4.2.1. Production and characterisation of the monoclonal
antibodies FUB 1 and FUB 3.
Anti-BrM RBC (FUB1 and FUB 3) and anti-Rat RBC (FUB 3 and FUB 4)
hybridomas were obtained and subcultured. The levels of IgM were determined for FUB
1 and FUB 3, in conjunction with LPS serum and normal mouse serum by radial
immunodiffusion in agar with a commercial kit (Table 4.1). Levels of IgG in FUB 4
culture supernatants were not assessed for two reasons , namely, FUB 4 was not
routinely used in this study and the cost of a separate kit for the determination of IgG
was prohibitive.
Endpoint titres of LPS serum, FUB1 and FUB 3 were determined in a
suspension c-ELISA against BrMRBC and NMRBC (Table 4.1.). For LPS serum the
total level of IgM was determined by RID, whereas for FUB the level of IgM determined
is indicative of the amount of anti-BrMRBC activity.
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Table 4.1 Levels of IgM in different batches of LPS stimulated serum (LPS), normal
mouse serum (NMS) and Flinders University Biological Sciences Monoclonals (FUB)
as determined by radial immunodiffusion in agar at 100 hours and reciprocal binding
titres of LPS serum and FUB monoclonal antibodies against BrMRBC and NMRBC in a
suspension c-ELISA
Antibody

Level of IgM

LPS (2/3/90)

7.6 mg/ml

NMS (1990)

722fig/ml

LPS (1988)

BrMRBC

NMRBC

6.6mg/ml

850#

1.2

FUB 1A

65|ig/ml

65

0

FUB IB

65jig/ml

180

0

FUB 1C

60.5pg/ml

100

0

FUB3B

56pg/ml

0

0

LPS (1987)*

27.8jig/ml

* This batch of serum has probably deteriorated over time, serum was evaluated in 1990 from stocks
kept at -20°C.
# Reciprocal endpoint titres of LPS serum and FUB monoclonals in asuspension c-ELISA experiment
against BrMRBC and NMRBC. Average of duplicate titrations.
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con d ition s o f blocking, w ashing and levels of

second antibodies in Dot Blots o f m ouse red blood cells, ghosts and
blood group substances.
In preliminary dot-blot experiments, LPS serum, FUB 1 and FUB 3 were
tested against BrMRBC, NMRBC, BrM ghosts, NM Ghosts, gut washings and gut
scrapings (Figure 4.1.). The pattern of reactivity was found to be : IgM antibodies in
LPS serum recognised all six target antigens; FUB 1 could detect BrMRBC and
BrM-ghosts; whereas FUB 3 recognised BrMRBC alone. In the PBS control to detect
if second antibody is binding directly to antigens, some binding is noted against
BrMRBC and NMRBC, and the background on all blots was quite high. In other dot
blot experiments, the minimum number of RBC detected was 1x10^ RBC/spot (not
shown). W hen LPS-serum was titrated against 1 x 1 0 ^ RBC/spot similar levels of
binding (for LPS serum at dilutions of 1:10 to 1:10,000) were seen against both
NMRBC and BrMRBC, suggesting perhaps autoantigens similar to those revealed by
bromelain occur on normal RBC when they are attached to a solid phase support like
nitrocellulose. A similar situation to this was previously encountered in ELISA
experiments where NMRBC were fixed to plastic microtitre plates (Jonusys 1986;
Jonusys and Steele 1988)
In most of the early Western blot experiments, utilising 1% BSA as a blocking
and diluting reagent the conditions were: LPS serum at 1:10 or 1:30, PBS as a
washing buffer, 1:500 goat anti-mouse IgM-alkaline phosphatase conjugate and Fast
Red substrate. Immunoreactive bands were present and recognised by LPS serum and
FUB 1, however, the background staining was too high to clearly discern these bands.
High background levels were a problem with optimising conditions in this system for
several reasons. Firstly, some of the background interference on control blots is due to
the second antibody binding directly to the same immunoreactive bands that LPS
serum and FUB 1 bound to, suggesting that these bands may be a common target for
for naturally occuring antibodies in many different animals. This problem was dealt
with by absorbing all second antibody developing reagents with normal mouse
erythrocytes and BrMRBC. The washing and blocking conditions also need to be
fairly stringent when using IgM antibodies to rem ove antibodies binding
non-specifically to nitrocellulose that contribute to high background. Efforts were
concentrated on reducing the background staining and thus each aspect of the Western
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blot assay was tested, changed and improved. These improvements included using
different washing and blocking buffers, decreasing the levels of primary antibodies
used, changing the second antibody to a biotin-streptavidin system, preabsorbing the
second antibody with RBC before use and changing the substrate to BCIP/NBT which
gave a distinct purple band on a white background.
4.2.3. C om parison of different blocking and washing buffers
The relative effectiveness of BSA and gelatin as blocking agents was tested in
dot blot experiments. Gelatin was found to give a reduced background. When gelatin
and BSA were both used at 1%, and Tween-20 was added at 0.1% to washing
buffers there was little difference to background binding observed (Figure 4.2.). Fresh
gut was prepared and pooled from a group of 4 CBA/H retired breeder female mice.
However, it shows as strongly positive on the control blot, suggesting direct staining
of endogenous alkaline phosphatase or a second antibody-antigen interaction. In some
dot blot experiments with 1% gelatin, it was noted that NMRBC were detected with
natural antibodies (LPS serum and FUB 1). If a suspension c-ELISA is conducted
with either 1% gelatin or 1% BSA, no difference can be detected in the patterns of
binding although LPS serum appears to bind to BrMRBC with a higher titre in the
presence of 1% BSA (Table 4.2.).
The dot blot experiment was repeated on a larger scale (Figure 4.3) to examine
different levels of primary antibodies in LPS serum, BrMRBC absorbed LPS serum,
NMRBC absorbed LPS serum and FUB 1 and FUB 3 in gelatin and BSA, with PBS
as a washing buffer against a panel of six antigens (BrMRBC NMRBC, BrM ghosts,
NM ghosts, Gut Washings, gut scrapings). Since there is no change in the pattern of
reactivity of LPS serum that had been preabsorbed with BrMRBC, the titres of the
antibodies used in the dot blot experiment were tested in a suspension c-ELISA
against BrMRBC and NMRBC (Figure 4.4). For LPS serum absorbtions, 1ml of LPS
serum was absorbed twice with 0.5ml packed RBC for 30 mins at room temp, and 30
m ins on ice. One volume of second antibody, Goat anti-mouse IgM alkaline
phosphatase conjugate was absorbed twice with 1 volume of NMRBC, then twice
with 1 volume of BrMRBC fo 30 minutes at room temperature and 30 minutes on ice,
but this treatment did not remove all anti-BrMRBC activity from LPS serum. LPS
serum therefore required far more extensive absorption to remove anti-BrM antibodies
(section 4.3.4.).
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F ig u re 4.1. Initial dot blot experim ent to determ ine the binding pattern s
o f LPS se ru m , FUB
m a te ria l.

1 and

L PS -serum [A ],

FUB 3 ag ain st RBC, g h o sts and gut
FUB1

(anti-B rM R B C )[B -D ]

and

FUB

3

(anti-BrMRBC/anti-RatRBC)[E-G] and the PBS control [H] were titrated at 1 in 10
dilution against BrMRBC [top row left] and NMRBC[top row right], BrM
ghosts [middle row left], NM Ghosts [middle row right], gut washing[bottom row left]
and gut scrapings[bottom row right].

A

B

E

F

C

D

G

H
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4.2.4. Im provem ent in the staining protocols for alkaline phosphatase.
In an effort to reduce the background staining problem, different second
antibody (biotinylated goat anti-mouse IgM) and staining protocols were evaluated.
BCIP/NBT coupled with biotinylated second antibodies and streptavidin-alkaline
phosphatase offered the clearest reduction in background when compared to
streptavidin-peroxidase coupled with 4-chloro-l-napthol. Streptavidin, a neutral
non-glycosylated protein, was used in preference to egg-white avidin because of the
reported problems with avidin binding directly to sugar-binding proteins on cell
surface (Wilchek and Bayer 1988).
In later immunoblotting experiments, Fast red substrate was replaced by
BCIP/NBT due to the increased sensitivity and contrast obtained. Fast Red gave a
bright pink band on a light pink background, whereas BCIP/NBT gave a purple band
on a white background.

4 .2 .5 .0 p tim u m conditions for blotting.
The best results for blotting experiments were obtained with the following
conditions. The membrane was allowed to dry at room temperature after electroblotting
and prior to the blocking steps; 3-5% BSA in PBS was used as a blocking agent for 90
minutes to overnight, while 1% BSA in PBS was used as a diluent for the first and
second antibodies. PBS was used in initial washing steps, with PBS+ 0.1% Tween 20
used as a washing buffer after the second antibody step. The second antibody was
changed to a streptavidin-biotin system and BCIP/NBT was used as a substrate in the
place of Fast Red.
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4.2.

1 00

C o m p a ris o n

of

l% (w /v )

l% (w /v ) g elatin as blocking agents

B ovine

se ru m

a lb u m in

and

a n d PBS versus PB S-Tw een 20 in

dot blotting. Sheets 1-4 tested different antibodies. LPS serum was used at 1:50
dilution (Sheet 1), FUB 1 at 1:10 ( Sheet 2) and FUB 3 at 1:10 ( Sheet 3), PBS
control ( Sheet 4) . Plates were blocked in 1% gelatin and washed in PBS; second
antibody was 1:500 Goat anti-mouse IgM-alkaline phosphatase conjugate, and Fast
red substrate.
LPS at 1:50 was used on plates 5-8, with PBS-Tween/Gelatin (Sheet 5),
PBS-Tween/BSA ( Sheet 6) PBS/Gelatin ( Sheet 7) and PBS/BSA( Sheet 8). Antigens
applied to the plates were a) 12|il of l%BrMRBC, b) 12|il of 1%NMRBC , c) 12jil
BrM ghosts , d) 12jil NM ghosts , e) Gut Washings - 12p,l of lmg/ml suspension , f)
Gut scrapings - 12jil of lmg/m l suspension, g) Fresh gut and h) PBS.
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T ab le 4.2. S uspension c-E L IS A co n d u cted w ith e ith e r 1% BSA o r 1%
g e la tin as b lo ck in g a n d w ash in g ag en ts . Reciprocal endpoint titres of
LPS-stimulated serum or FUB 1 against BrMRBC or NMRBC determined at the
y=0.2, OD410nm at 30 minutes after the addition of substrate.

1% BSA

1% Gelatin

BrMRBC

LPS-stimulated serum
FUB 1

NMRBC

BrMRBC

NMRBC

700

14

300

12

50

0

87

0
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F ig u re 4.3 Dot blotting e x p erim e n t to test the p a tte rn s of binding of
LPS serum and FUB 1 that have been preabsorbed with either B rM RB C
o r NM RBC.
Sheets 1-10 LPS serum; Sheets 11-20 BrMRBC absorbed LPS serum; Sheets 21-30
NMRBC absorbed LPS serum; Sheets31-40 FUB 1; Sheets 41-50 FUB 3; Sheets 51
&52 are PBS controls for 1% BSA and 1% Gelatin respectively. For LPS serum,
second antibody was used at 1:500 and for the monoclonal antibodies at 1:200. Fast
Red substrate used. The antigens used were in the same configuration as Figure 4.2.
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F ig u re 4.4. S u sp en sio n c-E L IS A to te st th e a n tib o d ie s u sed in th e
p re v io u s e x p e rim e n t fo r titre s a g a in st B rM R B C a n d N M R B C using
e ith e r 1% gelatin o r 1% BSA as blocking an d diluting agents.

A sample

o f the antibodies used in the previous dot blot experiment was concurrently test^ in a
suspension ELISA against either BrMRBC (Figures 4 .4 a ) or NMRBC (Figures 4.4 b
a), in the presence of 1% BSA. Similar experiments were conducted in the presence of
1% gelatin with BrMRBC (Figure 4.4c) or NMRBC (Figure 4.4d.) The following
antibodies were examined :Unabsorbed LPS serum ( # ) , BrMRBC-absorbed LPS
serum (O), NMRBC absorbed LPS serum (■), FUB 1 (□) and FUB 3 ( A ) .

O p tic a l

O

_■ o

D e n s ity , 4 1 0 n m

O

in

b

-*■

fO

in

o

4.4b. NMRBC/1%BSA

I u t

w> 4 m

I-

4.4a
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Optical density,
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4.4c.

Reciprocal endpoint titre

Optical
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4.4d. NMRBC/1% gelatin

Reciprocal endpoint titre
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AND

IM M U N O B L O T T IN G

OF

M O U SE

ERYTH RO CYTES.
4.3.1. SDS-PAGE o f mouse erythrocytes.
Electrophoresing whole red blood cells is not a common procedure for two
main reasons. Firstly, the red blood cell has been used principally as a ’’model cell
membrane" or to study haemoglobin because both may be easily prepared free of
contaminantion by cytoplasmic organelles. The abundance of haemoglobin in the
erythrocyte can result in a smear if the desire is to clearly visualise membrane proteins,
so the components of the membrane or haemoglobin are usually studied in isolation
from one another. In this case, however, after experiences with protein-free ghosts I
was determined to electrophorese the whole erythrocytes to ensure that a portion of the
antigenic determinant was not inadvertently discarded. The best resolution of whole
MRBC obtained by increasing the percentage of acrylamide of the separating gel to at
least 15% T (Figures 4.5. and 4.6).
NMRBC ghosts contain only high molecular weight protein whereas BrM
ghosts have high molecular weight bands in stacking gel, but in addition, there are
diffuse bands present at 29kD and 42kD (Figure 4.5). In the lanes loaded with gut
material, there is a smear of protein with prominent bands occurring between
40-60kD. When NMRBC are electrophoresed, there is a prominent haemoglobin
smear below 14kD, with the second highest protein bands occurring in 30kD region
with faint but distinct bands present at other molecular weights. BrMRBC have the
same basic pattern as NMRBC but with several bands faint or missing between 60 and
90kD.
In SDS-PAGE experiments with mouse erythrocyte ghosts (Figure 4.6), it can
be seen that alkali-treatment removes most of the protein with only some of the protein
remaining in the stacking gel. Different proteins appear to be retained in BrM ghosts as
opposed to NM ghosts and the amount of protein found in these ghosts used in
Figure 4.6 is summarised in Table 4.3.
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T able 4.3. Protein content o f ghosts used in SDS-PAGE experim ents
Ghost type (prepared from 25 mice)

Protein (jig/ml)+ SEM (n=4)

fig protein/RBC*

BrM ghosts

4616±232

1.5 x 10"12

BrM ghosts(KOH treated)

1650+82

0.55 x 10'12

NMghosts

3058± 293

1.0 x 10-12

NMghosts(KOH treated)

430± 38.5

0.14 x 10'12

* Assuming that there is 3 x 10^ RBC/ml of whole blood, the amount of protein remaining after
treatment on a per initial RBC basis may be determined by: {RBC protein p g /m l} divided by {3 x
10^ RBC /ml}. The measurement of the number of ghost particles/ml was not determined for these
samples.
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4 .5.

S D S -P A G E

c o n d u c te d

under

r e d u c in g

c o n d itio n s

and

C o o m assie B lue sta in in g o f g h o sts, g u t sc ra p in g s a n d m ouse re d blood
cells. Lane 1 NM RBC ghosts; Lane 2 BrM RBC ghosts; Lane 3 Fresh gut scrapings;
Lane 4 NM RBC and Lane 5 BrMRBC; Lane 6 Biorad low molecular weight markers.

Mwt (kD)
97.4

66.2
45
31
21.5
14.4
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2

3

4

5 6
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R educed

and

n o n -re d u c e d

s a m p le s

of

g h o s ts

e le c tro p h o re s e d on 15% s e p a ra tin g gels
Lane 1 Low m olecular weight markers;Lane 2 BrM ghosts;Lane 3 BrMghosts (KOH
treated); Lane 4 NMghost; Lane 5 NM ghosts (KOH treated).

Reduced samples
1

Mwt (kD)
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Non-reduced samples
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4 .3 .2 . W estern blot ex p erim en ts w ith m ouse eryth rocytes

In a num ber o f earlier w estern blotting experim ents w ith LPS serum , FUB 1
and Fast red substrate, bovine erythrocyte carbonic anhydrase from the m arker lane
and bands from the 30 kD region o f NM RBC and BRM RBC appeared as a dark pink
b and on a lig h t p in k background w ith the F ast R ed substrate. In subsequent
experim ents (Figure 4.7.), the resolution o f the 30kD bands w as im proved by
em ploying biotinylated second antibodies with streptavidin-alkaline phosphatase and
B C IP/N B T substrate (M aterials and M ethods section 2.9.1.). W hole norm al mouse
red blood cells, B rM R B C and bovine carbonic anhydrase w ere electrophoresed on
d isc o n tin u o u s S D S -P A G E (4% stacking gel and 15% sep aratin g gel) and
electroblotted onto nitrocellulose in m ethanolic transfer buffer. A doublet band from
the 30kD region o f both N M R B C and BrM RB C was detected with the m onoclonal
FUB 1 (1:10) and polyclonal L PS-stim ulated serum (1:10). The im m unoreactive
bands from m ouse erythrocytes occurred at 31 kD and 29kD, while the band occurring
at 28kD was not reactive. Occasionally the two immunoreactive bands occurring at 31
and 29 kD on red blood cells are referred to as the "immunoreactive bands in the 30 kD
region" o r "bands in the 30 kD region" as a shorthand w ay o f referring to these
specific bands.
A t first, it was thought that these bands may represent glycophorin as shown by
Laing e t al. (1987, 1988) to occur on im m unoblots o f R at RBC recognised by mouse
anti-R atR B C m onoclonal antibodies. Thus LPS serum and FUB 1 w ere tested in
w estern blotting experim ents against purified hum an glycophorins and carbonic
anhydrase from a range o f different species. LPS serum (1:50) and FUB 1(1:2)
detected 10pg/lane o f purified rabbit, bovine, dog and hum an erythrocyte carbonic
anhydrase but not lOpg/lane hum an glycophorin or hum an asialoglycophorin (Figure
4.8). In further experim ents, erythrocytes from m ice, rats, rabbits, sheep and horses
w ere im m unoblotted and carbonic anhydrase bands were detected in the 30 kD region
(C hapter 5 , Figure 5.11).
To determ ine if the immunoreactive bands detected at approximately 30kD were
glycoproteins, SDS-PAGE gels were stained with Alcian Blue or Periodic acid-schiff.
The 29kD and 31kD im m unoreactive bands found on m ouse erythrocytes stain with
b o th A lcian B lu e and P eriodic acid -S c h iff stain in d icatin g the presence o f
glycoproteins (Figure 4.9).
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F o c u s s in g

and

tw o -d im e n s io n a l

m aps

o f w h o le

m ou se red b lood cells to fu rth er ch aracterise the im m u n oreactive bands.

IE F w as conducted to determ ine the isoelectric points o f the 29kD and 31kD
bands from w hole m ouse red blood cells. B oth bands have an isoelectric point o f
approxim ately 6.7 (Figure 4.10). This estim ate is based upon w here m ost o f the
carbonic anhydrase occurs on the tw o dim ensional gel, as certain difficulties were
experienced w ith solubilizing whole RBC, so that only the proteins that are present in
large quantities evident on 2-D m aps and focussing the IEF gels for sufficient time
w ithout excessive heat being generated. D ifferent m ethods o f solubilisation were
attem pted, eg different types o f detergents tried and other m ethods o f solubilisation
could be fu rther pursued to establish a clearer picture o f other m em brane proteins,
how ever, the data show n in Figure 4.10with CA doublet bands is relatively clearcut.
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a n d W este rn blot o f m ouse re d blood cells and

b o v in e c a rb o n ic a n h y d ra s e
Lane 1: Biorad low m olecular weight m arkers (10|il of a 1:20 dilution containing
rabbit muscle phosphorylase B, 97.4kD; Bovine derum albumin, 66.2kD; ovalbumin,
45kD; Bovine carbonic anhydrase 31kD; soybean trypsin inhibitor, 21.5 kD: and
lysozym e, 14.4kD.) The position of carbonic anhydrase is indicated by an arrow.
Lane 2 .-Normal M ouse RBC (lOpl of 2%RBC in reducing sample buffer). Lane 3:
BrM R B C . L<me 4:B ovine carbonic anhydrase (5jig) Lane 5: M olecular weight
m arkers.

Mwt (kD)
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- 45
. 31
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5
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F ig u r e 4.7 b. W e s te rn b lo t e x p e rim e n t w ith FU B 1 a n d L PS se ru m .
FU B 1 and LPS serum applied to blots at 1:10. The lanes were the same as for the
SD S-PA G E viz. Lanes 1& 5 Low m olecular weight markers, Lane 2 NMRBC, LAne
3 BrM RB C, Lane 4 Bovine carbonic anhydrase.Contol blots treated with PBS instead
o f first antibody were negative. Biotinylated goat anti-m ouse IgM was applied at
1:2500, Streptavidin-alkaline phosphatase at 1:2000.

FUB 1

1 2 3 4 5

LPS serum

1 2 3 4

5
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4 .8 .

W e s te r n

b lo ts

of

p u r if ie d

c a rb o n ic

a n h y d ra se

fro m

d if f e r e n t sp e cie s, h u m a n g ly c o p h o rin a n d a sia lo g ly c o p h o rin
LPS serum and FUB 1 were used at 1:10 in western blotting experiments against
carbonic anhydrase from dog RBC [Lane 5], rabbit RBC [Lane 6], human RBC
[Lane 4] and bovine RBC [Lane 7], NM RBC [Lane 8], BrMRBC [Lane 9 ] , human
glycophorin [Lane 3] and asialsoglycophorin [Lane 2].

Low m olecular weight

M arkers [Lane 1] and prestained m olecular weight markers [Lane 10] were used.
Carbonic anhydrase could be detected on western blots using the Fast red detection
system, however, glycophorin and asialoglycophorin could not be detected.

1

2 3 4

5 6 7 8 9

10

LPS serum

FUB 1
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F ig u r e 4 .9 . G ly c o p r o t e i n s t a in in g o f S D S - P A G E g e ls w ith A lc ia n B lu e
and PAS.

In Figure 4.9a) Alcian Blue staining w as conducted with the following protein
samples: Lane 1 Low m olecular weight markers, Lane 2 Normal Mouse RBC ghosts,
Lane 3 BrM RBC ghosts Lane 4 NM RBC and Lane 5 BrMRBC. In Figure 4.9.b) the
same samples have been stained for glycoproteins with PAS staining.
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Two

d im e n sio n a l

m ap

of

w h o le

m ouse

eryth rocyte

p r o te in s a n d I E F s t a n d a r d c u r v e .

Lane A m olecular weight markers run in the second dim ension SDS-PAGE.
Capillary isoelectric focussing gels were layered over the SDS-PAGE in the second
dimension. On the next page is the standard curve (figure 10b.)used for determining
the pi from standard m arker proteins focussed on different capillary gels under the
same conditions.

Mwt (kD)
97.4
66.2

-

45 _
31 _
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Figure

4.10.b.

Distance from anode (cm)
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Tw o different m ethods o f solubilisation were tried with erythrocytes, Triton
X-100 and Triton X -100/10% SDS. The RBC membrane proteins proved difficult to
solubulise as noted previously (Rosenblum et a l 1982; D ockham et al. 1986;
R ouyer-Fessard e t al. 1987). Nevertheless, the two m ost abundant RBC proteins,
haem oglobin and carbonic anhydrase can be visualised, and the p i o f carbonic
anhydrase determined by comparison to a standard curve (Figure 4.10).
These results suggest that there are two isoform s of carbonic anhydrase in
m urine erythrocytes w ith sim ilar isoelectric points o f 6.7 but slightly different
m olecular w eights . The m olecular weight differences m ay be accounted for by
"neutral" am ino acid substitutions, glycosylations or phosporylations. The fact that
both FUB 1 and LPS serum recognise a doublet suggests that only similar regions on
the glycoproteins are recognised and not the regions that account for the difference in
m olecular w eight. The question o f which epitopes on carbonic anhydrase are
recognised by autoantibodies is addressed in further experiments in Chapter five.
4.3.4. D eterm in ation o f the involvem ent o f carbonic anhydrase in the
B rM ep itop e.
An experiment to determine if the bands detected on Western Blots were related
to the BrM epitope on BrM RBC was conducted by preabsorbing antibodies (FUB 1
and LPS-serum ) with BrM RBC to try to remove anti-BrMRBC antibodies. Both the
bovine carbonic anhydrase bands and the 30kD bands from mouse erythrocytes were
reduced in staining intensity if FUB1 had been preabsorbed with BrMRBC (Figure
4.11, B lot 1), but not by absorbtion with NM RBC (Figure 4.11 Blot 2). Similar
results were obtained with LPS-serum (Figure 4.12.), however, much more extensive
absorbtion with BrM RBC was was required to remove the 30kD bands. W hen the
absorbtions were carried out under identical condition to Figure 4.11, then not all
anti-BrM activity could be rem oved from LPS serum. This problem was previously
encountered in dot blot experim ents ( Figure 4.3. and Figure 4.4.). LPS serum
requires m ore extensive absorption with NM RBC and BrM RBC and this became
evident w hen the levels o f IgM in LPS serum were determ ined (Table 4.1). This
experim ent clearly dem onstrates that carbonic anhydrase is associated with the
serologically defined BrM epitope.
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4.4. L ip id Im m u n ob lottin g.

The technique o f lipid immunoblotting (Chapter 2 Section 2.9.2) was employed
with NM RBC, BrM RBC and an extract of fresh stomach in PBS. No immunoreactive
spots were detected in preliminary experiments and the possible immunoreactive lipids
were not further investigated (result not shown). It has already been established that
phosphatidylcholine forms an im portant part o f the BrM -epitope (Mercolino et al.
1986,1988; C ox and H ardy 1985, K aw aguchi 1987) but to dem onstrate
phosphatidylcholine isolated from RBC or stom ach m ay require some further
extraction or concentration process. However, given the novelty of the results obtained
with carbonic anhydrase and the fact that natural antibodies can recognise carbonic
anhydrase on RBC without the need for extraction or concentration, it was decided to
furth er investigate the epitopes on carbonic anhydrase recognised by natural
autoantibodies in LPS serum and FUB 1.
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F ig u re 4 .1 1 .W e ste rn b lo ts o f c a rb o n ic a n h y d ra s e a n d N orm al m ouse
re d blood cells tre a te d w ith u n a b so rb ed an d a b so rb ed FUB 1. C onditions
for western blotting were standard, except that carbonic anhydrase (lane a) and
NM RBC (lane b) were blotted side-by side and the nitrocellulose was stored dry
before use. FUB 1 was preabsorbed extensively by either 20% packed BrMRBC
(blotl), 20% NMRBC (blot 2) or unabsorbed (blot 3) before application to the blots.
Preabsorption o f FUB 1 with BrMRBC lowers the intensity o f binding to carbonic
anhydrase and the 30kD bands from NMRBC, whereas preabsorbing with NMRBC
does not.

Blot 1

Blot 2

Blot 3

◄

a

b

a

b

a

b
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F ig u re 4.12 W e s te rn b lo t o f c a rb o n ic a n h y d ra s e a n d n o rm a l m ouse
e ry th ro c y te s tr e a te d w ith u n a b s o rb e d a n d a b s o rb e d L PS se ru m . In a
separate Western blot experiment with LPS serum used at 1:500 against NMRBC (lane
a) and carbonic anhydrase (lane b) a similar result to Figure 4.11 was obtained. LPS
was preabsorbed extensively with 40% packed BrMRBC (Blot 2), 40% NMRBC
(Blot 3) or left unabsorbed (Blot 1) before application to the blots. Blot 4 is the PBS
control. Sim ilar results were obtained with LPS-serum at 1:100 and 1:5000 (not
show n).

Blot 1

a

b

Blot 2

a

b

Blot 3

a b

Blot 4

a

b
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D isc u ssio n

In this chapter, it has been demonstrated that carbonic anhydrase forms part of
the B rM RB C epitope and is recognised by m onoclonal and polyclonal natural
autoantibodies. The different approach attempted in this chapter has been successful; it
may explain some of the negative results initially obtained in the previous chapter with
erythrocyte ghosts.

FUB 1 was found to be specific for BrMRBC in the suspension c-ELIS A assay
and does not react with NM RBC (Table 4.1.). One surprising result was that FUB 3
had no recognisable anti-BrM RBC titre in suspension assays. FUB 3 had been
originally selected for its ability to lyse BrMRBC in lytic assays, and it has been used
in dot-blot experim ents (Figures 4.1. ,4.2. &4.3.) but was found to have a low titre
against BrM RBC in suspension c-ELIS A experiments (Figure 4.4.), and accordingly
was not generally used in setting up dot-blot experiments. The levels of IgM were
determ ined by radial im m unodiffusion in agar (Table 4.1). LPS stimulation can
increase the level o f IgM to levels that are ten-fold higher than those found for normal
mouse serum. Similar levels o f IgM were found in all batches of FUB 1.
In preliminary dot-blots NM RBC and BrMRBC were both recognised by LPS
serum, suggesting that hidden antigens on NM RBC could be revealed by adhesion of
cells to nitrocellulose. It was not clear, however, if these "neoantigens" are related to
genuine BrM RBC antigens. The action o f the proteolytic enzym e brom elain is
presumably to remove another molecule that shields a "hidden" antigen, as rats injected
with NM RBC can make distinct antibody responses against BrMRBC (Cunningham
1974). A sim ilar reactivity against "normal" mouse erythrocytes was found in
c-ELISA assays w here fixatives were employed to adhere erythrocytes to plastic
m icrotitre plates or when erythrocytes were allowed to settle and adhere overnight to
m icrotitre plates (Jonusys BSc. Honours Thesis 1986; Jonusys and Steele,1988) or in
certain haemolytic assays (Kennedy and Axelrad, 1971) where seemingly gentle cell
fixation conditions are sufficient to reveal some antigenic determinants on normal
erythrocytes.
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The fact that the same immunoreactive 30kD bands are recognised in NMRBC
and BRM RBC w ould tend to support the idea that the hidden antigen revealed by
attachment o f cells to surfaces (plastic, nitrocellulose) is the same as antigens revealed
by brom elain treatm ent. There is , therefore, an extremely subtle line between a
non-antigenic NM RBC in solution and antigenic NMRBC attached to certain surfaces.
A similar process could be envisioned to take place in vivo in the formation of blood
c lo ts

and

d u rin g

a g g re g a tio n

or

c lu m p in g

of

n o rm al

e ry th ro c y te s.

The background staining on dot blots and western blots proved to be a major
problem in analysing the specificity o f IgM natural antibodies (section 4.2.3.).
H ow ever, these problem s were gradually resolved by im proving upon the basic
protocol, although some significant results were recorded during the initial stages of
dot blotting. D ifferent patterns o f binding were noted with LPS serum, FUB 1 and
FUB 3, with LPS serum binding to all target antigens and the monoclonal antibodies
specifically recognising only BrMRBC and/or BrMRBC ghosts (Figure 4.1.). For the
monoclonal antibodies, this indicates each antibody preparation is subtlely different in
the capacity to bind to the antigenic site(s) displayed on BrMRBC or BrM ghosts. The
difference is not due to different concentrations of IgM in the two preparations, but
reflects a difference in fine specificities of the antigen combining site s. LPS serum, on
the other hand, w ould perhaps have a num ber o f different antibodies with the
capability of binding to antigenic sites on all target antigens tested.
The pattern o f reactivity against different antigens is dependent upon the type as
well as the level o f blocking and washing solutions u s e d . Gelatin appeared to result
in a lowered background in some dot blotting experiments (Figure 4.2.) but FUB 1
could recognise NM RBC when 1% gelatin was p re se n t. This suggests that although
gelatin is an effective blocking agent capable of reducing the levels o f background
staining , it also has an effect o f allowing natural antibodies to bind to antigenic sites
on norm al erythrocytes that are not exposed when BSA is used. This pattern does not
hold for suspension c-ELISA conducted in 1% gelatin or 1% BSA (Table 4.2.).
In the titration dot blot experiment (Figure 4 .3 .), preabsorption of LPS serum
w ith BrM RBC and NM RBC did not appear to reduce or rem ove immunostaining
against the target antigens when compared to unabsorbed LPS serum suggesting that

CHAPTER FOUR

126

either not all anti-B rM R B C activity had been rem oved from LPS serum or that
"neoantigens" w ere form ed when RBC attached to nitrocellulose. The amount of
anti-BrMRBC activity rem oved was later tested in a suspension c-ELISA (Figure 4.4.)
and this confirm ed that not all the

activity (90-98.2% rem oval for antibodies

preabsorbed with BrM RBC tested in 1% BSA, but only 32-36% removal if the same
antibodies had been preabsorbed with BrM RBC in the presence o f 1% gelatin) was
rem oved by the absorption protocol followed, lending support to the first reason and
not the second. It was decided to use BSA as a blocking agent due to the different
binding patterns noted against NM RBC with FUB 1 when BSA or gelatin were used.
FUB 1 is selective for BrM RBC and BrM ghosts, but only when 1% BSA is used for
blocking, and this may reflect a better capacity for blocking than gelatin or represent a
different charge effect.

In the suspension c-ELISA experiment (Figure 4.4.), FUB 3 was found to be
of low titre, and was not further routinely used in western blotting. In suspension-type
ELISA NM RBC are not recognised as antigenic, whereas they are on nitrocellulose
(Figure 4.3.).
In experiments where components of mouse erythrocytes were electrophoresed
in polyacrylam ide gels, several im portant points emerged. Firstly, the most abundant
proteins from erythrocytes are the haemoglobins, followed by carbonic anhydrase with
the membrane proteins forming only a minor proportion of the total erythrocyte protein
profile. In SDS-PAGE experiments with ghosts that have been pretreated with alkali or
left untreated in PBS, there are distinctly different patterns o f proteins depending upon
the type o f treatment. In general, treatm ent o f BrMRBC and NMRBC ghosts with
potassium hydroxide reduces the amount o f protein to 14-37% o f the corresponding
untreated ghosts (Table 4.3.). W hen these ghosts are adjusted to the same protein
concentration and electrophoresed under reducing or non-reducing conditions, there
are bands present on BrM RBC ghosts that are not present on NMRBC ghosts and a
further difference in pattern can be detected after KOH treatment. The ghosts were
prepared initially from the same batch of RBC, then split into two groups one of which
w as left as N M R B C and the other batch treated with brom elain. NM RBC and
BrM RBC were subject to hypotonic lysis under identical conditions and then further
split into alkali treatment or untreated.
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Thus, the differences seen when untreated BrMRBC ghosts are compared with
untreated NM RBC ghosts m ust be due to a rearrangem ent of the proteins in the RBC
after brom elain treatm ent that are resistant to removal by further washes in hypotonic
lysis buffer. Further, alkali-treated BRM RBC ghosts also tend to retain more protein
than alkali-treated NMRBC.

In contrast to SD S-PA G E experim ents w ith ghosts, when NM RBC and
BrM RBC are electrophoresed under reducing conditions a full profile of cytoplasmic
and m em brane proteins m ay be seen (Figures 4.5. and 4.7.). W hen an extract of gut
is electrophoresed under reducing conditions, many proteins are present (Figure 4.5).
In w estern blotting experim ents w ith N M RBC and BrM RBC, a doublet at
approxim ately 30kD was found to be specifically detected by FUB 1 and LPS serum
(Figure 4.7.). Bovine erythrocyte carbonic anhydrase is also detected under the same
conditions.
There are a num ber o f bands present at 29-3 lkD on human RBC membranes
such as Band 7, glycophorin and tropomyosin (Bennet 1985). W hat is the nature of
the doublet Band at 31kD and 29kD on m ouse erythrocytes? Is it equivalent to
glycophorin? W hy does the carbonic anhydrase band from the m arker lane react in
western blots?
T w o factors fortuitously lead to the discovery o f the cross reaction o f
anti-BrM RBC and carbonic anhydrase. Firstly, the m arker lanes were not excised
from blots for separate processing to determine the molecular weight because coloured
m olecular weight m arkers had been electrophoresed in earlier blots, and the second
factor w as that Biorad included carbonic anhydrase (CA) amongst proteins in its low
molecular weight markers.
From glycoprotein staining with Alcian Blue and periodic acid-Schiffs base,
these 30kD bands were found to be glycoproteins (Figure 4.9.). The carbohydrates
present on carbonic anhydrase have not been characterised in depth, apart from a
method where carbonic anhydrase had been purified on a lectin column and eluted with
N -acetyl galactosam ine suggesting that this sugar m ay be present (Femley et al.
1988, 1989). It is not known if m ouse carbonic anhydrase possess similar terminal
sugars and if they contribute to the antigenicity o f the molecule. From IEF experiments
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the doublet bands were found to have the same isoelectric point o f 6.7 (Figure 4.10).
M ouse carbonic anhydrase has not been isolated and sequenced by traditional
m ethods, and the sequence has been derived from cDNA sequences. Thus there is a
paucity o f specific data relating to the isoelectric point or glycosylations that
characterise m ouse carbonic anhydrase. The isoelectric point has been published for
various isoenzymes from a num ber o f species (reviewed in Deutsch 1987)
In recent w estern blotting experim ents it has been demonstrated that mouse
anti-Rat RBC serum and m onoclonal antibodies are capable of detecting glycophorins
on rat erythrocytes (Laing et a l 1987,1988). In contrast, natural antibodies that are
specific for BrM RBC bound to carbonic anhydrases exclusively in Western blots and
do not generally recognise other m arker proteins, other erythrocyte proteins or
glycophorins. This point is reexam ined in the next chapter with studies on red blood
cells from a range of species.
Preabsorption o f FUB 1 and LPS serum with BRM RBC and the subsequent
reduction in staining intensity of carbonic anhydrase bands from western blots (Figure
4.11 and 4.12) suggests that part o f the epitope on BrMRBC recognised by anti-BrM
antibodies is carbonic anhydrase. The possibility that the disappearance of the
im m unoreactive bands may be caused by proteolytic cleavage o f antibodies by trace
contam inants o f bromelain is unlikely for a num ber o f reasons . Firstly, bromelain is
not evident in BrM RBC lanes on SD S-PAGE gels. Secondly, given a removal
efficiency (say) o f 95% of bromelain after each washing step the theoretical dilution of
bromelain would be too low to account for the required levels o f enzyme to cleave the
antibody ( i.e. starting with 0.5ml RBC and 0 .5 m l o f a lOmg/ml bromelain solution,
95% o f 5m g o f brom elain would be rem oved directly after the first centrifugation
leaving 0.25 mg; a W three rounds of washing each rem oving 95% the remaining
brom elain w ould leave approxim ately 3.125 x 1 0 '°g or 31.25pg o f bromelain).
Thirdly, the same BrMRBC are used in ELISA assays, thus if residual bromelain was
responsible for cleavage o f antibodies, there would be a reduced titres rather than
elevated titres against BrMRBC. In absorption experiments conducted by Cunningham
and Steele (1981) BrM RBC are capable o f specifically absorbing anti-BrMRBC
antibodies and not anti-Horse red blood cell antibodies, and if cleavage of antibodies
was non-specific in the presence of bromelain there would have been a reduction in the
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These

considerations im ply that binding in absorption experiments is specific and that the
reduction in binding seen due to preabsorption is due to specific binding to BrMRBC
and not non-specific due to proteolytic cleavage o f antibodies by bromelain. Thus,
these experiments suggest that part o f the carbonic anhydrase molecule may become
exposed at the surface o f the erythrocyte after brom elain treatm ent o f mouse
erythrocytes.

Some IgM antibodies in unabsorbed LPS serum also recognised haemoglobin
subunits on blots suggesting that some other BrM -specific epitopes, recognised by
other serum antibodies may be located on haemoglobin (the faint band in the 12-14 kD
region Figure 4.12, Blot 1 lane a). This faint 12-14 kD band has been augmented in
intensity following absorption o f LPS-serum with NM RBC (Figure 4.12, Blot 3 »lane
a), which may be due to IgM-haemoglobin complexes binding to the band.
Lipid immunoblotting was not successful in preliminary experiments. Therefore
it w as decided to further investigate the portion o f carbonic anhydrase that was
recognised by natural antibodies. This line o f investigation may demonstrate whether
endogenous lipids are recognised by anti-BrM RBC, but specific controls including
anti-lipid antibodies and control lipids would need to be used to determine if this
m ethod is suitable for cellular lipids. H ow ever, given that BrM RBC-specific
antibodies have already been demonstrated to bind to phosphatidylcholine in a number
o f studies (Cox and Hardy 1985; Mercolino e ta l. 1986,1988; Kawaguchi 1987b), the
dem onstration here that carbonic anhydrase may also be specifically recognised by
anti-B rM RBC antibodies is novel and required a more detailed examination. In
Chapter 5 the epitopes that natural antibodies bind to on carbonic anhydrase will be
examined.

C H A P T E R F IV E
C H A R A C T E R IS A T IO N O F C A R B O N IC ANHYDRASE FR O M
M U R IN E S T O M A C H , AND F R O M E R Y T H R O C Y T E S O F
D IF F E R E N T SP E C IE S AND D E T E R M IN A T IO N O F
C A R B O N IC A N H Y D RA SE E P IT O P E S R E C O G N ISE D
BY L PS -S E R U M AND FUB 1.

5 . 1 . A B R IE F IN T R O D U C T IO N T O C A R B O N IC A N H Y D R A SE
Carbonic anhydrase (E.C. 4.2.1.1) is an enzyme involved in catalysing the
reversible hydration o f carbon dioxide that is principally required for acid-base
balance, fluid secretion and respiratory functions in mammals. The biochemistry,
physiology and genetics o f carbonic anhydrase have been extensively studied and
review ed since the discovery o f the enzyme in red blood cell lysates by Meldrum
and Roughton in 1933 (M eldrum and Roughton 1933; M aren 1967; Carter and
P arsons 1971; C arter 1972; Bundy 1977; B aeur et al 1980; Tashian and
Hewett-Emett 1984; Carter and Jeffery 1985; Deutsch 1987; Tashian 1989).
Carbonic anhydrase is a zinc metalloenzyme and glycoprotein consisting of a
single polypeptide chain o f 259 or 260 amino acids. It may exist as a number of
different isoenzymes with different enzyme activities within the one tissue or organ.
The m olecular w eight is approxim ately 30 kilodaltons although this may vary
betw een 27-35kD depending upon the species and the type o f isoenzyme. The
am ino acid sequence is highly conserved amongst a range o f different species
(reviewed in Tashian and Hewett-Emett 1984; Deutsch 1987; Tashian 1989)
Carbonic anhydrase isoenzym es are located mainly in the gastrointestinal
tract, erythrocytes, salivary glands, lungs and the kidneys (Maren 1967; Carter
1972; Spicer et a l 1979,1990). Different isoenzymes are also present in platelets,
osteoclasts, skeletal muscle and some brain tissue but are not found in osteoblasts,
fibroblasts, m onocytes or granulocytes (Holm es 1976,1977; Tashian 1989).
Carbonic anhyrdase has been found in follicle-associated epithelial cells in ileal
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Peyer’s patches o f lam bs and goat kids (Landsverk et al. 1987) and in the gastric
parietal cells, brush border o f sm all intestine enterocytes, nephron, glial cells,
erythrocytes and adipose tissue o f rodents (Spicer et al. 1979). In a recent study,
particles containing carbonic anhydrase that are associated with gut epithelial cells
have been shown to be transported to lymphoid follicles in the gut of the foetal lamb
where they fuse with the plasm a m em brane of lymphocytes in the early stages of
the form ation o f Peyer's patches (Landsverk et al. 1990).

The sequences o f various isoenzym es o f carbonic anhydrase have been
ascertained for a variety o f species (reviewed by Hewett-Em m ett et al.. 1984,
Tashian 1989, Edwards et al. 1990), but relatively little work has been attempted
with characterising the entire amino acid sequence o f mouse carbonic anhydrase
isoenzym es although some partial sequences have been published (Eicher et al.
1976; Curtis 1983; Curtis et al. 1983; Venta et al. 1984, 1985,1987; Fraser and
C urtis 1986; W hitney 1984; Tweedie and Edwards 1989; A m or-G ueret and
Lévi-Strauss 1990). For the mouse, amino acid sequencing has been hampered
because the N -term inus is "blocked" or acetylated, thus the available mouse
carbonic anhydase amino acid sequences have all been derived from c-DNA cloning
(Figure 5.1.). W hile this technique has given im portant information on the likely
am ino acid sequence, there is currently no indication o f the possible
post-translational glycosylations, phosphorylations or sulphonations that may be
present on murine carbonic anhydrase or other carbonic anhydrases.
In studies on the genetics o f m urine carbonic anhydrase, currently three
closely linked genes on mouse chromosome 3 have been characterised (Beechy et
al. 1990). Erythrocytes and stomach express Car-1 and Car-2, whereas Car-3 is
restricted to skeletal muscle. Other isoenzymes are membrane-bound, such as the
carbonic anhydrase present in the lung (Whitney and Briggle 1982) or are secretory
types present in salivary glands (Femley 1988; Femley et al. 1989).
D ifferent isoenzymes m ay be found in one organ, for example, high and low
activity form s o f carbonic anhydrase have been dem onstrated in erythrocytes
although the function that these isoenzymes may play is not clear because the low
activity form is usually inhibited at physiological levels o f anions (Maren et al.
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1976). Recently, the rate o f enzyme activity has been found to be enhanced when
carbonic anhydrase is assayed in association with erythrocyte membranes, and this
is thought to be due to an effect o f distortion of the conformation to facilitate proton
transfer at the active site of the membrane (Parkes and Coleman 1989). In red blood
cells, carbonic anhydrase is the central enzyme o f the Jacobs/Stewart cycle (1942)
where hydrogen ions are produced to protonate haemoglobin to an activated form
so that it can bind effectively to oxygen. Links have been established between
carbonic anhydrase and haemoglobin (Silverman et al .1978,1979) and, although it
has not been physically demonstrated, presumably carbonic anhydrase would also
associate closely with the anion channel (Band 3 protein) in the membrane.
In this chapter, various aspects of the binding o f natural antibodies to stomach
and erythrocyte carbonic anhydrase will be examined. Firstly, experiments in which
carbonic anhydrase has been denatured by various m eans were exam ined to
determ ine if the antigenic sites recognised by LPS serum and FUB 1 are due to
certain structural conform ations o f the glycoprotein or if a linear sequence is
revealed and recognised when the protein is unfolded. Secondly, soluble carbonic
anhydrase was used as an inhibitor in ELISA experiments to determine if natural
autoantibodies recognise native or denatured sites on target carbonic anhydrase that
has been allowed to bind to plastic. Thirdly, attempts were made to present carbonic
anhydrase as inhibitory particles in suspension ELISA experiments with BrMRBC.
A nother aim w as to determ ine if carbonic anhydrase isolated from the murine
stomach and the erythrocytes o f different species is recognised by LPS serum and
FUB 1 in imm unoblotting experiments. Finally, attempts were made to determine
the regions o f the carbonic anhydrase molecule that were recognised by antibodies
by cleavage o f the glycoprotein with specific glycolytic and proteolytic enzymes.
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se q u e n c e o f Y B R s tr a in m ice: S tructure and E xon to p ro tein dom ain
rela tio n ships o f the m ouse carbonic anhydrase I I gene. P.J. Venta. J.C.
M ontgom ery, D. Hew ett-Em m ett, K. W iebauer and R.E. Tashian J.Biol. Chem
(1985) 260, 12130-12135.

T he theoretical sites o f proteolytic cleavage by

endoproteinase Arg-C and every 10 amino acids in the sequence are indicated. The
theoretical m olecular w eights o f the cleavage products can be determined by
addition o f the m olecular weights o f the constituent amino acids and from the
N-term inal end are o f relative m olecular weight (rMW): 3.2 kD, 6.4 kD, 8.9 kD,
4.4 kD, 1.6kD, 2.2 kD, 864 D, 803 D.

M e t S e r H is H is T r p G ly T ry S e r L y s H is ^ ° A s n G ly P r o G lu A s n T rp H is L y s A s p P h e 20
P r o Ile A l A s n G ly A s p A r g G in S e r P r o 30 V a l A s p lie A s p T h r A la T h r A la (G ln /H is ) H is

40

A s p P r o A la L e u G in P r o L e u L e u lie S e r 80

80

T y r A s p L y s A la A la S e r L y s S e r lie V a l

A s n A s n G ly H is S e r P h e A s n V a l G lu P h e 70 A s p A s p S e r G in A s p A s n A la V a l L e u L y s ®0
G ly G ly P r o L e u S e r A s p S e r T y r A r g L e u 00 lle G I n P h e H is P h e H is T r p G ly S e r S e r ^ 00
A s p G ly G in G ly S e r G lu H is T h r V a l A s n ^ ° L y s L y s L y s T y A la A la G lu L e u H is L e u

^20

V a l H is T r p A s n T h r L y s T y r G ly A s p P h e ^ 30 G ly L y s A la V a l In G in P r o A s p G ly L e u ^40
A la V a l L e u G ly T y r P h e L e u L y s lie G ly ^80 P r o A la S e r G in G ly L e u G in L y s V a l L e u ^ 80
G lu A la L e u H is S e r lie L y s T h r L y s G ly 170 L y s A r g A la A la P h e A la A s n P h e A s p P r o 180
C y s S e r L e u L e u P r o G ly A s n L e u A s p T y r 190 T r p T h r T y r P r o G ly S e r L e u T h r T h r P r o 2 0 0
P r o L e u L e u G lu C y s V a l T h r T r p lie V a l 2 ^ ° L e u A r g G lu P r o lie T h r V a l S e r S e r G lu 220
G in M e t S e r H is P h e A r g T h r L e u A s n P h e 230 A s n G lu G lu G ly A s p A la G lu G lu A la M e t 240
V a l A s p A s n T r p A r g P r o A la G in P r o L e u 2 5 0 L y s A s n A r g L y s lie L y s A la S e r P h e L y s

260

CHAPTER FIVE

5 . 2 . NATURAL

134

A U T O A N T IB O D IE S

R E C O G N ISE N A T IV E AND

D E N A T U R E D FO R M S OF C A R BO N IC A N H Y DRA SE.

In the preceding chapter it was established in western blotting experiments
that natural antibodies are capable o f binding to carbonic anhydrase but it was not
immediately obvious if FUB 1 and LPS serum could recognise carbonic anhydrase
in its native or in a denatured form because o f the possible denaturing steps that
may occur during electrophoresis and blotting procedures. In order to investigate
this question, an ELISA was conducted where FUB 1 and LPS serum was used to
detect either untreated carbonic anhydrase or carbonic anhydrase that had been
allowed to bind overnight to plastic m icrotitre plates in the presence of various
denaturing agents (acid, urea, guanidine hydrochloride) or treatment with SDS or
heat to form random coils or to irreversibly cross-link the protein respectively
(Figure 5.2.). U rea and guanidine hydrochloride were used at concentrations
slightly above the concentration known to cause human carbonic anhydrase to
dissociate into random structures (Carlsson 1973).
T hese assays indicate a reduced ability o f FUB 1 to bind to heat and
SDS-denatured BCA, whereas native BCA and other denatured forms of BCA are
bound by FUB 1 and display sim ilar titration curves. For LPS serum, high
binding titres are observed for native and m ost denatured forms of carbonic
anhydrase, the exception being SD S-treated carbonic anhydrase. This reduced
ability o f FUB 1 to bind to SDS- or heat-treated carbonic anhydrase and of LPS
serum to bind to SDS- treated carbonic anhydrase may be due to destruction of an
antigenic portion of the molecule and/or a reduced ability o f these forms of carbonic
anhydrase to adhere firmly to plastic.
In dot blotting experiments conducted in parallel with the same samples used
in Figure 5.2., LPS serum can detect 0.4p,g of untreated bovine carbonic
anhydrase, or acid-treated BCA, heat-treated BCA or guanidine-HCl treated BCA,
but only O .lm g spots o f SDS-treated BCA or ljig of urea treated BCA (Figure
5.3.). In contrast, FUB 1 can detect ljig of untreated bovine carbonic anhydrase,
or acid-treated BCA, heat-treated BCA or guanidine-HCl treated BCA and 0.1 mg
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o f SDS and urea-treated BCA (Figure 5.3). From these results, FUB 1 and LPS
serum are capable o f recognising native and certain types of unfolded carbonic
anhydrase when they are bound to nitrocellulose membranes.
W hile these experim ents show that both native and denatured forms of
carbonic anhydrase are recognised by FUB 1 and LPS serum, there rem ains a
problem in that "neoantigens" may be revealed when carbonic anhydrase binds to
either microtitre plates or nitrocellulose. Thus, to determine if the same or different
epitopes are exposed on plastic-bound carbonic anhydrase, soluble carbonic
anhydrase was preincubated with FUB 1 in competitive ELISA experiments on CA
coated plates (Figure 5.4a.), acid-denatured CA coated plates (Figure 5.4b. or
guanidine -HC1 denatured CA coated plates (Figure 5.4c.). Acid denatured carbonic
anhydrase could not inhibit FUB 1 at dilutions of 1 in 2 . It was inferred from
observation o f from control plates coated with PBS only, that the high optical
density seen was due to non-specific deposition of FUB 1-acid denatured carbonic
anhydrase complexes onto the microtitre plate. However, in general, soluble forms
o f carbonic anhydrase could inhibit binding of FUB 1 to all CA-coated microtitre
wells and this would indicate that the reduced binding titre o f FUB 1 to microtitre
w ells coated w ith heated or SD S-heated carbonic anhydrase (Figure 5.2.) is
probably not solely due to a loss o f BrM-specific determinants but possibly due to a
reduced ability o f these heat-denatured forms o f carbonic anhydrase to adhere to
plastic.
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F igu re 5.2. T itration curves for a) FUB 1 and b) LPS serum in an
E L ISA w ith native or denatured form s o f carbonic anhydrase.
The wells o f a plastic m icrotitre plate were coated overnight with 50 (il of a
2.5 m g/m l solution o f bovine carbonic anhydrase that had been left untreated (o)
i.e. dissolved in phosphate buffered saline or denatured in various ways. The
following denaturation treatments were used : acid treatment in Im M HC1, pH 2.4
(# ); Heated in PBS at 60°C for 15 minutes (□ ); heated in 10% SDS at 60°C for 15
minutes ( ■ ) ; 10M urea treatm ent

(A); 8M guanadine-HCl (A). Antibodies were

titrated in three-fold steps, biotinylated second antibody was applied for 3 hour at
1:5000, in conjunction with streptavidin-alkaline phospahtase. OD 410nm was read
at 30 minutes.
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F ig u r e 5.3.
D ot blot o f n a tiv e o r d e n a tu re d sam ples of c a rb o n ic an h y d rase.
The samples of carbonic anhydrase from Figure 5.2. were also titrated onto
nitrocellulose membrane in 1 pi volumes starting at a concentration of : (columns
left to right) O.lmg, 0.03mg, 0.01 lm g, 3.7pg, 1.23pg, 0.41pg. FUB 1 and LPS
serum were used at 1:10, biotinylated second antibody and streptavidin-alkaline
phosphatase were used at 1:1000, with the Fast red developing substrate. The
row s correspond to a) bovine carbonic anhydrase, b) acid-treated carbonic
anhydrase, c) heated carbonic anhydrase, d) SDS-treated carbonic anhydrase, e)
urea-treated carbonic anhydrase and f) guanidine-HCl treated carbonic anhydrase.

LPS serum

FUB 1
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Polyclonal antibodies w ould presum ably recognise m ore than a single
antigenic site on the protein, and it was thought that FUB 1 would be more suitable
in clearly dem onstrating com petitive inhibition in these types o f assays (Figure
5.4.). The binding o f FUB 1 to carbonic anhydrase coated to microtitre plates is
clearly inhibited by soluble forms o f carbonic anhydrase in native or denatured
form s, suggesting that the antigenic portions o f carbonic anhydrase are not
destroyed upon binding o f the enzyme to plastic. LPS serum was not included in
these competitive ELISA experiments due to difficulties in clearly inhibiting binding
using the same conditions under which inhibition could be demonstrated for FUB
1. In direct ELISA experiments with LPS serum (Figure 5.2) high binding titres are
noted against native and denatured form s o f carbonic anhydrase, and clearly
inhibition m ay have been difficult to demonstrate due to the binding of a number of
different antibodies in polyclonal serum to more than a single specificity on the
carbonic anhydrase molecule.
W hen the results in this section are viewed as a whole, it would appear that
FUB 1 and LPS serum are capable of recognition of a linear portion of the carbonic
anhydrase m olecule that does not strictly depend upon the three dimensional
structure o f the protein.
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C o m p e titiv e

in h ib itio n

E L IS A

w ith

u n tre a ted

or

denatured carbonic anhydrase.
In control wells (O), FUB 1 was titrated in three-fold steps starting from a 1:3
dilution in 1% BSA and allowed to incubate at room temperature for 90 minutes,
while in test w ells, FUB 1 was titrated in the presence of 200pg/m l carbonic
anhydrase in 1% BSA (either untreated carbonic anhydrase (□ ), acid treated
carbonic anhydrase ( • ) or SD S-treated carbonic anhydrase (■ ), urea-treated
carbonic anhydrase (A) or guanadine-HCl-treated carbonic anhydrase (A). The
antigen-coated plates were coated with either (a) bovine carbonic anhydrase, (b)
acid-denatured carbonic anhydrase or (c) guanadine-HCl denatured carbonic
anhydrase.
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BIN D IN G

OF ANTIBODIES TO

BRM RBC W ITH VARIOUS FORMS OF CARBONIC ANHYDRASE.
W hile it has been demonstrated that FUB 1 and LPS serum are capable of
binding to carbonic anhydrase in dot blot and ELISA experiments, and that FUB 1
can be competitively inhibited from binding to carbonic anhydrase, it was thought
that carbonic anhydrase may be capable of inhibiting the binding of FUB 1 and LPS
serum to epitopes on BrMRBC. Several different attempts were made to inhibit
antibodies against target BrMRBC with carbonic anhydrase but inhibition was
difficult to achieve. Carbonic anhydrase was used at a number of different
concentrations and in various forms such as soluble carbonic anhydrase, carbonic
anhydrase conjugated to Sepharose beads and carbonic anhydrase crosslinked with
glutaraldehyde.
Native bovine carbonic anhydrase was used to inhibit the binding of FUB 1
and LPS serum against BrMRBC in a suspension c-ELISA by preincubation of
antibodies with bovine carbonic anhydrase (Figure 5.5.). The inhibition observed
was not significant, even when carbonic anhydrase was used at between
200-500|J.g/ml. In some experiments, when titrations were conducted in the
presence o f bovine carbonic anhydrase, slight augmentation rather than slight
inhibition was noted which may suggest an ability of IgM to bind simultaneously to
both carbonic anhydrase and BrMRBC to form lattice complexes. This inability to
inhibit binding o f FUB 1 and LPS serum to BrMRBC may be due to several
reasons, namely : the number of antigenic sites on BrMRBC may be greater than
the number of inhibitory carbonic anhydrase molecules present; IgM autoantibodies
may preferentially bind to BrMRBC due to a antigenic epitopes being presented in a
recognisable array in conjunction with phosphatidylcholine or other membrane
components, or conversely IgM autoantibodies may be capable of binding
simultaneously to bovine carbonic anhydrase and BrMRBC via different antigen
combining sites on IgM.
Conjugates o f carbonic anhydrase immobilised on Sepharose beads were
constructed to try to determine if carbonic anhydrase presented on particles would
be capable o f inhibiting the interaction of antibodies with BrMRBC. Carbonic
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anhydrase was coupled to Sepharose either in soluble form, or crosslinked with
glutaraldehyde before conjugation. In a suspension c-ELISA conducted with these
conjugates, FUB 1 failed to recognise carbonic anhydrase coupled to Sepharose in
any form, but LPS serum demonstrated binding to all conjugates (Figure 5.6). A
large proportion of the binding was however, directed towards control Sepharose
beads that had no carbonic anhydrase attached, thus these conjugates were
unsuitable to use in inhibiting the binding of antibodies to BrMRBC. This avenue
was not further pursued because inhibition depends upon specific recognition of the
inhibitor by the antibodies and this was not the case for both FUB 1 and LPS
serum. This problem with inhibiting the binding between antibody and BrMRBC
may be due in part to the way carbonic anhydrase is presented as an inhibitor,
because on the BrMRBC carbonic anhydrase may be present at a certain distance or
in the right conformational array to be recognised, or presented in association with
other membrane constituents.
Since the problem of inhibiting binding of autoantibodies appeared to reside in
the formation of lattices between IgM, carbonic anhydrase and BrMRBC, inhibition
may be more clearly demonstrated by the reductive cleavage of IgM to monomers.
R ed u ction

o f IgM

w as usually

conducted

w ith 2-m ercaptoethanol,

2-mercaptoethylamine or dithiothreitol followed by alkylation with iodoacetamide.
Similar patterns of low binding were demonstrated by all three reduction treatments.
Two types of inhibition experiments were conducted with the IgM monomers viz.
inhibition of the binding of the monomers to BrMRBC (Figure 5.7.) and inhibition
of the binding to BCA plates (Figure 5.8.). By creating monomers, there is a loss
in binding activity especially noted with FUB 1 in ELISA assays with CA-coated
plates and suspension c-ELISA with BrMRBC. This indicates that the individual
combining sites are of very low affinity and that the binding avidity of the intact
antibody is due entirely to the increased valency of IgM.
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Figure 5.5. Attem pt to inhibit binding of FUB 1 to BrMRBC with
bovine carbonic anhydrase.
A standard suspension-transfer c-ELISA was used to detect specific inhibition
o f binding o f antibodies against BrMRBC using 500pg/ml bovine carbonic
anhydrase. Inhibition of FUB 1 binding to BrMRBC could not be demonstrated
when FUB 1 was preincubated with 500|ig/ml carbonic anhydrase (□) for 2 hours
at room temperature when compared to control titrations where bovine carbonic
anhydrase was not present (■).
A different pattern was noted for LPS serum either preincubated with BCA
(O ) or left uninhibited (#), with a marked prozone effect evident but inhibition
could not be demonstrated.
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F ig u re 5.6.

B in d in g o f L PS se ru m to C A -sepharose conjugates in a

su sp e n sio n E L IS A .
LPS serum and FUB 1 were titrated in three-fold steps starting with undiluted
antibodies. Conjugates of CA-sepharose were added at a rate of 50|il/well of a 1%
suspension in PBS and allowed to incubate for 8 hours at room temperature. The rest
of the ELISA was the same as for a suspension-transfer ELISA. FUB 1 bound at
very low levels to the conjugates (not shown). Conjugates of carbonic anhydrase
contained either 40 mg of carbonic anhydrase/g of Sepharose 4B that were untreated
(O); or crosslinked with glutaraldehyde at 0.1% for 15 minutes (•) or 2 hours (□); or
crosslinked with 1.0% glutaraldehyde for 15 minute (■) or 2 hours (A). Control
beads were constructed that had no carbonic anhydrase but were allowed to bind to a
1% solution of glutaraldehyde (A).
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F igure 5.7. R eduction o f LPS serum and FUB 1 to monomers and
inhibition ELISA with BrM RBC.
In Figure 5.7a., LPS serum (#) was reduced by treatm ent with
2-mercaptoethylamine (M) or dithiothreitol

or left untreated and tested against

BrMRBC in c-ELISA experiments to establish baseline binding in the absence of
carbonic anhydrase. To demonstrate inhibition, untreated serum (O) or the
monomers 2-mercaptoethylamine (□) or dithiothreitol (A) were inhibited with 50|il
of 500 |ig/m l carbonic anhydrase for 2 hours before BrMRBC were added. In
figure 5.7b., the same IgM monomers derived from LPS serum were tested against
NMRBC.
In Figure 5.7c., FUB 1 (O) or the monomers created by treatment with
dithiothreitol ( □ ) were tested against BrMRBC in the absence of carbonic
anhydrase. To demonstrate inhibition, FUB 1 (#) and the dithiothreitol monomers
(■ ) were preincubated with carbonic anhydrase. Results for FUB treated with
2-mercaptoethylamine could not be graphed due to lysis of BrMRBC and FUB 1
has low, ungraphable binding titres against NMRBC. OD 410nm was measured at
30 minutes.
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5 .8 . T itr a tio n

o f m o n o m e rs

o f FU B

1 a g a in s t c a rb o n ic

a n h y d ra se .
In

F ig u re

5 .8 a.,

LPS

serum

w as red u ced

by

treatm en t w ith

2-m ercaptoethylam ine (■) or dithiothreitol (A) or left untreated (#) and tested
against carbonic anhydrase-coated microtitre plates to establish baseline binding in
the absence o f inhibitory carbonic anhydrase. Plates were coated with 50 |il of a
500 |Xg/ml solution o f bovine carbonic anhydrase overnight, washed and blocked
with 100 (xl o f 1% BSA in PBS for 60 minutes. To demonstrate inhibition of
binding to carbonic anhydrase-coated plates with soluble carbonic anhydrase,
untreated serum (O) or the monomers created with 2-mercaptoethylamine (□) or
dithiothreitol (A) were titrated in two fold steps from 1:20 in fifty microlitres of
500}ig/ml soluble carbonic anhydrase. In Figure 5.8b., comparable data is
demonstrated for FUB 1 starting at a 1: 2 dilution.
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Inhibition o f binding between IgM autoantibodies and BrMRBC was difficult
to achieve. This could be an effect o f intrinsic low affinity o f each antigen
combining site in IgM as well as an effect of avidity due to the binding of the IgM
to a m ultivalent array o f different epitopes on the BRMRBC surface, i.e.FUB 1
preferentially recognises murine carbonic anhydrase in the membrane in association
with phosphatidylcholine and other mem brane proteins. The likelihood of
multipoint binding may indicate that it is difficult to achieve inhibition in this system
using soluble bovine carbonic anhydrase.
The discrepancy in the antigen inhibition results for FUB 1 between the
ELISA assays involving carbonic anhydrase-coated plates (Figure 5.4, Figure
5.8b) and BrM RBC targets in suspension (Figure 5.7.) must be interpreted as
evidence that the carbonic anhydrase associated BrMRBC epitope is only one of
several ligands that can be accomodated within the antigen combining site of these
naturally occurring murine IgM anti-BrMRBC antibodies. Thus, failure of soluble
bovine carbonic anhydrase to inhibit binding to BrMRBC is interpreted as mainly
due to an increase in binding avidity contributed by the multipoint array of several
different epitopes on the surface of BrMRBC. This situation does not apply when
soluble carbonic anhydrase competitively inhibits binding to carbonic anhydrase
coated ELISA plates.
For LPS stimulated serum, the situation is slightly more complex due to the
difficulties experienced with trying to inhibit polyclonal serum. A large loss of
binding is noted however with monomers derived from LPS serum (Figure 5.8a)
suggesting that the same sort of processes are at work with IgM antibodies in
polyclonal serum i.e. binding to BrMRBC and CA is dependent upon the presence
of intact IgM.
The production of monomers and the lowered binding observed raises
questions o f the binding affinity of each antigen com bining site of IgM
anti-B rM RBC antibodies. Perhaps a clearer picture will emerge once the
measurement of "affinity" is conducted in a radioimmunoassay with radiolabelled
bovine carbonic anhydrase. However, these experiments could not be conducted at
the present due to time constraints and the need to examine other aspects of binding
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o f natural antibodies to carbonic anhydrase such as the purification o f carbonic
anhydrase from stom ach m ucosae and the definition o f antigenic epitopes on
carbonic anhydrase.

The complement dependent haemolytic assay may be more appropriate to use
in the dem onstration o f inhibition o f the interaction of antibody with RBC. In
preliminary experiments, specific lysis o f BrMRBC (and not NMRBC) could be
dem onstrated for LPS diluted to 1 in 2187 and FUB 1 to 1 in 729. Thus, the
antibody concentrations that gave approximately 50% lysis were 1 in 1100 for LPS
serum and lin 360 for FUB 1.

In assays using serial dilutions of carbonic

anhydrase from 1 x 10"~* moles/well to 1.5 xlO '^ moles/well, inhibition of the
haemolytic assay could be demonstrated with levels of carbonic anhydrase ranging
from 1 x 10"^moles/well to 1 x 10'^moles per well for 1 in 1100 LPS seru m . For
a 1 in 360 dilution o f FUB 1 inhibition o f lysis could be achieved with carbonic
anhydrase at 1 x 10"^ to 1 x 10"^ moles per well. It is difficult to compare the
results between assays because the methods o f determining endpoints are vastly
different, and what may be considered as a significant result in the haemolytic assay
is dealing with levels o f antibody that would be considered background levels of
antibody in c-ELIS A experiments. While c-ELIS A experiments offer the advantage
o f defining an endpoint more precisely than haemolytic assays, haemolytic assays
would appear to be more appropriate for the further investigation of the ability of
carbonic anhydrase to inhibit the interaction of binding between antibody binding to
BrM RBC at different levels of antibody and inhibitors. The main differences
betw een haem olytic assays and c-ELIS A would be the increased numbers of
w ashing steps and incubation tim es in ELISA experiments that may remove
antibodies o f low "affinity". These antibodies would however be present in
haemolysis assays and may easily be competitively inhibited by carbonic anhydrase
under the conditions used.
5.4. MOUSE STOMACH CARBONIC ANHYDRASE.
Since the murine stomach has been shown to be a rich source or BrMRBC
antigen, one aim here has been to characterise autoantigens that arise from the
stomach (Cunningham and Steele 1981; Chapter 3). A problem with attempting to
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demonstrate the presence of an autoantigen in murine gut using second antibody
reagents that have an alkaline phosphatase detection system has been the
interference o f endogenous alkaline phosphatase activity in the stomach. Attempts
were made to fractionate soluble gut material over Sephadex G-75 and assess the
fractions for autoantigens by dot blotting, but this could not be achieved without
interference from endogenous alkaline phosphatase. Other second antibody systems
using peroxidase conjugated antibodies had been used but were not as sensitive as
the alkaline phosphatase reagents used throughout this study. Western blotting with
appropriate control blots are the best alternative to deal with this problem because
although background staining due to endogenous alkaline phosphatase may be
present, it may be controlled for by comparison between bands on test blots and
bands on blots that have not been treated with first antibody.
Carbonic anhydrase was isolated from the stomach mucosae of retired breeder
fem ale CBA /H m ice and sem i-purified by ammonium sulphate precipitation,
fractionation on Sephadex G-75 using a m ethod that had been used to purify
carbonic anhydrase from guinea pig stomach (Carter and Parsons 1970). Fractions
from the column were tested for protein (Figure 5.9a.) and positive fractions were
electrophoresed on SDS-PAGE and stained with Coomassie Blue (Figure 5.9b.).
O f the protein containing fractions isolated from the column fractions (22 to 7 4 ),
fractions 31 to 35 were found to contain most of the proteins in the 30kD region
and bands from this region were immunoreactive in western blots when tested with
FUB 1 and LPS serum (not shown; Fraction 32 is shown in Figure 5.10). In a
side-by-side western blot, gut extract from the step immediately prior to passage
over the Sephadex column and fraction 32 were western blotted with FUB 1 and
LPS serum (Figure 5.10.). The bands present on the PBS blot indicate endogenous
gut alkaline phosphatase and these bands may be clearly distinguished from the
bands that FUB 1 and LPS serum react against.
The staining intensity of these bands is also significantly reduced if antibody
sam ples are preabsorbed with BrM RBC, but not with NM RBC, which is
indicative of carbonic anhydrase forming part of the BrM-epitope (Figure 5.10).
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F ig u re 5.9. C h a ra c te ris a tio n of m ouse sto m ach c arb o n ic anhydrase
fra c tio n s by m icro-L ow ry and SD S-PA G E .
a) Micro-Lowry Assay of protein fractions, (next page)
A micro-Lowry protein assay was conducted to determine the protein containing
fractions from the column. Carbonic anhydrase appears in the first major peak
eluted from the column (principally Fractions 31-39).
Column details : Sephadex G-75 ; 30cm x 1.5 cm, V0 = 12ml, 100fJ.l of Blue
dextran 2000 applied to the column, eluted

10.5 to 11.5ml, 0.5 fractions

collected

b) Fractions 31-39 were electrophoresed by SDS-PAGE and stained with
Coomassie Blue. Bands in the 30kD region appear in all of these fractions.

M wt (kD)

31

32

33

34

35

36

37

38

39

CHAPTER FIVE

156

Mlcrolowry assay on fractions from separation of gut carbonic anhydraifl.

UJU0C9 Q O
Column

Fractions
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F ig u r e 5.10. S D S -P ag e a n d W e s te rn b lo t o f w hole g u t e x tra c t a n d
fra c tio n 32 w ith FU B 1 a n d L P S se ru m .
SDS-PAGE (silver stained) o f whole gut extract and fraction 32 with: Lane a. Low
molecular weight markers; Lane b Column Fraction 3 2 ; Lane c W hole gut extract.
In the w estern blots, B lot 1 PBS control versus a,b,c; Blot 2 FUB 1 unabsorbed
Fug»
versus a,b,c; B lot 3 N M RBC absorbed, versus b &c and ; B lot 4 BrM RBC
f» S i

absorbed,A versus b&c.

A

In a separate experim ent, LPS-serum was absorbed more extensively : Blot
5 LPS stim ulated serum versus c,b,a ; B lot 6 LPS stim ulated serum NMRBC
absorbed versus b,a,c and ; B lot 7 LPS stim ulated serum BrM RBC absorbed
versus b,a,c. N ote the reduction in staining intensity o f carbonic anhydrase bands
upon absorption with BrM RBC, for Fraction 32 and whole gut extract. Enzymatic
stain in g o f gut alk alin e p h o sp h atase is ev id en t on the PBS control.
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SDS-PAGE & Western Blots of whole stomach and mouse stomach carbonic
anhydrase.

i) SDS-PAGE

a bc a b

Mwt (kD)
97.4

66.2
45
31
21.5
14.4

ii) Western Blots

a bc

a bc

Blots

1

2

b c

d

3

4

c

c

b a

5

b a c

6

b a c

7
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In Figure 5.10, there are high m olecular weight bands that appear on the
control blot in the whole gut extract lane (BLOT 1, lane c). These bands react
directly with the substrate or are recognised directly by the second antibody because
the second antibody has been preabsorbed with NM RBC and BrM RBC but not
with gut extract. These nonspecific bands m ay be accounted for on test blots (lane
c). On blots w here FUB 1 has been used as the first antibody (Blots 2-4) a 31kD
band

and a fainter 29kD band is recognised from fraction 32 (lane b), that

disappears with FUB 1 that has been preabsorbed with BrM RBC (Blot 4) but not
w ith N M RBC (Blot 3). In a separate experim ent w here LPS serum has been
absorbed more extensively with NM RBC or BrMRBC, (Blots 5-7) a similar result
is seen . LPS serum clearly recognises a 31 kD band and a fainter 29kD band from
Fraction 32 that disappears after LPS serum has been absorbed with BrMRBC
(Blot 7 lane b) but not NM RBC (Blot 6 lane b). As silver staining indicates (Figure
5.10a) Fraction 32 contains a wide spectrum of proteins and cannot be considered
to be p u rified carbonic anhydrase, how ever both FUB 1 and LPS serum
specifically recognise a 3 lkD protein and a fainter 29kD protein that is present in
the stomach mucosae.
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5 . 5 . M U R IN E IgM A N T I-B rM R B C N A TU R A L AUTO A N TIBO D IES
R E C O G N IS E

C A R B O N IC

AN H Y DRA SE

FROM

THE

E R Y T H R O C Y T E S OF D IFFER EN T SPECIES.

Do murine IgM natural autoantibodies recognise carbonic anhydrase from the
erythrocyte^of different species ? In a survey o f red blood cells from a range
o f different species, a doublet band o f carbonic anhydrase can be detected
from mouse, rat and rabbit RBC, whereas a single carbonic anhydrase band
is found upon immunoblotting sheep, horse and human RBC with LPS serum
and FUB 1 (Figure 5.11). FUB 1 and LPS serum have been shown to be capable
o f specifically detecting purified carbonic anhydrase from human, dog and
rabbit erythrocytes on W estern blots (Chapter 4). These western blotting results
suggest that com m on sites may be recognised on carbonic anhydrases of different
species by natural antibodies. To provide evidence o f the universality o f this
statement, it would be interesting to test natural antibodies from different species for
their ability to bind to carbonic anhydrase from a range o f species.
Suspension cell-ELISA experim ent were also conducted with FUB 1 and LPS
serum against a panel o f erythrocytes from different species (Figure 5.12). FUB 1
does not bind to untreated RBC at high levels ( Figure 5.12a), but shows some
binding against BrM RBC and Bromelain-SheepRBC (Figure 5.12c). LPS serum,
in contrast, binds to untreated rabbit and rat RBC (Figure 5.12b.) and all
brom elain-treated RBC (Figure 5.12d.).
T hese suspension c-ELISA experim ents and western blotting experiments
with the same red blood cells allow a comparison of how CA may be presented on
the erythrocytes o f different species. In western blotting experiments, all carbonic
anhydrases are recognised by FUB 1 and LPS serum because o f the way that the
proteins have been separated from their normal association with the membrane. In
contrast, different results are obtained in suspension c-ELISA experiments. FUB 1
can only recognise antigenic molecules on bromelain-treated mouse and sheep red
blood cells, suggesting that portions of carbonic anhydrase may be presented in a
recognisable form. On the brom elain-treated RBC from other species, FUB 1
which is capable o f binding to carbonic anhydrase from these species is prevented
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from doing so by the incorrect presentation or orientation of carbonic anhydrase.
LPS serum, on the other hand, is capable o f binding onto all brom elain-treated
erythrocytes to varying degrees in western blots and suspension c-ELISA assays.
This m ay reflect either the presence o f antibodies o f higher avidity for carbonic
anhydrase in LPS serum or o f antibodies that recognise other species specific
determinants in addition to carbonic anhydrase.
W hen m ouse and rat RBC are probed with monoclonal antibodies that
are specific for rat RBC (FUB 4 -IgG mouse anti-Rat RBC specific; and FUB 3
-IgM m ouse anti-BrM RBC and Anti-Rat RBC), it was found (Figure 5.13) that
LPS-serum , FUB 1 and FUB 3 recognise carbonic anhydrase on both mouse and
rat RB C , w hereas FUB 4 recognises two bands on rat RBC at 56 and 58 kD .
Faint reactivity on both mouse and rat carbonic anhydrase was observed with FUB
4. This result is an indication that IgM and IgG autoantibodies may recognise
different targets on w hole m ouse and rat erythrocytes and w arrants a more
extensive investigation o f the relationship between the targets recognised by natural
IgM autoantibodies and those recognised by IgG autoantibodies.
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F IG U R E 5.11 S D S -P A G E & W e ste rn b lo t of RB C fro m d iffe re n t
s p e c ie s
Erythrocytes were electrophoresed under standard conditions and stained with
Coom assie Blue (N euhoffs method): Lane 1 markers, Lane 2 CBA/H mouse
RBC, Lane 3 W istar Rat RBC, Lane 4 NZW Rabbit RBC, Lane 5 human RBC,
Lane 6 Sheep RBC, Lane 7 Horse RBC
a)SDS-PAGE

M x,

Mwt (kD)

1 2

3

4

5 6

7

97.4

66.2
45
31
21.5
14.4

b) BLOTS
Erythrocytes from rat, rabbit, human, sheep and horse were electroblotted under
standard conditions, except that FUB 1 was used at 1:10 and LPS serum at 1:5000,
G oat anti-m ouse IgM -biotin was applied at 1:5000 and Streptavidin-alkaline
phosphatase at 1:4000.
L a n e a. Rat RBC; L an e b. Rabbit RBC; L ane c. Human RBC; L an e d. Sheep
RBC; L ane e. Horse RBC.

LPS-serum

PUB

1

PBS control
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F igu re 5.12 Su sp en sion c-E L ISA to test the capacity o f FUB 1 and
LPS serum to bind to norm al and brom elain-treated erythrocytes from
m ouse, rat, rabbit, sheep and hum an.
' FUB 1 (Figure 5.12a) and LPS serum (Figure 5.12b) were titrated against
m ouse ( O ), rat ( # ) , rabbit (□), human (■ ) and sheep (A) red blood cells. Horse
RBC and brom elain-treated horse RBC lysed on all plates upon the addition of
substrate buffer. In Figure 5.12c, FUB 1 was titrated against bromelain-treated
erythrocytes and the results for LPS serum against bromelain-treated erythrocytes
are demonstrated in Figure 5.12d.
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F IG U R E

5.13. W e s te rn

d e te c te d

w ith

b lo t o f R B C

m o n o c lo n a l

fro m

a n ti- B r M R B C

m ouse a n d
and

r a t RBC

a n ti - R a t

RBC

a n tib o d ie s .
M ouse and rat RBC were blotted side-by-side from 15% separating gels onto
nitrocellulose. FUB 1 (BLOT 2), FUB 3 (BLOT 3), and FUB 4 (BLOT 4) were
applied to the membrane at 1:10 and LPS serum (BLOT 1) was used at 1: 5000
overnight at room temperature. BLOT 5 is the PBS control.The second antibody
was 1: 5000 goat anti-mouse IgM biotin labelled for 3 hours at room temperature,
followed by 1: 4000 streptavidin-alkaline phosphatase for 1 hour. The membranes
were extensively washed (3 x 20ml x 30mins) between all steps. All antibodies
tested could detect carbonic anhydrase bands from both rat and mouse RBC,
however, in addition FUB 4 (an IgG anti-Rat RBC specific m onoclonal) detects
two bands on Rat RBC at 56kD and 58kD. On rat RBC these bands have been
shown by Laing et al. (1988) to be glycophorin dimers.

Blot

1

Lane

MR

2
MR

3
MR

4
MR

5
MR
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5.6. D efining

the

IgM

autoantibodies.

natural

epitopes

of

carbonic

anhydrase

recognised

by

W hat portion o f the carbonic anhydrase molecule is recognised by natural
autoantibodies? Are carbohydrate epitopes or protein epitopes recognised ? From
Alcian blue and PAS staining (Chapter 4) it is known that carbonic anhydrase is a
glycoprotein, but there is currently no information on the nature o f carbohydrates
present. From previous ELISA results, it was established that FUB 1 could bind to
denatured, as well as native forms of carbonic anhydrase indicating possibly that a
linear protein epitope may be recognised. Hydrophilicity and mobility analysis are
two theoretical indicators of the position of possible antigenic epitopes in proteins
(Hopp 1986, Van Regemortel, 1986,1989).
From an examination o f the mouse carbonic anhydrase II sequence (Venta et
al 1985, Figure 5.1), there are a number of possible sites of glycosylation (Ser,Thr
and Asn) present in the N-terminal end of the molecule. From this sequence, any
carbohydrate attachm ents are likely to be through O -linkages rather than
N-linkages, because the m otif common for N-linkages viz. Asn-X Ser(Thr) (Spiro
1974) is not present in the sequence. If the constituent amino acid molecular
weights are totalled, other post-translational modifications of the protein account for
about 3% of the molecule. Thus, due to these theoretical considerations, as well as
the practical considerations o f lim ited tim e and funds only the O-linked
carbohydates have been investigated at this stage. O-linked carbohydrates may be
selectively removed with a specific enzyme, O-glycanase (Figure 5.14) or oxidised
with sodium metaperiodate (Spiro 1966).
W hen bovine carbonic anhydrase is treated with neuram inidase and
O-glycanase there is no obvious shift in molecular weight although control proteins
such as fetuin and asialofetuin are digested. Thus, it appeared as if carbonic
anhydrase was not heavily sialated or glycosylated, because it was difficult to detect
a lowering of the molecular weight with these treatments. The situation was similar
for whole mouse red blood cells treated with neuraminidase and O-glycanse, with
no obvious shift in mouse CA bands noted (Figure 5.14 b). O-glycanase has a
m olecular w eight o f approxim ately 160,000, while the m olecular weight of
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neuraminidase is approximately 97,000 (Boehringer literature).
In w estern blotting experim ents (Figure 5.15), treatm ent o f carbonic
anhydrase with neuram inidase and O-glycanase does not alter the binding of
LPS-serum to carbonic anhydrase. However, FUB 1 does not bind to carbonic
anhydrase that has had O-linked sugars removed. Sodium metaperiodate oxidation
treatment does not markedly alter the binding of LPS serum or FUB 1 to carbonic
anhydrase and this may be due to the oxidised sugars remaining attached to the
protein.
In another theoretical excercise concerned with protein epitopes, the likely
sequence o f amino acids that form a protein epitope may be determined by
hydrophilicity/hydrophobicity analysis (Hopp 1986). In this scheme, each amino
acid has been assigned a value on a scale of hydrophillicity or hydrophobicityand
the likely antigenic sites would occur between amino acids 71-75, 26-30,101-105,
111-115 and 251-254 (Figure 5.16.). There are a number o f different methods
available for attempting to define potential antigenic sites in proteins and there is still
controversy as to the merit o f different methods (reviewed in Van Regenmortel
1989). Hydrophilicity/hydrophobicity is thought to be appropriate in this case given
that phosphatidylcholine is an established component of the BrMRBC epitope and
th at h y d ro p h o b ic reg io n s o f carbonic

anhydrase m ay in teract w ith

phosphatidylcholine to form a complex once membrane integrity has been breached.
Alternatively, protein epitopes may be investigated by limited proteolysis with
proteolytic enzymes (Cleveland 1983), specific chemicals that cleave proteins such
as cyanogen bromide or hydroxylamine (Lam and Kaspar 1980,Sam s et al .1983)
or N-succinimide/urea (Lischwe and Ochs 1982) or heat (Rittenhouse and Marcus
1984). Analysis o f the sequence (Figure 5.1) suggested that cleavage of the mouse
carbonic anhydrase at a limited number of sites may be the best approach to try to
hone in on the specific site of recognition. Once antigenic epitopes could be isolated
to large sections of protein , then other proteolytic enzymes could be used to further
cleave antigenic portions into smaller sections. Initial experiments were conducted
by a method o f heat cleavage (Rittenhouse and Marcus 1984) which cuts proteins at
the carboxylic side of arginine. For these experiments, mouse carbonic anhydrase
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bands were excised from an SDS-PAGE gel and incubated for 2 hours at 110°C in
reducing sample buffer under mineral oil. This procedure was unsuccessful when
the gel slices and sample buffer were electrophoresed for the second time due to the
presence of smears of protein in place of bands, or to the lack of sufficient material
in the second gel to resolve cleavage products.
By examination o f a range of enzymatic and chemical cleavage procedures
including, trypsin, chymotrypsin, pepsin, endoproteinase Lys-C, V8 protease,
hydroxylamme, cyanogen bromide, papain, bromelain and endoproteinase Arg-C,
it was decided that enzymes that cleaved at arginine such as endoproteinase Arg-C
and papain would be the m ost suitable enzymes to cleave carbonic anhydrase.
Protein cleavage of bovine carbonic anhydrase was conducted with Endoproteinase
Arg-C & papain (Figure 5.17). In these experiments, proteolytic enzyme solution is
layered over the carbonic anhydrase in the wells of the polyacrylamide gel and this
procedure has been more successful to date.There are problems associated with
spillage o f the enzyme into other lanes that need to be resolved, because it was
found that, especially with papain, there was a tendency for the enzyme to float
across to digest other lanes even when increased levels of glycerol had been added
to make the proteolytic enzyme less likely to do this. This series of experiments
have raised a number of technical problems to resolve . Given sufficient time these
could be resolved to yield information on the antigenic sites when coupled to
western blotting procedures.
Further technical problems were encountered in preliminary Western blotting
experiments, with LPS serum and FUB 1 binding to endoproteinase Arg-C (Figure
5.18). C onsidering that the enzym e (0.45mg) has been purified from the
subm axillary glands o f 1000 mice (Boehringer literature) this may not under
physiological concentrations act as an autoantigenic target in the mouse. Another
problem encountered was due to the leakage o f proteolytic enzymes across lanes
prior to electrophoresis making determination of the exact molecular weight of the
cleavage fragments difficult (Figure 5.18). Nevertheless, LPS serum appears to be
capable of recognising a number of peptide fragments from the endoproteinase
Arg-C cleavage (Lane 3), whereas FUB 1 only detects two faint bands (Lanes 3
and 4). FUB 1 can detect endoproteinase Arg-C alone (Lane 1) but not after
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proteolysis (Lane 3). As FUB 1 recognises O-linked carbohydrates, the fact that
two protein bands are recognised here would indicate that these segments of protein
may carry O-linked carbohydrates. Clearly there is much information to be derived
from futher experiments on carbonic anhydrase along these lines.
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F ig u re 5.14a) Digestion of c a rb o n ic a n h y d ra se w ith O -glycanase to
rem ove O -lin k ed c a rb o h y d rate s.
SDS-PAGE was conducted on 15% separating gels under reducing
conditions. In lane 1: Low molecular weight markers, Lane 2 5|ig bovine carbonic
anhydrase, Lane 3 CA + neuram inidase, Lane 4 CA + neuraminidase +
O-glycanase, Lane 5 Fetuin 2}ig, Lane 6 Fetuin + neuraminidase, Lane 7 Fetuin +
Neuraminidase + O-glycanase, Lane 8 Asialo fetuin 2|ig, Lane 9 Asialofetuin +
O-glycanase, Lane 10 Neuraminidase + O-glycanase.

Mwt (kD)

1

2

3

4 5

6 7

8 9

10
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F ig u re 5.14 b). D igestion of m ouse e ry th ro c y te s w ith neu ram in id ase
a n d O -glycanase. SDS was conducted on 15% separating gels under reducing
conditions and silver stained. The gel is overloaded for silver staining but allows all
bands to be visualised, especially the purity of the commercial source of bovine
carbonic anhydrase. Lane 1: lOpg bovine carbonic anhydrase, Lane 2: CA
+neuram inidase Lane 3 NMRBC, Lane 4: NMRBC + neuraminidase, Lane 5:
NMRBC +neuraminidase + O-glycanase Lane 6: Asialofetuin Lane 7: asialofetuin +
O-glycanse Lane 8: O-glycanase and neuraminidase Lane 9: low molecular weight
markers.
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F IG U R E 5.15 W e s te rn b lo ttin g e x p e rim e n t

w ith L PS se ru m a n d

FU B 1 a n d d eg ly co sy lated c a rb o n ic a n h y d ra se .
Carbonic anhydrase was treated with neuraminidase and O-glycosidase, or sodium
meta periodate, blotted and probed with LPS-serum and FUB 1. L ane 1 Bovine
carbonic anhydrase L an e 2 Neuram inidase treated CA L ane 3 O-glycanase
treated CA L an e 4 0.0 IM NaIÛ 4 treated CA L ane 5 0.08M NaI 04 treated CA .
Carbonic anhydrase was deglycosylated with sodium metaperiodate (0.01 and
0.08M in sodium acetate buffer, pH 4.5, overnight at 4°C in the dark). These
treatm ents did not alter the apparent m olecular weight of bovine carbonic
anhydrase. However, upon calculating the theoretical molecular weight based on
the am ino acids in the sequence, carbohydrate or other post-translational
m odifications to the protein would account for only 3% of the molecule. Upon
blotting, carbonic anhydrase and the various de-glycosylation regimes did not alter
the binding to carbonic anhydrase of IgM natural autoantibodies in LPS serum,
w hich suggests that some portion of the protein is likely to be recognised.
However,the monoclonal FUB 1 displayed reduced binding to carbonic anhydrase
from which O-linked sugars had been removed with O-glycosidase, whereas
po ly clo nal L PS -serum could presum ably recognise de-glycosylated and
glycosylated forms.

L P S seru m
L ane

1 2 3 4

5

FUB1
1 2 3 4

5

P B S c o n tr o l
1 2 3 4 5
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F ig u r e 5 .1 6 . H y d r o p h ilic ity /H y d r o p h o b ic ity
carbonic anhydrase:

a n a ly sis

of

m ouse

Amino acids may be assigned a number on a scale of hydrophobicity, with
high , positive numbers { +3} indicating a very hydrophobic amino acid and high
negative numbers {-3} indicating hydrophilic amino acids (Hopp 1986). If these
values are assigned to the mouse carbonic anhydrase II sequence a number of
hydrophobic areas, which are thought to represent antigenic sites on the molecule
appear (Bold type).

F r o m H o p p ( 1 9 8 6 ) r e v ie w t h e r e is a s c a l e o f h y d r o p h o b ic ity s u c h th a t:
R A rg

E G lu ta m ic a
D A s p a c id
K L y s in e
S Ser
Q G Iu
N A sp ar
G G ly
P P ro
T Thr

3 .0
3 .0
3 .0
3 .0
0 .3
0 .2
0 .2
0.0
0.0

-0 .4

A A la
H H is
C C y st
M M et
V V al
I I s o le u
L L eu
Y T yr
FPhe
W T ryp

-0 .5
-0 .5
-1 .0
-1 .3
-1 .5
-1 .8
-1 .8
-2 .3
-2 .5
-3 .4

M S H H W G Y S K H N G P Q N W H J L D F P I A G D R E S P V f i T A T A (G /H ) H D P A
LEPLLISW fiK A ASK SIV NN G H SFNV (E F D D S G P )N A V L K G G P L
S D SY R L IE F H F W G S SfiG Q G SE H T V N L ( K K KYAAE_)LHLVHWN
TKYGDFGKAVQQPfiGLAVLGYFLKIGPASQGLQ&VLEALH
S I(K T K G K R )A A F A N F D P C S L L P G N L D Y W T Y P G S L T T P P L L E
C V T W IV L N E P IT V S S E Q M S H F N T L N F N ( E E G D A £E _) A M V D N
w e p a q p l ( k n R _K I K ) A S F K
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F ig u re 5.17 P ro te ly tic cleavage o f CA

w ith e n d o p ro tein ase A rg-C

a n d p a p a in .
SD S-PA G E conducted on 15% gels under reducing conditions,stained with
Coomassie Blue. Lane 1; Endoproteinase Arg-C, Lane 2; papain, Lane 3; Bovine
carbonic anhydrase + endoproteinase Arg-C, Lane 4; Bovine carbonic anhdyrase
+papain, Lane 5 Low molecular weight markers. Since the molecular weight marker
lane has been digested it is impossible to indicate molecular weight, however,
endoproteinase Arg-C has a molecular weight of 25kD.
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F ig u re 5.18. W estern blot of carb o n ic a n h y d rase th at had been cleaved
w ith e n d o p ro tein ase A rg-C a n d p a p ain .
LPS serum was used at 1 in 1000 dilution and FUB 1 was used at 1:10. The second
antibody was preabsorbed 1: 5000 biotinylated goat anti-mouse IgM, with 1:1000
streptavidin-alkaline phosphatase. The samples from figure 5.17 are in the same
configuration , hence, Lane 1; Endoproteinase Arg-C, Lane 2; papain, Lane 3;
Bovine carbonic anhydrase + endoproteinase Arg-C, Lane 4; Bovine carbonic
anhdyrase +papain, Lane 5 Low molecular weight markers.

1

2

3

4

5

1

2

3

4

5
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5.7. DISCUSSION

In this chapter a number of different aspects of the interaction between natural
autoantibodies and carbonic anhydrase have been examined. These experiments
attem pted to further characterise a previously unknown erythrocyte and gut
autoantigen. W ith a novel result such as has been dem onstrated numerous
experimental pathways would be possible. It was important however, to further
dem onstrate links w ith previous studies by exam ining gut m ucosae and
erythrocytes from different species, as well as to forge ahead with attempting to
define precisely the regions of the molecule that may be antigenic.
In the series of experiments with denatured forms of carbonic anhydrase, the
aim was to determine if the native structure was important for recognition by IgM
natural autoantibodies in LPS serum and FUB 1. FUB 1 and LPS serum could bind
directly to the native and some of the unfolded forms of carbonic anhydrase. There
was a decreased ability o f FUB 1 to bind to heat and SDS-denatured forms of
carbonic anhydrase, but as these molecules are subsequently found to be effective
in competitive inhibition ELISA experiments or capable of being recognised on dot
blots, the lowered binding titres observed in Figure 5.2 must be due to a reduced
ability o f these forms of denatured carbonic anhydrase to bind effectively to plastic
microtitre plates rather than to the irreversible destruction of antigenic determinants.
A slightly different pattern of binding was noted between the direct ELISA
with antigen coated plates and dot blotting experiments. SDS- and urea-treated
forms are not readily recognised when attached to nitrocellulose. The action of the
detergent SDS is to bind to amino acids in proteins to form rod-like structures with
a strong net negative charge (Smith et al. 1987). Thus the reason for the lack of
antigenicity may be due to the loss of tertiary structure or, more likely, the change
in surface charges on carbonic anhydrase.
In the competitive inhibition ELISA assays with carbonic anhydrase coated
plates, the epitopes displayed are not altered by the action of binding to the plastic
microtitre plates because soluble native carbonic anhydrase can inhibit binding. The
same pattern is seen when denatured forms of carbonic anhydrase are used for
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inhibition on untreated carbonic anhydrase plates (Figure 5.3a.). On plates coated
with denatured forms o f CA (Figure 5.3.b and c), binding may also be effectively
inhibited w ith native and denatured form s o f carbonic anhydrase. These
experiments demonstrate that the site or sites bound by IgM natural autoantibodies
are likely to consist o f a linear sequence of ammo acids that can be recognised on
the native carbonic anhydrase molecule. At high concentrations of FUB 1, FUB 1
form s a com plex with acid-denatured forms o f carbonic anhydrase which are
deposited onto plates,but this does not affect the demonstration o f inhibition of
FUB 1 at lowered antibody concentrations.
A ttem pts to inhibit binding o f natural autoantibodies to BrMRBC with
carbonic anhydrase in suspension c-ELISA experim ents w ere generally
unsuccessful (Figures 5.5 , 5.6 and 5.7).

Soluble forms o f bovine carbonic

anhydrase could not inhibit the interaction of natural antibodies and BrMRBC
(Figure 5.5) and carbonic anhydrase attached to Sepharose beads proved to be
unsuitable for use in inhibition experim ents using the suspension c-ELISA
technique (Figure 5.6). Perhaps in these types of ELISA assays the optimum
conditions to demonstrate inhibition may require some manipulation of the amounts
o f antibodies used or the amounts of target BrMRBC. No estimate has been made,
as yet, o f the num ber o f possible antigenic sites that occur per BrMRBC for
carbonic anhydrase. However, considering that it is the second most abundant
protein in erythrocytes after haemoglobin this may be quite high. The other
possibility is that anti-BrMRBC autoantibodies will always preferentially bind to
BrMRBC with at least one antigen combining site, leaving other antigen combining
sites to bind freely to carbonic anhydrase or phosphatidylcholine. Another
possibility is that carbonic anhydrase may need to be presented in conjunction with
a membrane to effectively inhibit binding to BrMRBC.
R ather than a suspension c-ELISA assay where there are a number of
stringent washing steps, inhibition may have been more conclusively demonstrated
in an inhibition o f haemolysis assay with the inhibitor continuously present. Some
preliminary experiments indicated that CA may be inhibitory in haemolysis assays
but the nature of the assay and defining an endpoint in this assay is vastly different
to ELISA assays. Inhibition may then be difficult to demonstrate in cellular ELISA
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assays without drastically altering condtions of the level of target cells or the levels
of antibodies and/or inhibitors used.

It was thought that a major part of the problem encountered with the inability
to inhibit binding may have been due to the formation o f lattices between IgM,
carbonic anhydrase and BrMRBC. One way to demonstrate inhibition was to
reduce IgM to monomers to prevent this type of lattice formation . Experiments
with monomers of IgM were revealing (Figures 5.7 and 5.8). One would expect
that the m onom ers should retain some binding activity against BrMRBC and
carbonic anhydrase, but this was not the case. For FUB 1, and to a lesser extent the
IgM autoantibodies in LPS serum, the binding of monomers was drastically
reduced suggesting that the entire IgM molecule is required to bind to BrMRBC and
carbonic anhydrase. This implies that the binding seen is due in a minor way to the
"affinity" of each antigen combining site for BrMRBC but largely a consequence of
having a number of low "affinity" binding sites per IgM molecule. Inhibition could
still not be demonstrated whether monomers were produced or not.
In experiments with monomers of FUB 1, monomers of IgM antibodies from
LPS serum and carbonic anhydrase-coated plates (Figure 5.8) the binding of all
monomers is reduced regardless of the presence o f inhibitors. Some difficulty was
also experienced in attempting to inhibit the binding of LPS serum to CA-coated
plates with carbonic anhydrase (Figure 5.8.) whereas some inhibition may be noted
for FUB 1 in the presence o f CA.
Characterising autoantigens from the stomach mucosa is important in order to
try to identify the source o f the BrM antigen that had been demonstrated by
Cunningham and Steele (1981). Carbonic anhydrase from murine stomachs was
sem i-purified from an aqueous extract o f whole gut, electrophoresed on
polyacrylam ide gels and bound specifically by FUB 1 and LPS serum. The two
im m unoreactive bands from the gut extract were located at 31kD and 28kD,
how ever the exact relationship between these bands and those expressed on
erythrocytes has not yet been established by protein sequencing. The identity
between carbonic anhydrase and the serological BrMRBC epitope has however,
been dem onstrated in western blotting experiments where FUB 1 or LPS serum
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have been preabsorbed w ith BrM RBC before use. In these experim ents,
preabsorbtion with BrM RBC but not NMRBC results in the disappearance o f the
immunoreactive bands from the whole gut extract and fraction 32.
Another im portant consideration was whether carbonic anhydrase could be
detected from the red blood cells of different species in W estern blotting and
suspension c-ELISA experim ents with m urine IgM natural autoantibodies. A
different pattern o f binding is observed depending upon the assay system. In
western blotting, all red blood cell proteins are rem oved from the erythrocyte
membrane and carbonic anhydrase bands are recognised from all erythrocytes. A
doublet band is found for mouse, rat and rabbit RBC and a single band is noted for
sheep, hum an and horse erythrocytes. In ELISA experiments, FUB 1 binds
exclusively to BrM RBC and Br-SheepRBC, while LPS serum displays binding
activity towards all bromelain-treated RBC and untreated rabbit and rat RBC. This
binding is independent of whether the blood cells can be typed with anti-A or anti-B
typing sera (Chapter 3) and suggests that bromelain may have different actions
upon different RBC membranes as regards its ability to reveal carbonic anhydrase.
Since FUB 1 is capable of recognising CA from all species on western blots, there
m ust be a quirk of presentation to explain why it is only capable of recognising
BrM RBC and to a lesser extent BrSheep RBC rather than all bromelain-treated
RBC. For LPS serum, some binding titre is evident for untreated rabbit and rat
RBC, and there is a spectrum of binding against bromelain-treated RBC:
BrMRBC > Br-Human RBC > Br Rabbit RBC > Br Rat RBC > BrSheep RBC.
W hen m ouse and rat RBC are probed with anti-Rat RBC m onoclonal
antibodies, carbonic anhydrase bands are recognised by FUB 3 and FUB 4 . In
addition FUB 4, an IgG anti-Rat RBC specific monoclonal, recognises bands at 56
and 58 kD on rat RBC alone.
The series o f experiments to define the epitopes o f carbonic anhydrase
recognised by LPS serum and FUB 1 were revealing, although the experiments
conducted with the aim o f examining protein epitopes had to be truncated due to
time constraints. These experiments show that there is evidence for the involvement
o f carbohydrates with the BrMRBC epitope and this would be compatible with
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C unningham and Steele's preparation of "blood-group-like" antigens from the
stomach. A full exam ination of whether N-linked carbohydrates are present on
carbonic anhydrase and the determination o f the actual types o f carbohydrates
involved w ould be required to clarify the importance o f carbohydrates to the
BrM RBC-type o f autoantigen. Clearly the novel results presented here require
further investigation and require a reexamination of some of the more puzzling
aspects o f the BrM RBC phenomenon, such as the inability to elicit a response if
BrM RBC are injected. Nevertheless, the results must lead us forward to examine
the significance o f the finding that carbonic anhydrase is specifically recognised by
natural autoantibodies and also the relationship between carbonic anhydrase and
phosphatidylcholine.

CHAPTER SIX
GENERAL DISCUSSION AND CONCLUSIONS

Carbonic anhydrase has been shown in this study to be related to the serological
autoantigen(s) revealed on mouse erythrocytes that have been treated with bromelain. In
this study, emphasis has been placed on characterising the endogenous autoantigens
recognised by IgM natural autoantibodies on bromelain-treated red blood cells and in the
stomach. The involvement of carbonic anhydrase with this autoantigenic epitope is a
novel finding, as previously phosphatidyl choline and trimethylammonium compounds
had been implicated in this autoantigenic determinant (Serban et al 1981; Pages et al.
1982; Serban and W itz 1988; Cox and Hardy 1985; Mercolino et a l 1986,1988,1989;
K aw aguchi 1987b). The involvm ent o f carbonic anhydrase in the BrMRBC
autoantigenic epitope has far reaching implications on the role of this autoantigen in
norm al and autoimmune animals and this will be discussed below. The discovery of
carbonic anhydrase has answered the basic aim of the study to characterise endogenous
autoantigens expressed on bromelain-treated mouse erythrocytes and in murine gut.
However, there are many questions raised by the fact that carbonic anhydrase may be
recognised as part o f this epitope and there are many experimental pathways to follow in
the future from this finding. One major question to address in the future is the role of
carbonic anhydrase and other types of autoantigens and natural autoantibodies in self
tolerance and autoimmunity.
The early negative results can now be reviewed in perspective, since carbonic
anhydrase has been found to be involved in this epitope (Chapter 4 and 5). In ELISA
experim ents (Chapter 3, Figure 3.1) LPS stimulated serum could be demonstrated to
bind to ghosts. The degree of binding was found to be dependent upon the amount of
protein present in the ghosts. When the ghosts were electro- phoresed, it was found that
m ost o f the protein remaining after formation of BrM ghosts occurred at high molecular
weights and did not leave the stacking gel.A diffuse band of protein also occurred at
29kD and there is some evidence of haemoglobin subunits at 12-14kD. If ghosts had
been treated with potassium hydroxide using the Dodge method, all membrane proteins
were stripped from the ghosts. Although binding of ghosts could be demonstrated in
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ELISA assays (Chapter 3, Figure 3.1.), difficulties were experienced when ghosts were
used as inhibitory particles in ELISA assays (Chapter 3, Section 3.4.3.) or if they had
been attached to affinity columns (Chapter 3, Section 3.4.2.). Several studies have used
ghosts to show that part o f the BrM determinant may be accounted for by a portion of
the RBC m em brane ( Bussard et al. 1977; Pages et al 1982; Poncet et al. 1985)
however, one criticism o f these studies is that it is not clear if the ghosts used were
protein-free or if they were resealed the right way around or inside out. In the
production of erythrocyte ghosts, the membrane configuration may not be representative
o f the intact erythrocyte. Since it has subsequently been demonstrated here that IgM
natural autoantibodies recognise carbonic anhydrase and that most of the carbonic
anhydrase was rem oved when ghosts were produced, it is hardly surprising that the
early experiments conducted were not successful.
One interesting observation on bromelain treatment is that BrMRBC do not lyse
after proteolytic treatment but form echinocytes rather than the predominantly biconcave
discs that are visible in intact NMRBC under the microscope. From this observation and
the fact that NM RBC are not norm ally recognised by natural autoantibodies, it was
thought that when erythrocytes have been treated with bromelain some the hydrophobic
regions of some cytoplasmic proteins may assist to stabilise the membrane in association
with membrane lipids and in doing so form a complex autoantigen.
The difficulties experienced with the earlier experiments coupled with the
availability of a monoclonal antibody that showed specificity for phosphatidylcholine
and BrM RBC, FUB 1, led to a different approach in characterising autoantigenic
epitopes on mouse red blood cells. In order to define autoantigenic molecules on
brom elain-treated and norm al erythrocytes, whole erythrocytes were used in
SDS-PAGE and W estern blotting experiments. This is quite a novel approach because
norm ally research has been focussed on membrane proteins exclusively (Fairbanks et
al. 1971) or other cytoplasmic proteins such as haemoglobin, and a purification step
would normally be included before electrophoresis. Experiments were conducted with
whole cells in preference to membranes because most assay systems (haemolytic assay,
ELISA) have demonstrated the BrMRBC to be present on "intact" cells.
Although care had to be taken to ensure the best possible signal- to- background
noise conditions with im m unoblotting experiments (Chapter 4, Section 4.2.), IgM
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natural autoantibodies in LPS serum and the monoclonal antibody FUB 1 detected a
doublet band occurring at 29kD and 31kD from bromelain-treated and normal mouse
erythrocytes (Chapter 4, Section 4.3). At the same time, bovine carbonic anhydrase
from bovine erythrocytes was detected by the same IgM autoantibodies in the marker
lane. Subsequent experiments showed that purified carbonic anhydrase from a range of
species was recognised ( Chapter 4, Figure 4.8) and also carbonic anhydrase from the
red blood cells o f a num ber of different species could also be detected by western
blotting ( Chapter 5, Figure 5.11.). Serological identity between the epitopes expressed
by intact BrM RBC in suspension and the western blotted proteins was established in
absorption experiments with BrM RBC and NMRBC ( Chapter 4, Figures 4.11. and
4.12.). Thus, absorbtion of FUB 1 and LPS serum with BrMRBC specifically removes
the doublet band of carbonic anhydrase detected by western blotting.
In binding to both mouse carbonic anhydrase and bovine erythrocyte carbonic
anhydrase, common sites on the proteins may be recognised by natural autoantibodies.
Furthermore, carbonic anhydrases from a number of species, both purified and derived
from erythrocytes, are also recognised by m urine IgM autoantibodies. Carbonic
anhydrase is a highly conserved protein with high sequence homology between different
species for a particular isoenzyme (Hewett-Emmett et al. 1984 , Tashian 1989), so it is
likely that a comm on site may be recognised on carbonic anhydrase from different
species. Conversely, experiments will need to be conducted to determine if natural
autoantibodies from different species may also recognise carbonic anhydrase as an
autoantigen.
Both o f the doublet bands of carbonic anhydrase from mouse erythrocytes were
found to be glycoproteins ( Chapter 4, Figure 4.9) and both bands had a p i of
approximately 6.7 ( Chapter 4, Figure 4.10). Alcian blue is used at low pH to stain acid
m ucopolysaccharides and sulphated mucopolysaccharides by salt linkage with acidic
groups, whereas periodic acid- Schiff staining is a general carbohydrate stain for
glycoproteins, heparin, chondroitin sulphate and polysaccharides (Kieman 1981) .
Therefore, the difference between the two different forms of carbonic anhydrase is not
due to one form being glycosylated and the other not. The nature o f the difference
betw een the proteins m ay be due to differences in the amino acid sequence, but
apparently the differences in m olecular weight do not alter the binding of natural
autoantibodies to either of the carbonic anhydrase isoenzymes. Other post-translational
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m odifications such as phosphorylation or sulphonation have not yet been reported for
m ouse carbonic anhydrase, but the fact that both bands in the doublet have the same pi
would suggest that the nature o f the modification is electrically neutral, and unlikely to
alter the basic antigenic structures recognised by natural antibodies.
One study with human erythrocytes has attempted to provide two-dimensional
maps o f erythrocytemembrane and lysate proteins (Edwards et al. 1979 ). A different
picture o f the proteins emerges when compared to the two dimensional maps of purified
erythrocyte m em brane proteins (Fairbanks 1971). W hen whole erythrocytes are
electrophoresed, haemoglobin and carbonic anhydrase are the two dominant proteins
and membrane proteins are scarce. The pattern of glycosylated proteins is somewhat
different when whole erythrocytes were examined rather than membrane proteins with a
prominent band appearing at 26kD, the doublet bands of carbonic anhydrase occuring at
29 and 31 kD ( Chapter 4, Figure 4.9).
During initial western blotting experiments, there was concern that the procedures
involved in SDS-electrophoresis and W estern blotting may be quite harsh on the
BrM RBC epitope. In this type o f dot-blotting and immunoblotting system, the best
result were obtained by employing the most sensitive system possible with biotinylated
second antibody reagents and an alkaline-phosphatase detection system. Care needed to
be taken with the second antibodies used and the preabsorbtion of second antibodies
with the target RBC must be considered as mandatory with this autoantigen due to the
likelihood of antibodies in the second antibody prepartions with specificity for carbonic
anhydrase. W ith gut material, problems were encountered due to endogenous alkaline
phosphatase. Endogenous alkaline phosphatase may be inhibited by preincubation of the
gut sam ple with levisim ole (Am ersham notes), however, in the western blotting
procedure, these bands may be accounted for by control blots that have not received first
antibody. NBT/BCIP resulted in a better resolution of bands than earlier blots conducted
with Fast Red, and the washing and blocking buffers need to be carefully chosen to
eliminate background and enhance specific binding.
Previous experience in ELISA assays for BrMRBC and NMRBC showed that
NM RBC could be recognised by IgM autoantibodies in LPS serum after cells were
allowed to settle to plastic microtitre trays overnight or if cell fixatives such as poly-Llysine or glutaraldehyde had been used (Jonusys and Steele 1988). Thus, to exclude the
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creation o f neo-antigens by fixing carbonic anhydrase to microtitre plates, competitive
ELISA experiments were conducted with soluble carbonic anhydrase (Chapter 5, Figure
5.2). In this experiment carbonic anhydrase was left untreated or pretreated with agents
know n to denature proteins, such as urea, acid, guanidine hydrochloride and SDS.
Antibodies could bind to m ost of the denatured forms and intact carbonic anhydrase in
these assays. In addition, native and denatured forms were capable of inhibiting FUB 1
binding to plastic-bound native and denatured forms of carbonic anhydrase (Chapter 5,
Figure 5.4), thus showing that the epitopes recognised were not due to the conformation
o f the molecule or the interaction between carbonic anhydrase and plastic microtitre
trays. In a dot blot experiemnt, antibodies could also detect native or denatured carbonic
anhydrase that was bound to nitrocellulose (Chapter 5, Figure 5.3). Thus, the epitopes
on carbonic anhydrase recognised by LPS and FUB 1 in western blots are not due to the
creation of neoantigens form ed when the molecule binds to nitrocellulose or plastic
substrates.
W hile inhibition of bound carbonic anhydrase with soluble carbonic anhydrase
could be demonstrated ( Chapter 5, Figure 5.4.), inhibition experiments conducted to
inhibit the binding between IgM autoantibodies and BrMRBC proved to be more
difficult. Inhibition could not be demonstrated when large amount of soluble carbonic
anhydrase were used for inhibition ( Chapter 5, Figure 5.5) or when carbonic anhydrase
had been coupled to sepharose beads for use as inhibitory particles ( Chapter 5, Figure
5.6.). This was attributed to the formation of lattices between carbonic anhydrase, IgM
and BrM RBC, rather than carbonic anhydrase being capable o f saturating all antigen
combining sites on IgM molecules. Monomers were createdffom IgM with a number of
different reducing agents to determine if the binding of the monomers rather than intact
IgM could be inhibited by carbonic anhydrase (Chapter 5, Figures 5.7. and 5.8.).
Inhibition could not be demonstrated with monomers, and in fact the binding of the
uninhibited monomers was found to be drastically reduced, suggesting that each antigen
combining site may have an intrinsic low "affininty" for BrMRBC, but that the binding
seen is due to the avidity of IgM. This may be a unique feature o f anti-BrMRBC
antibodies and other natural autoantibodies, since it has been previously noted that there
is a reduction in the binding of Fab '2 of multireactive natural autoantibodies was noted
although binding specificity for a specific autoantigen was retained (Poncet et al. 1988).
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These results raise many questions on the strength of the antigen combining site
o f these antibodies for BrMRBC. It would be interesting to determine the affinity of
each o f the antigen com bining sites fo r carbonic anhydrase as w ell as
phosphatidylcholine, in an effort to determine the relative strength of the interaction
between natural autoantibodies and autoantigens . It is possible that phosphatidylcholine
may be bound in one antigen combining site leaving other antigen combining sites free
to bind to carbonic anhydrase if these antibodies behaved as bifunctional antibodies
(Richards and Königsberg 1973, Varga et al. 1973), or conversely phosphatidylcholine
may be able to form a complex with carbonic anhydrase that could be recognised by one
antigen combining site. Experiments using liposomes or resealed erythrocyte ghosts
loaded with carbonic anhydrase may provide an answer as to the possible interactions
between phosphatidylcholine and carbonic anhydrase.
It is also interesting to recall at this point a precedent for a complex antigen
involving both a phosphatidylcholine and unidentified 28.5 kD protein antigen, viz the
human Rh (D) antigen (Moore et al. 1982). The BrMRBC antigen is not likely to be
the m ouse analogue of the human Rh (D) antigen because to reveal the BrMRBC
autoantigen Band 3 has been rem oved from the membrane whereas Rh (D) would
presum ably be a cell surface antigen. However, it is feasible that a complex antigen
consisting o f glycoprotein and lipid may be bound by a single type of antibody.
Lipid im m unoblotting was approached briefly as a method to examine the
endogenous lipids and try to dem onstrate w hether lipids isolated from murine
erythrocytes were indeed recognised as antigenic. These methods were not pursued
vigorously due to the lack of specifc control lipids and anti-lipid antibodies required to
establish if the method could be feasibly applied to erythrocyte lipids. There is no doubt
that phosphatidylcholine is involved in the BrMRBC epitope, but the existence of
phosphatidylcholine does not exclude other molecules interacting in a complex of lipid,
protein and /or carbohydrate. Therefore, once the epitopes on carbonic anhydrase have
been elucidated, then the possible interactions of phosphatidylcholine and carbonic
anhydrase should be examined i.e. if hydrophobic portions of carbonic anhydrase were
found to be recognised by natural autoantibodies then it may be possible to examine if
hydrophobic regions in the protein are complexed to phosphatidylcholine. One way to
do this would be to construct 7-10 |im micelles containing phosphatidylcholine and
carbonic anhydrase to see if these particles were either recognised or capable of
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inhibition. Another experiment could involve the construction of protein-free ghosts or
protein-containing ghosts, to which carbonic anhydrase was added back at different
concentrations and incubated in buffers so that they reseal. These particles could
perhaps be bromelain treated and the fate of carbonic anhydrase and phosphatidylcholine
follow ed to determine if natural autoantibodies bind to these particles in vitro and in
vivo .
Other studies with phosphatidylcholine have used commercial supplies derived
from sources apart from MRBC. Studies on the actual lipid content of mouse and sheep
RBC have shown that phosphatidylcholine is present on the inner side of MRBC but
not present at all on sheep RBC (Nelson 1967, Saito et al. 1983). Thus, this places the
relationship between BrMRBC and SRBC in a quandry if phosphatidylcholine alone is
involved in this epitopeas it had been supposed that the epitopes were cross-reactive or
at least closely related structures. A more likely candidate for the crossreactive epitope
shared betw een BrM RBC and sheep RBC is a w ater soluble substance isolated by
Seman et al. (1970), which is of higher molecular weight than haemoglobin subunits
and a protein . Further work would need to be done to establish that this immunogenic
substance was in fact carbonic anhydase, but there is a strong evidence that the second
m ost abundant protein in their antigenic extract from whole erythrocytes was indeed
carbonic anhydrase. Clearly, this point o f the nature of the cross-reactive antigenic
structure shared by BrMRBC and sheep RBC needs to be resolved by examination of
the constituent protein and lipids o f the respective red blood cells. If carbonic anhydrase
was found to be this cross-reactive structure shared by sheep RBC and BrMRBC, then
sheep carbonic anhydrase may be present in a more "exposed" way on erythrocytes than
m ouse carbonic anhydrase, perhaps due to the lack of phosphatidylcholine on the inner
lipid bilayer of sheep erythrocytes to anchor the protein to the cytoplasmic side of the
cell.
Recently, one group has examined the interaction on carbonic anhydrase and
erythrocyte ghosts (Parkes and Coleman 1989). Carbonic anhydrase functions more
efficiently when in association with a membrane and this is thought to be due to the
carbonic anhydrase molecule being held in a certain orientation on the membrane to
facilitate a more open structure of the active site of the enzyme. Other studies have been
concerned with purifying membrane bound forms of carbonic anhydrase isoenzymes,
but one comment that arises is that carbonic anhydrase cannot be purified free of lipid
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(Whitney and Briggle, 1982, W hitney 1984).

In histological studies on the distribution of carbonic anhydrase in rodent tissues,
it has been found that carbonic anhydrase is abundant in stomach tissues, red blood
cells, kidney , lungs, salivary glands and adipose tissue (Spicer et al 1979,1990). The
fact that adipose tissue contains carbonic anhydrase is interesting, as it could be a site
where carbonic anhydrase would be in close juxtaposition with lipids. The distribution
o f carbonic anhydrase is then similar to the distribution of the BrM-antigen which has
been found in stom ach, kidney, lungs and salivary glands (Cunningham 1974;
Cunningham and Steele 1981; Garzelli et al 1987). It would be interesting to determine
if the distribution o f carbonic anhydrase extended to the platelets as these have been
shown to be recognised by anti-BrM antibodies (Kawaguchi 1989).
A partially purified blood-group-like substance was isolated from the gut that
was capable of inhibiting haemolysis assays with BrMRBC (Cunningham and Steele
1981). The stomach mucosae is a rich source of water soluble blood group substances
attached to proteins, whereas blood group substances on red blood cells may be linked
to lipids (Kabat 1956, W atkins 1974). Blood group substances were prepared and used
in dot-blotting experiments (Figure 4.1.), but while some reactivity was noted with LPS
serum, FUB 1 and FUB 3 did not bind to these preparations. Mouse blood groups are
not strictly A-like or B-like because anti-A and anti-B typing reagents do not agglutinate
either NM RBC or BrM RBC (Chapter 3). However, the Ii blood group has been
demonstrated to occur on mouse red blood cells (Feizi and Childs 1985) and mouse red
blood cells can also express stage-specific antigens (Solter and Knowles 1978 ). It was
not possible to rule out these types of antigens at the present time, however, it may be
more fruitful to further examine the carbohydrates attached to carbonic anhydrase since
the binding of FUB 1 appears to depend upon the presence of O-linked sugars (Chapter
5, Figure 5.15.).
In experiments with RBC and Bromelain-treated RBC from different species, the
action of bromelain was found to be independent of the blood group expressed, as far as
A- and B- blood group substances were concerned, i.e. B-blood group was still
expressed on rabbit, rat and horse RBC whether they were bromelain- treated or not in
serological experiments, but different levels of reactivity were noted in ELISA assays
with the same cells depending upon whether they had been treated with bromelain or
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not. In experim ents using A ET or periodate to determine if blood group receptors
destroying substances could reveal the BrMRBC antigen on NMRBC, target cell were
lysed in protocols designed for use with preparing human RBC for agglutination
assays.These agents may be better suited for use with NMRBC ghosts, if blood group
receptors are still present after haemolysis, and these treated ghosts may be useful as
inhibitors of the BrMRBC-autoantibody interaction. There is some evidence, at least for
FUB 1, that O-linked carbohydrates present on CA may be involved in the formation of
the BrM RBC autoantigen, so this may not be a productive exercise considering that
carbonic anhydrase is rem oved from the cell in the production of ghosts. The
experiments with AET and periodate and whole mouse red blood cells may require
different assay conditons than those suitable for human red blood cells.
Studies on the epitopes recognised by carbonic anhydrase were at a preliminary
stage w hen tim e becam e short. H ow ever, there are indications that O-linked
carbohydrates are involved in the epitope that FUB 1 binds to on carbonic anhydrase
(C hapter 5, Figure 5.15). The result with LPS serum was not clearcut because
polyclonal serum may recognise more than a single site on the protein, thus different
natural antibodies specific for carbonic anhydrase may recognise protein and/or
carbohydrate epitopes of the molecule.
O f all the proteins used in this study, including all of the marker proteins, all of
the other erythocyte proteins and proteins from the mouse stomach, LPS serum and
FUB 1 predom inantly recognised carbonic anhydrase from RBC and the stomach. It
was thus surprising that endoproteinase Arg-C purified from mouse submaxillary
glands should also be detected by LPS serum and FUB 1, although it must be borne in
m ind that the enzyme is present on the gel in supraphysiological concentrations . The
relationship between endoproteinase Arg-C and carbonic anhydrase is not known apart
from the fact that both enzymes occur in the salivary glands (Levy et al. 1970; Spicer et
a l 1990).
How m ight bromelain-treatment expose antigenic sites that are normally hidden
on red blood cells ? Coating the red blood cell is a layer of erythroglycan, consisting of
carbohydrate chains attached to membrane proteins and principally Band 3, that is
thought to be responsible for the mechanical resilience of the cells during circulation
(Jam efelt et al 1978, 1982). This layer of carbohydrates is presumably why NMRBC
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are not normally recognised by natural antibodies and also why in effect even the outer
layer o f the lipid bilayer may be considered to be "hidden” from the immune system
under a layer of erythroglycan. In the removal of Band 3, some erythroglycan must also
be rem oved leaving an "intact" BrM RBC that does not spontaneously lyse, but with
exposed phosphatidylcholine sites and exposed components of the anion channel that
would have otherwise physically interacted with Band 3. In human red blood cells,
phospahtidylcholine accounts for

30% o f the total phospholipid content of the

membrane, with about 76% present in the outer lipid bilayer and the remaining 24%
present in the inner lipid bilayer (Op den Kamp et al. 1985). Similar studies also need to
be conducted as to the disposition o f phosphatidylcholine in mouse erythrocyte
m em branes, how ever, assum ing that they are similar, the phospholipids in the
m em brane m ust reorganise to seal cytoplasmic proteins inside the membrane. To
continue as a functioning cell capable of transporting oxygen and carbon dioxide,
carbonic anhydrase , that must be functionally associated with the anion channel, may
find itself inserted in the membrane albeit in a more exposed position. In this model of
the action o f brom elain on the topology o f the m em brane, it is feasible that
phosphatidylcholine and carbonic anhydrase may both become accessible targets for
natural autoantibodies. A more subtle mechanism is thought to allow this process in
vivo .
W hat is the possible relevance of carbonic anhydrase to autoimmunity ? How can
this protein become recognised by natural autoantibodies in vivo ? Although arguments
have been put forward as to the relevance o f the epitope revealed by bromelain when
there is no analogous process known to occur in vivo, it may only take a subtle process
such as the inactivation of the anion channel to render a red cell nonfunctional, or some
pathway in the process of the red blood cell binding onto oxygen to break down before
the cell becomes nonfunctional and "autoantigenic". Carbonic anhydrase plays a central
role in the function o f the erythrocyte, given that the function of the enzyme in the
erythrocyte to provide hydrogen ions to protonate haemoglobin to an activated form
where it can bind to oxygen. Carbonic anhydrase may be the perfect target for signalling
that the red blood cell can no longer function in its major capacity of oxygen and carbon
dioxide transport since it m ust play a central role in interacting between the anion
channel and haemoglobin (Silverman et al. 1978,1979). In addition, it may be recalled
that different isoenzymes of carbonic anhydrase are located at numerous sites, such as
the stomach, kidney, the liver, muscle and could potentially act as autoantigens helping
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to signal senesence if the cells containing the enzyme became damaged or unfunctional.
In norm al anim als this may be a subtle physiological process, however, at
present erythrocyte senesence has not been investigated from this perspective. One
experimental approach could be to examine the interactions of carbonic anhydrase and
natural autoantibodies at the numerous anatomical sites where carbonic anhydrase
resides, and widen the perspective of this interaction from the red blood cell to the other
tissues and organs containing carbonic anhydrase.
Carbonic anhydrase has been demonstrated to be specifically involved with the
serological determinant revealed when mouse erythrocytes have been treated with the
proteolytic enzym e bromelain. This is a novel and unexpected finding, as previous
studies have dem onstrated a role for phosphatidylcholine in this autoantigenic
determinant. Further studies need to be undertaken to establish the relationship between
phospahtidylcholine and carbonic anhydrase and to determine the immunological and
physiological functions o f natural autoantibodies binding to carbonic anhydrase.
Carbonic anhydrase, as a target for natural autoantibodies may be of importance as a
m arker o f erythocyte senescence, and thus play a vital physiological role in the
mammalian body to signal to the immune system that an erythrocyte no longer has the
full capacity to carry oxygen.
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Abstract—The

aim was to develop a cellular-ELISA assay to detect natural autoantibodies specific for
bromelain-treated mouse red blood cells (BrMRBC). High, unexpected IgM titres against normal mouse
red blood cells (NMRBC) were detected in day 7-14 sera of CBA mice treated with E. coli lipo
polysaccharide (LPS). These “autoantibodies” bound to normal mouse red blood cells in the presence or
absence of commonly used c-ELISA adhering agents. Such high reactivity to NMRBC was never detected
using complement dependent haemolytic assays in earlier work in this system. The question whether these
IgM a-NMRBC molecules were binding nonspecifically (via Fc) or specifically (via Fab) was answered
indirectly by comparing the binding titres of LPS-stimulated serum and several purified IgM antibody
preparations (a-PC, a-KLH, MOPC 104E) on the same antigen coated plates. The observed binding
ratios (titre on antigen X: titre on NMRBC) varied widely between different antibody sources, indicative
of specific binding. In addition no significant unequivocal binding against NMRBC could be detected in
vivo (LPS-stimulated mice) nor could bound IgM antibody be detected in a suspension-c-ELISA assay
(high binding titres to BrMRBC could be detected in the latter test system). In conventional c-ELISA
assays, modification of normal erythrocyte by adhesion to plastic microtitre plates appears to expose or
create “neoantigens” on NMRBC which are not encountered in suspension-type c-ELISA, nor in lytic
or agglutination assays where the erythrocyte targets are in suspension at physiological pH and isotonicity.

INTRODUCTION

It is clear that significant levels o f IgM autoantibodies
specific for m any buried cellular and soluble au to
antigens exist in n orm al anim als (13th F orum in
Im m unology, 1986). F or exam ple, in strains o f nor
mal, inbred C B A m ice w hich do n ot spontaneously
develop au toim m un e diseases, a large fraction o f the
potential Ig secreting repertoire (2% in spleen,
50-90% in peritoneum , 10% in b one m arrow) has
been show n to con tain natural autoantibodies specific
for brom elain-treated au tologou s erythrocytes (Steele
and C unningham , 1978, 1981). A nti-B rM R B C IgM
antibodies appear to b elon g to a fam ily o f restricted
V -regions (P on cet et al., 1985; K aushik et al., 1986)
and they arise from the L y -1 + class o f B-cells (H ayakawa et al., 1983, 1984, 1986).
N atu ral au toan tibod ies to B rM R B C antigens are
cross-reactive w ith determ inants on sheep R BC
(Pages and Bussard, 1975), p igeon R BC and hum an

♦This work was supported in part by a University of
Wollongong research grant.
fAddress for correspondence.
Abbreviations: BrMRBC, bromelain-treated mouse red
blood cells; NMRBC, normal mouse red blood cells;
c-ELISA, cellular-enzyme-linked immunosorbent assay;
LPS, lipopolysaccharide; PBS, phosphate buffered
saline; PLL, poly-L-lysine; GA, glutaraldehyde; i.p.,
intraperitoneal; BSA, bovine serum albumin; PC, phosphorylcholine; KLH, keyhole limpet haemocyanm.
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R BC (Pages and Arnaud, 1980) and isologous m ouse
IgG (Fc) (Cunliffe and Cox, 1980). Im munochem ical
studies have shown that trimethylammoniumcontaining com pounds are capable o f inhibiting IgM
m ediated com plem ent-dependent lysis o f BrM RBC
(Serban et al., 1981; Pages et al., 1982; C ox and
H ardy, 1985). In addition, L y-1+ B-cells recognize
phosphatidylcholine (M ercolino et al., 1986) as well
as BrM R BC (H ayakaw a et al., 1984, 1986).
There is good evidence, therefore, that a com m on
m em brane phospholipid headgroup m ay be one p o s
sible natural ligand for the bromelain-specific family
o f natural antibodies. The exact identity in vivo
however o f the responsible endogenous stim ulating
determinants is unknown. In earlier studies using
antigen inhibition o f the com plem ent m ediated lytic
assay, BrM R BC antigens were found in the gastro
intestinal tracts o f normal inbred C BA /J mice (Cun
ningham and Steele, 1981) and germ-free outbred
Swiss mice (Steele and C unningham , 1979). In addi
tion, com plem ent-dependent lysis o f antibodysensitized BrM R BC could be specifically inhibited
w ith a “ blood-group-like” substance extracted from
m ouse stom achs (Cunningham and Steele, 1981) fol
low ing the m ethods o f K abat (1956). The gastro
intestinal distribution and em ergence o f the
BrM R BC antigen early in ontogeny and the sub
sequent appearance o f specific natural autoantibodies
in 1-w eek-old m ice, suggest that the B rM R BC anti
gen m ay act as an im portant stim ulator o f large
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num bers o f potential autoantibody-secreting B-cells

Erythrocytes

(Steele and C unningham , 1979; C unningham and

R ed b lo o d cells w ere co llected under ether ana
esthesia from adult m ale and fem ale C BA /H mice
into A lsever’s so lu tio n . R ed b lo o d cells were used
either on the d ay o f co llec tio n or stored at 4°C and
used 1 -2 days after co llec tio n . Erythrocytes were

Steele, 1981).
The initial aim here w as to develop c-E L ISA
techniques to detect natural IgM au toan tibod ies
against buried determ inants on m ouse erythrocytes to
aid in the isolation o f the gut associated B rM R B C
antigen. The advantages o f E L ISA techniques are
that they provide a non-com plem ent-dependent,
sem i-quantitative endpoint based on optical density.
H ow ever, we encountered an obstacle in achieving
this sim ple goal. Thus, in LPS-stim ulated m ouse
serum (a convenient source o f high titre B rM R B C specific IgM ) we detected, using a straightforward
c-E L ISA assay where the cells were attached to wells
o f plastic m icrotitre plates, high levels o f antibody
binding against both brom elain-treated and norm al
m ouse erythrocytes. If, how ever, the initial antibody
binding was carried out using target erythrocytes in
suspension specific IgM binding w as found only
against brom elain-treated m ouse erythrocytes.
MATERIALS AND METHODS

M ice
C B A /H Can m ice (1 0 -1 9 w eeks old) were obtained
from the A nim al Breeding Establishm ent o f the John
Curtin S ch ool o f M edical R esearch, Canberra,
Australia.

Antibodies
M ale C B A /H m ice received lipopolysaccharide
(LPS) from Escherichia coli strain 0127: B8 (Phenol
extract, Sigm a N o . L -3129, Sigm a C hem ical C o. St.
Louis, M O , U .S .A .) 500 /ig /m l intraperitoneally (i.p.)
in 0 .1 m l o f sterile p h ysiological saline. LPSstim ulated serum from a group o f 5 m ice w as co l
lected and p ooled 7 days or 14 days after injection
and diluted 1:10 or stored neat in sm all lots at —20°C
until use. Serum from norm al m ice w as collected in
the sam e manner.
In the determ ination o f the antigen binding
specificity o f IgM antibody preparations for
N M R B C , one IgM m yelom a, M O PC 104E specific
for the hapten alpha 1 —►3 linked glucose residues
(L itton B ionetics, K ensington, M A , U .S .A . Cat. N o .
8402-29) was used at 500/^g/m l, and tw o affinity
purified preparations, IgM an ti-p hosp horylch olin e
(IgM a-P C ) at 5 //g/rnl and IgM anti-keyhole lim pet
haem ocyanin (I g M a -K L H ) at 5 0 /ig /m l were used.
The affinity purified IgM antibodies were isolated
from ascitic fluid o f B A L B /c m ales hyperim m unized
w ith P C -K L H (by the procedure o f T u ng et al., 1976)
by binding and elution (in 3 M N a S C N ) from PCBSA -Sepharose 4B or K L H -S ep h arose 4B. C o n 
tam inating IgG was rem oved by passage through
Sephadex G -200. The purified IgM preparations were
stored at 4°C in the presence o f 1% B SA in p h o s
phate buffered saline (PBS) con taining 0.1% (w /v)
sodium azide.

w ashed three tim es in phosphate-buffered saline
(PB S, p H 7.4) before use, carefully removing the
buffy coat after each cen trifu g a tio n step. Bromelaintreated m ou se R B C (B rM R B C ) w ere prepared by the
sam e procedure as C u n n in gh am (1974). Briefly, one
volu m e o f packed R B C w a s treated w ith one volume
o f lO m g /m l brom elain (S igm a N o . B-2252) in PBS
for 30 m in at 37°C. B rM R B C w ere w ashed an addi
tional three tim es in P B S b efore use. R ed blood cells
were diluted in PB S, co u n ted under the microscope
w ith a h a em ocytom eter and applied to the wells of
the E L ISA plates at cell d en sities betw een 103 and 106
cells per well.

Other antigens
K eyh ole lim pet h aem o cy a n in (K L H ) w as obtained
from C alb ioch em (C at. N o . 374805). p-Nitrophenylp hosp h orylch olin e (Sigm a N o . N -5 8 7 9 ) was con
verted to the reactive p -d ia zo n iu m intermediate,
D P P C , fo llo w in g the m eth o d o f C hesebro and
M etzger (1972). (W e are grateful for the expert
assistance at this step o f D r. W . C ow den, Department
o f M edical C hem istry, John C urtin S ch o o l o f Medi
cal R esearch.) A liq u o ts o f D P P C w ere stored at
—20°C . T o prepare con jugated proteins, the DPPC
w as reacted w ith B S A or K L H fo llo w in g the methods
outlined by G earhart et al. (1975) and Q uintans and
C osaen za (1976). T he m olar co n ju g a tio n ratios were
tw o m oles o f PC per m o le o f B S A and approximately
on e m ole o f PC per 100,000 m ol. w t subunit o f KLH.

c -E L IS A with cell fixa tives
W ells o f activated , fla t-b o tto m ed , 96-w ell polyvinylch oloride im m u n o a ssa y p lates (Titertek, Cat.
N o . 77-173-05, F lo w L abs) w ere co a ted w ith 50 //I of
poly-L -lysine (PL L ) h ydrobrom id e (Sigm a N o . P
2636; 1 0 //g /m l in P B S) for 30 m in at room tem
perature. W ells were aspirated and 50 /¿I o f N M R B C
and B rM R B C su spensions w ere added to the wells at
various cell d en sities and left to settle under gravity
for 6 0 -9 0 m in. The cells w ere fixed for a further
30 m in w ith 50 /¿I o f a 0.2% so lu tio n o f glutaraldehyde (G A ) in P B S, freshly prepared from a
25% aq u eou s stock so lu tio n o f glutaraldehyde
(Sigm a N o . G -6457) per w ell. E xcess glutaraldehyde
w as aspirated, the w ells w ashed tw ice w ith PBS and
b lock ed w ith 1 0 0 /¿I o f 1% B S A in P B S (w /v) with
0.1% sod ium azide for 6 0 -9 0 m in.
E xcess B S A so lu tio n w as aspirated, and the pri
m ary (first) an tib od ies were titrated in 1 % B S A in
PB S, and left to incubate at room tem perature for
60 m in. U n b o u n d first a n tib o d y w as rem oved by
three w ashes w ith G T S [0.5% gelatin (w /v ) T w een 20

Natural autoantibodies to erythrocyte antigens

(v/v) (Sigma No. P-1379), 0.9% saline (v/v)
pH 6.5-7.0]. The second antibody, alkaline phos
phatase conjugated goat anti-mouse IgM (/z-chain
specific) (Sigma No. A-7784), was used at 1:500
dilution in 1% BSA in PBS and 50 /tl of the dilution
used per well for 1 hr at room temp. The second
antibody was removed from the wells by three washes
with GTS. The phosphatase substrate solution was
prepared by dissolving 1 mg of disodium pnitrophenyl phosphate (Sigma No. 104-0) per ml of
diethanolamine buffer (0.5 mM MgCl2 (AR) in 1 M
diethanolamine (BDH 10393), pH adjusted to 9.2
with 3 M HC1) and 100 ^ul delivered to all wells on the
microtitre plates. Optical density was measured at 30
and 60 min after the addition of substrate using a
Dynatech M R 600 microplate reader set at 410 nm.
Endpoint titres were determined at either 30 or
60 min by taking the titre (x-value) at an optical
density (OD410nm) = 0.2 cutoff point (y-value) as the
endpoint. The replicate error of the endpoints is the
difference about the duplicate mean expressed as a
percentage.
Only the inner sixty wells of the immunoassay
plates were used in all experiments due to thermal
effects at the plate perimeter—“the edge effect” (Burt
et al., 1979). The outer wells on the immunoassasy
plates were blocked with 1% BSA in PBS from the
first antibody step onwards, and all wells contained
substrate in the final step to minimize the thermal
effect.
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The supernatant was carefully aspirated from around
the pellet to minimize cell loss. The RBC pellet was
resuspended in 100 p\ of 1% BSA in PBS and centri
fuged at 1000 rpm for 2 min. The pellet then received
two further washes in 1% BSA in PBS. After wash
ing, the pellet was resuspended in 100/H of 1% BSA
in PBS and transferred to another freshly aspirated
V-bottomed plate that had been blocked overnight
with 1% BSA in PBS.
The second antibody and substrate steps were the
same as above, however, at 20 min the plates were
centrifuged at 1000 rpm for 2 min and 75/d of the
supernatant was removed and transferred into stan
dard flat-bottomed wells of 96-well immunoassay
plates for optical density measurement at 30 and
60 min.
Serum absorptions
For serum absorptions, 400 p\ of packed, washed
RBC were incubated for 30 min at room temp, and
30 min on ice with 400 /zl of serum. After the first
absorption, the red blood cells were centrifuged and
the serum transferred to a freshly packed pellet of
RBC. Slight haemolysis was noted in the absorbed
serum samples.
RESULTS

High autoantibody activity against red blood cells
detected by c-ELISA with and without cell adhering
agents

c-ELISA without cell fixatives

In initial experiments designed to establish the
c-ELISA
assay parameters for the BrMRBC
Red blood cells at densities ranging from 2 x 105to
1.25 x 106 cells per well were placed in the inner sixty specificity, a high level of IgM binding against
wells of the standard immunoassay plate and allowed NMRBC was detected in the presence of cell adher
to settle under gravity overnight at room temperature ing agents (Fig. 1). IgM (but not IgG) was then found
(20-25°C). The assay was completed the next day by to bind NMRBC at high titres, with no prozones,
following the procedure from the first antibody incu whether fixatives were present or absent (Fig. 2a,c).
bation onwards in the standard c-ELISA (above). The effects of combinations of the adhering agent
Suspension -transfer c-ELISA
Suspension c-ELISA techniques have been used to
detect human anti-HLA antibodies (Morris et al.,
1983; Morris, 1983) and human anti-platelet anti
bodies (Gudino and Miller, 1981). These methods
were modified in this work by including a cell-transfer
step prior to the addition of second antibody and
substrate to circumvent the significant background
optical density generated following the centrifugation
and washing of erythrocytes in microtitre trays.
Rigid, V-bottomed, 96-well plates (Linbro/Titertek,
Cat. No. 76-321-05, Flow Labs) were blocked with
100 /H of 1% BSA in PBS per well and left overnight
at room temp. Plates were aspirated before use, and
first antibodies titrated in three-fold steps. Fifty
microlitres of a 1% suspension of erythrocytes was
added to each well, and left at room temperature for
60-90 min. Each plate was centrifuged at 1000 rpm
for 2 min at room temp on plate carriers in the
Beckman TJ6 bench centrifuge to pellet the RBC.

Fig. 1. Binding of a batch of day 7 LPS-stimulated serum
and normal mouse serum (1:50 dilutions) on wells contain
ing no cells, or coated by adding 2.5 x 105 red blood cells
per well. c-ELISA technique with cell adhering agents was
followed and OD410nm was measured 15 min after the addi
tion of substrate. Each column represents the mean of
duplicate wells with the blank subtracted (50^1 of PBS
substituted for first antibody). The error around the dupli
cate mean was between 0.8% and 7.0%.
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Fig. 2. The effects of different combinations of cell adhering agents, poly-L-lysine and glutaraldehyde, on
the binding of day 7 LPS-stimulated serum to plates where the wells were coated by adding 1.25 x 106
red blood cells per well. IgM autoantibodies against NMRBC (O ), BrMRBC ( ■ ) , and empty wells (# )
were detected by c-ELISA at 30 min after the addition of substrate. Prozones were not observed. On
immunoassay plates where PLL was absent (c, d), wells were coaled with RBC overnight at room temp.
Similar results were obtained at a range of RBC coating densities from 1 x 10J to 1.25 x iO6 cells per well.
Along the T-axis is the reciprocal of the serum dilution.

poly-L-lysine (PLL) and the fixative glutaraldehyde
(GA) were tested (Fig. 2, Table 1). Whilst it has been
suggested that glutaraldehyde may cause non
immunological adsorption of protein onto human red
blood cells by the formation of Schiff’s bases (Jamin
et al., 1986) we found that although fixatives do have
a marked effect on improving the titres of antibodies
in this system, respectable titres to the same level on
BrMRBC and NMRBC were nevertheless observed
when fixatives were absent (target cells left to bind to
plastic overnight at room temp.).

Table 1. Titres of LPS-stimulated serum in uncoated wells
and wells coated with NMRBC and BrMRBC (see Fig. 2)
with different combinations of cell adhering agents

Fixative

Reciprocal endpoint titre
Uncoated
wells
NMRBC
BrMRBC

+ PLL + GA
+ P L L -G A

125
22

2400
56

3150
60

—PLL + GA
—PLL —GA

11
9

5000
190

4900
235

Specificity o f autoantibodies to antigens on NMRBC
Since high anti-NMRBC activity could be demon
strated when fixatives were absent, the most im
portant consideration was whether these IgM anti
bodies were binding specifically (via Fab) or
non-specifically (via Fc). Since this point is difficult to
establish directly we tested it indirectly by looking for
possible Fc binding of affinity purified IgM antibody
preparations on erythrocytes and by comparing the
binding ratios of these pure IgM antibodies with their
corresponding specificities represented in LPSstimulated serum (Table 2). The mouse myeloma,
MOPC 104E, which is not crossreactive with the
BrMRBC determinant (Serban et al., 1981) was used
at 500 ¿tg/ml and gave low titres against all antigens.
In contrast the purified a-PC and a-KLH IgM anti
bodies gave relatively high titres against their specific
determinants compared with their titres on NMRBC
and BrMRBC (approximately 30-60-fold higher
specific titres). These data taken together, strongly
suggest that purified IgM molecules are unlikely to

Table 2. Reciprocal endpoint titres and antigen binding ratios of LPS-stimulated serum, IgM a-PC, IgM a-KLH and
_________________ ______ MOPC1Q4E against a panel of antigens (absence of fixatives)

LPS-stimulated
serum
IgMa-PC
IgMa-KLH
MOPC 104E

NMRBC
67.0

Reciprocal titre against
BrMRBC
PC
240.0

0.6

0.2

1.0

1.0

3.0

7.4

KLH

1.0

3200.0

38.0
N.D.
0.5

N.D.
35.0
1.7

Ratio of titres
PC: NMRBC
KLH: NMRBC
0.015

47.8

63.3
0.2

N.D. = not done.
IgM a-PC at 5/ig/ml, IgM a-KLH at 50/rg/ml and MOPC 104E at 500/ig/ml.

35.0
0.6

v

Natural autoantibodies to erythrocyte antigens
bind nonspecifically (via Fc?) to either norm al or
bromelain-treated erythrocyte m em branes. T his is
supported by the very different binding ratio on PC
versus N M R B C for L P S -stim u lated serum (0.015) as
opposed to I g M a -P C (63.3).

Attempts to detect autoantibodies binding against
NM BRC in v ivo
The above results su ggest that IgM in LPSstimulated serum binds in an im m u n ologically
specific w ay to N M R B C . A ttem p ts to dem onstrate
direct c-E L IS A bind in g o f such putative anti
erythrocyte an tib od ies to erythrocytes in vivo in m ice
injected 2 -6 days p reviously w ith LPS gave negative
results. In ad dition , in vivo b ou n d IgM could n ot be
detected using a direct C o o m b ’s antiglobulin test
(data not sh ow n ). T h ese unsuccessful direct attem pts
to dem onstrate in vivo bind in g o f IgM to N M R B C in
suspension-type assays suggests that the con 
formation o f the N M R B C m ay be altered in the
c-ELISA assay due to the attachm ent o f the cells to
plastic m icrotitre plates.

Comparison o f an ti-N M R B C and anti-BrM RBC ti
tres in a suspension c-E L ISA assay to those in a
conventional c-E L IS A assay and the effect o f antigen
absorption
Physical ch an ges to the red b lood cell m em brane
during ad hesion to plastic m icrotitre plates (either
with or w ith ou t fixative) m ay create “n eoan tigens” or
expose “ buried” antigens. W e tested this possibility
by com paring bind in g titres in the c-E L ISA assay
with those ob tain ed in a “ su spension ” c-E L ISA
assay. In ad d ition w e tested the specificity o f binding
by absorbing the serum w ith packed w ashed erythro
cytes. T ypical d ata from such experim ents are show n
in Table 3 and F ig. 3. It is clear that absorbing w ith
erythrocytes (in suspension) will not rem ove IgM
antibodies w hich bind to plastic adhering N M R B C
and B rM R B C (con ven tion al c-E L ISA assay in Table
3; Fig. 3 b ,d ,f). T his indicates that the antigenic
determ inants detected in this assay are not displayed
on the ab sorb ing erythrocytes’ surface. In contrast, a
different bind in g and ab sorption pattern is obtained
if the erythrocyte targets are kept in suspension
(suspension c-E L IS A assay in Table 3, Fig. 3a,c,e).
Here w e n o te a high binding titre on BrM R B C an
a very lo w (and probably insignificant) titre against
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N M R B C . Further, the high anti-BrM R BC titre is
com pletely rem oved by absorbing w ith brom elaintreated erythrocytes, yet on ly slightly affected (if at
all) by absorption w ith N M R B C .
It is possible, however, that the autoantibodies
detected in the conventional c-E L ISA recognize hid
den antigens exposed by treatm ent o f the cells with
the G T S w ashing buffer which contains the detergent
T w een-20. The Tw een-20 in the G T S w ashing buffer
m ay alter the lipid structure o f the cell m em brane
w hereas this problem w ould not arise for the sus
pen sion assay where 1 % BSA w as used as the w ash
ing buffer. This was tested by exam ining whether
significant IgM binding occurred in a conventional
c-E L ISA w hen 1% BSA -PB S was used as a washing
buffer. In addition, we exam ined the effect o f prior
absorption w ith erythrocyte antigens. These data,
collected at the sam e tim e as the results in Table 3 and
Fig. 3, are displayed in Table 4. The pattern o f titres
is the sam e as Table 3, i.e. the absorbing erythrocytes
do n ot rem ove IgM antibodies which bind to
N M R B C and BrM R BC adhering to plastic. This is
consistent w ith the proposition that the altered anti
genicity is due to the adherence o f the cells to the
plastic m icrotitre tray. It is also clear that the abso
lute titres in Table 4 are 5 -10-fold greater than the
corresponding ones in Table 3.
Before closing this section a com m ent can be m ade
about the suspension c-EL ISA . In establishing the
protocol, haem olysis often occurred and interfered
w ith optical density m easurem ents if G TS was used
as a w ashing buffer or if. high or prolonged centrifu
gation was em ployed. Further, m ore LPS-stim ulated
serum w as found to bind against N M R B C if the
transfer step was om itted, and this is probably due to
the form ation o f antibody com plexes or antibodies
binding to cell fragm ents caused by lysis during the
first centrifugation step.
DISCUSSION

E m ploying c-EL ISA techniques where cells are
attached to plastic, either w ith or w ithout cell adher
ing agents, we have show n that IgM autoantibodies
found in LPS-stim lated serum bind to similar levels
on both BrM R BC and N M R B C , and further, that
the binding detected is im m unologically specific.
H ow ever, by using a suspension c-E L ISA technique,

Table 1 Comparison of anti-NMRBC and anti-BrMRBC titres in a suspension c-ELISA assay to those
Table 3. Compans a conventional c-ELISA assay and the effect of ant.gen absorption-------------------NMRBC absorbed
BrMRBC absorbed
Unabsorbed
LPS-stimulated
LPS-stimulated
LPS-stimulated
serum
serum
serum
Suspension c - E L I S A “

NMRBC
BrMRBC
Conventional c -E L IS A

NMRBC
BrMRBC
.
“Washing buffer— 1% BSA in PBS.
^Washing buffer—GTS.

85
160
287
173

0.7
0
415
570

0.8
98.5
260
385
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Conventional c-ELISA

Reciprocal of Scrum Dilution

Reciprocal of Scrum Dilution

Fig. 3. Comparison of day 7 LPS-stimulated serum on 5 x 105 NMRBC ( # ) and BrMRBC (O ) in either
(a) titration curves of the suspension-transfer c-ELISA assay and (b) the c-ELISA assay with no adhering
agents. In the suspension-transfer c-ELISA, OD410nm was measured at 60 min after substrate addition and
after 30 min for the conventional c-ELISA. Titration curves for LPS-stimulated-serum that has been
absorbed with NMRBC for (c) the suspension-transfer c-ELISA and (d) the conventional c-ELISA; can
be compared to LPS-stimulated serum that has been absorbed with BrMRBC for (e) the suspension assay
and (f) the conventional c-ELISA.

we were able to detect specific IgM antibody binding
exclusively to BrMRBC. These experiments suggest
that neoantigenic sites may be uncovered on
NMRBC if cells bind to plastic (with or without
fixatives), and may provide a possible explanation for
the action of anti-erythrocyte autoantibodies in vivo
(below).
From preliminary experiments (Fig. 1), it was
thought that the autoantibody binding to erythro
cytes was due either to the effects of cell adhering
agents creating neo-determinants on normal mouse

erythrocytes or to the detection of a a non
complement fixing class of IgM anti-mouse erythro
cyte antibodies [akin to those detected by Salama and
Mueller-Eckhardt (1987) in human autoimmune hae
molytic anaemia]. Fixatives appear to have a marked
effect on the binding properties of anti-erythrocyte
antibodies (Fig. 2) and there is evidence that murine
natural antibodies may recognize a number of intra
cellular antigens created cell fixation procedures us
ing glutaraldehyde (Perrot et al., 1986). Others, how
ever, have successfully used c-ELISA with

Table 4. Anti-NMRBC and anti-BrMRBC titres in conventional c-ELISA assay
using 1% BSA in PBS as the washing buffer and the effect of antigen absorption
Unabsorbed
LPS-stimulated
serum
NMRBC
BrMRBC

2200
2300

Reciprocal titre against
BrMRBC absorbed
NMRBC absorbed
LPS-stimulated
LPS-stimulated
serum
serum
2600
1100

2250
2150
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poly-L-lysine and glutaraldehyde to dem onstrate
com plem ent receptors on hum an erythrocytes
(Thomsen et a l, 1985) and hum an b lood group
antigens (Sharon et al., 1986). In other experim ents
using G A to im m ob ilize cells to im m unoassay plates,
a slight reduction in antigenicity has been reported in
some cases (T h om sen et al., 1985) but n ot in others
(Douillard and H offm an , 1983). H igher titres were
observed here against m ouse erythrocytes when glu
taraldehyde w as present and this m ay be due to a
reduction o f cell loss during w ashing procedures or
the creation o f new antigenic determ inants. By using
PLL alone, how ever, the op posite effect was noted
and this reduction in titre m ay be attributed to the
form ation o f clum ps by R B C agglutination (M arikovsky et al., 1966) that cou ld be dislodged during
washing procedures. M eth od s using adhering agents
to bind erythrocytes to plastic or glass, such as the
Kennedy and A xelrad (1971) haem olytic plaque
forming cell assay and procedures based on this
assay, m ay reveal neodeterm inants on norm al eryth
rocytes. R egardless o f the effects o f cell adhering
agents, w e find that IgM autoantibodies bind to
“norm al” m ou se R B C even w hen cells are allow ed
to settle o n to plastic overnight w ith no fixatives
(Fig. 2c).
In experim ents designed to determ ine whether the
binding o f IgM au toan tibod ies against norm al m ouse
erythrocytes in c-E L IS A w as specific, we com pared a
group o f purified IgM preparations and LPSstimulated serum and show ed that binding is not
taking place via F c regions either w ith fixatives (data
not show n) or w ith ou t (Table 2). The wide variation
noted in the binding ratios o f the IgM antibodies
(Table 2) indicates that the binding observed against
normal m ou se red b lood cells is specific. Thus, in
contrast to the report o f “ n on-im m unological” bind
ing o f serum proteins to hum an red blood cells by the
form ation o f S ch iff’s bases in the presence o f al
dehyde derivatives (Jamin et al., 1986), the au to
antibodies detected here in the c-EL ISA appear to be
binding specifically to undefined determ inants on
m ouse erythrocyte m em branes.
D irect in vivo binding o f autoantibodies to R BC
could n o t be dem onstrated in LPS-stim ulated ani
mals by c-E L IS A and direct antiglobulin tests; h ow 
ever, this m ay be difficult to detect due perhaps to the
rapid clearance o f au toantibody-coated R BC by
“m acrophage-like” cells (Bussard and Pages, 1976) o f
the reticuloendothelial system . C ox and K east (1974)
also cou ld n o t detect autoantibodies using direct
antiglobulin tests after injection o f LPS-coated syngenic erythrocytes.
,, , A ,
U sin g a suspension c-E L ISA , w e could detect a
difference betw een antibodies binding to r
and N M R B C (Fig. 3a) which resembled previous
results ob tain ed w ith lytic assays (Cunningham and
Steele, 1981), i.e. very little if any antibody^ against
norm al m ouse erythrocytes, yet sigm fican y
g
titres against brom elain-treated erythrocy es.
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difference is not dem onstrable with plastic im m o
bilized cell targets in the conventional c-EL ISA assay
(Fig. 3b). Further, the suspension c-EL ISA assay
allow s detection o f a total reduction o f antibody
activity w hen LPS-stim ulated serum is absorbed with
BrM R BC (Table 3), whereas no significant reduction
in titre can be dem onstrated by the absorptions using
the conventional c-ELISA and no difference can be
show n between activity on N M R B C and BrM RBC.
This result was obtained whether GTS, containing
the detergent Tween-20 (Table 3) or 1% BSA in PBS
(Table 4) are used as the w ashing buffers (although
the later buffer allow s the detection o f higher absolute
titres). The suspension c-ELISA technique therefore
allow s us to conclude that the BrM R BC antigen can
be distinguished only when the cell retains its shape
in suspension and not when im m obilized on plastic.
Our experiments with LPS-stim ulated serum in
conventional c-ELISA assays, where IgM antibodies
were found to bind specifically to “normal m ouse
erythrocytes” (neoantigens), support a possible in
vivo role for these autoantibodies at local sites o f
erythrocyte damage. It is feasible that distortion o f
the erythrocyte membrane (akin to the type caused by
plastic adherence) could occur during coagulation o f
b lood cells at w ound sites or at sites o f local
inflamm ation. The subseqeunt distortion o f the m em 
brane and exposure o f neoantigens w ould allow
access o f a-N M R B C autoantibodies which m ay facil
itate erythrocyte clearance.
The present results suggest that it m ay not be
possible to look at all cellular antigens with con 
ventional c-ELISA assays if it is uncertain whether
the epitope(s) in question are subject to the easy
creation o f “neoantigens” . In another ELISA system
in our laboratory to detect m onoclonal antibodies
against im m unogenic peptides coupled to BSA we
have consistently found a significant number o f anti“neoantigen” clones, i.e. antibodies specific for BSA
determinants once BSA has adhered to plastic
(Tholen A .-S., H onours Thesis, 1987, University o f
W ollongong). The creation o f neoantigens does not
apparently affect all c-ELISA system s, for exam ple,
Bishara et al. (1983) could detect H L A antigens using
glutaraldehyde to im m obilize freshly prepared and
dried peripheral blood m ononuclear cells to m icro
titre plates, and Thom sen et al. (1985) readily m ea
sured com plem ent receptors on hum an RBC with
adhering agents w ithout neoantigen interference.
One recent concern has been the existence o f
antibodies (and autoantibodies) recognizing artifactually created antigens, especially with glutaraldehyde-fixed cells (Perrot et al., 1986; W asik et al.,
1986). C ohn (1986) and Langm an and C ohn (1986)
have stressed, in the context o f self versus n on-self
discrim ination as it applies to the viability o f the
idiotype network theory, that physical and chem ical
changes m ay readily occur to antibodies and antigens
rem oved from their normal physiological environ
m ents and questions have been raised as to the
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validity o f detecting true autoantibodies in ELISA
systems (Schwarz, 1986). Our results are consistent
with these concerns. Our experiments show that the
suspension-transfer c-ELISA is a valid technique for
the selective detection o f BrM R BC antigens, but that
these BrM RBC determinants cannot be distinguished
from the neoantigens revealed on N M R B C using
c-ELISA techniques when the target cells are im m o
bilized on plastic.
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IgM NATURAL AUTO ANTIBO DIES AG AIN ST
BRO M ELAIN-TREATED M OUSE RED BLO O D CELLS
RECO GNISE CARBONIC ANHYDRASE
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^Department of Biology, University of Wollongong, P.0. Box 1144, Wollongong, NSW 2500 Australia, School of
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(R tc tiv td August 29,19 9 0; in final form D tctm ber 13 ,19 9 0 )
Carbonic anhydrite (C A ) from mouse erythrocyte membranes is recognised as an autoandgen in Western
blotting experiments with FUB 1, a murine IgM monoclonal antibody that binds both phosphatidylcholine
and bromelain-treated mouse red Mood cells (BrM RBC). Serum from m ice stimulated with lipopolysaccharide (LPS-tetum ) also recognises C A . From SD S-PA G E , and blotting experiments with w hole mouse erythro
cytes. w e found tw o closely spaced glycoprotein bands in the 30 k D region that reacted with both FUB 1 and
LPS-terum . O ne o f the m olecular weight markers, bovine carbonic anhydrase which is o f a m olecular weight
o f about 30 kD, electrophoresed in the same 30 kD region also reacted with these antibodies. Carbonic
anh ydrites from a range o f mammalian species were found to be crossreactive with FU B 1 and LPS-terum
b y W estern blotting, whereas human glycophorin A and human asialoglycophorin were not recognised b y the
antibodies. FUB 1 specifically recognises both native and denatured bovine carbonic anhydrase in ELISA
assays. T he serological identity o f the determinants on C A and B rM R B C was confirmed by specific absorp
tion o f both FUB 1 and LPS-terum with B rM R B C and normal mouse erythrocytes. W e propose that a native
autoantigenic epitope on erythrocytes may be revealed by the proteop . .ction o f bromelain and that this
determinant it associated, at least in pan, with carbonic anhydrase.
>
K E Y W ORDS: Bromelain-treated red blood cells, carbonic anhydrase, natural autoantibodies, western blot
ting, ELISA.
A BB R E V IAT IO N S: C A , carbonic anhydrase; B rM R B C , bromelain-treated mouse red blood cells; N M R B C ,
normal mouse red blood cells; c-E L ISA , cellular-enzyme-linked immunosorbent assay;
PB S, phosphate buffered saline; i.p. mlrapetilaneal; B SA , bovine serum albumin; L ° S ,
lipopolytaccharide.

INTRODUCTION
Normal and germ-free mice from many strains display
high natural levels of IgM autoantibodies specific for
bromelain-treated erythrocytes, either autologous or
allogeneic1’2 (BrMRBC). These levels can be aug
mented by B cell mitogens such as lipopolysacchar
ide3, (UPS) or by procedures such as treatment with
antilymphocyte serum4 which interfere with homeos
tatic regulatory mechanisms or injections of bromel
ain-treated rat red blood cells3. An investigation of the
autoimmune response measuring serum antibody
levels, specific plaque forming cell capacity and the
appearance of the normal in vivo form of the BrMRBC
antigen established that both the capacity to synthesise
BrMRBC specific IgM antibody and the natural form
of the BrMRBC antigen appeared by the end of the
first week of life and reached adult levels by the third
week*. Tissues from the stomach and upper small
g A d d ie u for concspondence.

intestine were a rich source of antigenic material, cap
able of specifically absorbing the IgM anti-BrMRBC
antibody.
In recent years a number of groups have attempted
to identify the epitope(s) recognised by BrMRBC-specific IgM. In earlier experiments with serum from LPSstimulated mice (LPS-serum), Cunliffe and Cox5
showed a crossreaction with determinants located
within the Fc fragment of mouse IgG and BrMRBC.
Bussard and colleagues using anti-BrMRBC IgM mon
oclonal antibodies derived from peritoneal B-cells
from NZB mice found that they recognised trimethylammonium compounds (choline)1"10. Cox and Hardy"
further showed that anti-BrMRBC antibodies displayed
strong crossreactivity with the ubiquitous membrane
phospholipid, phosphatidylcholine but did not react
with very closely related phospholipids. Kawaguchi12
has demonstrated that anti-BrMRBC antibodies, in
addition to recognising phosphatidylcholine, bound to
low density lipoproteins of humans and chickens, but
not to mouse or rat low density lipoproteins. In more
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recent work. Haughton and coworkers” -14 have
employed liposomal probes of phosphatidylcholine
impregnated with fluorocien conjugates to allow detec
tion and isolation of BrMRBC specific peritoneal B
cells using the fluorescence activated cell sorter.
X
The aim of our work has been to identify th£)
X molecular form of the BrMRBC antigen normal 10
X found in vivo either on bromelain-treated mouse eryty
X rocytes or in its natural antigenically detectable form£h
the mouse gastrointestinal tract6. In this paper we show
that one possible natural ligand (autoantigen) on mouse
red blood cells is carbonic anhydrase.
METHODS
Mice

X

Retired female breeder CBA/Hr- mice (10-19 weeks
old) were obtained from the Animal Breeding Estab
lishment of the John Curtin School of Medical
Research, Canbqffja, Australia.
Antibodies
CBA/H mice, received lipopolysacchande (LPS) from
Escherichia coli strain 0127:B8 (Phenol extract, Sigma
no L-3129, Sigma Chemical Co. St. Louis, MO, USA)
50
intraperitoneally (i.p.) in 0.1ml of sterile
physiological saline. LPS-stimulated serum from a
group of 90 mice was collected and pooled 7 days after
injection stored in small lots at -20°C until use.
FUB 1 is an IgM monoclonal antibody produced by
fusion of an LPS stimulated C3H mouse spleen with
P3.653. The monoclonal was selected for its ability to
specifically lyse BrMRBC and not NMRBC in standaid haemolysis assays (Kenny et al., in preparation).
Antibody titres against normal and bromelaintreated mouse erythrocytes were determined by a sus
pension c-ELISA method11. The concentration of IgM
in the FUB 1 preparation was determined to be
65 M g/m l, using the single radial immunodiffusion kit
from The Binding Site (University of Birmingham
Research Institute, Medical Diagnostics Sydney RN
278). MOPC 104E for use as a negative control was
obtained from Sigma (M 3273).

(0.5-1.0 ml) of packed RBC was treated with one vol
ume of 10 mg/ml bromelain (Sigma no. B-2252) in
PBS for 30 minutes at 37°C. BrMRBC were washed an
additional three times in 10 ml volumes of PBS before
use.
Purified Antigens and Chemicals
Glycophorin A (G 5017), human asiaologlycophorin
(A 9791), carbonic anhydrase from bovine (C 7500),
human (C 6892), rabbit (C 1266) and dog (C 3513)
erythrocytes were purchased from Sigma Chemical Co.
SDS PAGE and immunoblotting
The discontinuous SDS-PAGE method of Laemmli16
with 4%T stacking gel and 15%T separating gel was
used in a minigel system (Biorad Mini Protean II) at
200 V constant for 55 min. Low molecular weight
markers were purchased from Biorad (161 0304). Gels
were stained for protein with Coomassie Blue R250
using NeuhofPs method for detecting nanopram
amounts of proteins in gels17. The alcian bluei r and
periodic acid-Schiff methods1* were used to stain gels
for glycoproteins.
Western blotting was performed according to the
methods of Towbin*. Western transfer was conducted
using a mini-transfer system (Biorad Mini Trans-blot)
and a 25 mM Tris-192 mM glycine, 20% (v/v) meth
anol buffer, pH 8.3 for 1 hour at 100 V constant. Blots
were blocked with 3% BSA in PBS overnight at room
temperature on a rocker, and washed extensively with
20 ml PBS containing 0.1% Tween 20 during all wash
ing steps.
The biotinylated goat anti-mouse IgM antibodies
(Sigma B 9265) used at 1:2500 or 1:5000 to develop
the blots, were routinely preabsorbed with NMRBC
and BrMRBC to remove antibodies that were capable
of directly binding to carbonic anhydrase-associated
determinants on mouse erythrocytes. An alkaline phos
phatase detection system21 involving 1:2000 or 1:2500
Streptavidin-Alkaline Phosphatase (Dakopattsfc>396)
and Nitroblue Tetrazolium (Sigma N6876)/5-bromo-4chloro-3-indolyl phosphate, p-toluidine salt (B 8503
Sigma) (NBT/BCIP) in diethanolamine/HCl, pH 9.2
was used.

Erythrocytes
Red blood cells were collected, under ether anaesthesia
from adult female CBA/H mice into Alsever's solution
and used on the day of collection. Erythrocytes were
washed three times in phosphate-buffered saline (PBS,
pH 7.4) before use, carefully removing the buffy coat
after each centrifugation step. Bromelain-treated
mouse red blood cells (BrMRBC) were prepared as
described by Cunningham (1974). Briefly, one volume

Enzyme-linked immunoassaysfor carbonic anhydrase
For the measurement of antibody titres against car
bonic anhydrase, the inner 60 wells of a plastic microtitre plate were coated overnight at room temperature
with 50/d of a 2.5 mg/ml solution of bovine carbonic
anhydrase that had been either left untreated (dissolved
in phosphate-buffered saline) or denatured in various
ways. Carbonic anhydrase was denatured by the fol-

NATURAI. AUTOANTIBODIES RECOGNISE CARBONIC ANHYDRASE

lowing treatments; acid treatment - | mM HC1. pH 2.4;
heat - 60°C for IS min in phosphate-buffered saline;
SDS+heat —heat in 10% SDS for 15 min at 60*G; urea
- 10 M urea; Gu-HCl - 8 M guanidine-HCl. ConcenX trations o f urea and guanidine-HCl used here a£b
X greater than the concentrations known to produce ran
dom coils o f purified human carbonic anhydrase22.

Wells were aspirated and then blocked with 100 fA
of 1% bovine serum albumin for 90 min at room tem
perature. FUB 1 was titrated in three-fold steps and
allowed to incubate for 90 min. Plates were washed
three times with 100/d/well of 1% BSA and then
coated with 50 fA of 1:5000 Biotinylated goat anti
mouse IgM for 3 hours. Plates were aspirated and 50 fA
of 1:2000 Streptavidin-alkaline phosphatase allowed to
bind for 1 hour. After three more washes. 100 fA of p nitrophenylphosphate substrate in diethanolamine/HCl
buffer, pH 9.2, was applied to each well and
absorbance read at 410 nm at 30 and 60 min. Endpoint
titres were defined as the reciprocal of the dilution of
FUB 1 at an OD cutoff point of 0.2 at 30 min.
In competitive inhibition assays with carbonic anhy
drase, plates were coated overnight with 50 fA of
500 ¿¡g/ml bovine carbonic anhydrase. Wells were
blocked for 90 min with 100 fA of 1% BSA in PBS.
FUB 1 was titrated in the presence of 200 f i g/ml car
bonic anhydrase with the remainder of the procedure
the same as a standard ELISA from the second anti
body step onward.

\

20% (v/v) packed pellet of either BrMRBC or NMRBC
was added for 60 min on ice for the three absorptions.

RESULTS
I m m u n o b lo ts o f m o u s e e r y t h r o c y te s

The primary aim was to examine mouse erythrocytes
by immunoblotting with FUB 1 and LPS-stimulated
serum to ascertain if any RBC proteins would allow
binding of the antibodies and thus behave as potential
autoantigens. Whole normal mouse red blood cells,
bromelain-treated mouse red blood cells and low
molecular weight markers were electrophoresed on dis
continuous SDS-PAGE gels and electroblotted onto
nitrocellulose (Figure 1). It can be seen that two bands
from the 30 kD region (29 kD, 31 kD) of both NMRBC
and BrMRBC, and bovine carbonic anhydrase from the
marker lane, were specifically recognised by the mono
clonal FUB 1 and polyclonal LPS-serum. The doublet
bands have been detected on SDS-PAGE and Western
blots from mouse, rat and rabbit erythrocytes, whereas
only a single band is detected with bovine CA and
sheep, horse and human erythrocytes (A.M. Jonusys,
unpublished). FUB 1 specifically detected carbonic
anhydrase from human, dog and rabbit erythrocytes but
not human glycophorin A or asialoglycophorin on
Western blots (result^ not shown). In further control
experiments no bands developed if blotted membranes
were first exposed to the myeloma protein, MOPC
104E, at concentrations comparable to those used for
S u s p e n s io n c e llu la r e n z y m e - lin k e d im m u n o a s s a y s f o r
FUB 1 at 1:10 dilution (viz. 6.5/rg/ml). From alcian
e r y th r o c y te s
blue and periodic acid-Schiff base staining, these
A suspension c-ELISA was used to detect BrMRBC- 30 kD mouse erythrocyte bands are glycoproteins
specific antibodies15. Alkaline phosphatase conjugated (result not shown).
goat anti-mouse IgM second antibodies were replaced
with 50 /A of 1:5000 biotinylated goat anti-mouse IgM
second antibody added to each well and left for 3 F U B 1 A c t iv i ty a g a in s t n a tiv e a n d d e n a tu r e d f o r m s o f
hours. Plates were centrifuged and aspirated, then 50 fA c a r b o n ic a n h y d r a s e
of 1:2000 streptavidin-alkaline phosphatase added and From these initial results, it was not clear if FUB 1 was
left for 1 hour.
recognising a native or denatured form of the auto
The replicate error of the mean between duplicate antigen because of the possible denaturating steps dur
titrations in ELISA assays expressed as a percentage ing the electrophoretic and blotting procedures. In
varied between 2 and 10%.
order to investigate this question, a direct ELISA was
performed where FUB 1 was used to detect either
untreated carbonic anhydrase or carbonic anhydrase
P r e - a b s o r p tio n o f p r im a r y a n d s e c o n d a r y a n tib o d i e s
that had ^een allowed to bind overnight to plastic micw ith e r y t h r o c y te s
rotitre plates in the presence of various denaturating
Commercial second antibody preparations used for agents (acid, urea, guanidine-HCl, SDS) (Figure 2).
immunoblotting and ELISA were routinely absorbed to The results show that FUB 1 can recognise native and
remove anti-carbonic anhydrase and anti-BrMRBC and unfolded forms of bovine carbonic anhydrase, but that
NMRBC antibodies: 20 fA diluted 10-fold to 200 fA in microtitre wells coated with heated or SDS-heated CA
1% BSA in PBS was absorbed on ice three times witij) lead to a substantial loss of FUB 1 binding. This could
500 fA of packed NMRBC and then an additional three be due to a destruction of the antigenic portion of car
bonic anhydrase and/or to a reduced ability of heat
times with 500 fA of packed BrMRBC.
For the pre-absorption of FUB 1 and LPS-serum, a denatured CA to adhere firmly to plastic.

In dot blot experiments using the same samples at
various concentrations, FUB 1 could detect down to
1 /rg of untreated CA, acid-treated, urea-treated and
Gu-HCl-treated CA, but only down to 100/tg of
SDS/heat and heat-treated CA (result not shown).
In competitive inhibition ELISAs, where different

forms of carbonic anhydrase were used to inhibit
increasing dilutions of FUB 1 binding to carbonic

anhydrase associated with plastic microtitre wells, we
found that native carbonic anhydrase, as well as the
denatured forms (acid-treated, SDS/heat treated) of
carbonic anhydrase, were specifically recognised by

Mwt.

1
Figure 1 SDS-PAGE and Western
blotting of mouse red blood cells and
carbonic anhydrase. Lane 1: Biorad low
molecular weight markers (10 /d of
1:20 dilution containing: rabbit muscle
phosphorylase B, 97.4 ld>, bovine
serum albumin, 66.2 kD; ovalbumin,
45 kD; bovine carbonic anhydrase,
31 kD; soybean trypsin inhibitor,
21.5 kD; and lysozyme, 14.4 kD). The
position of bovine carbonic anhydrase
is indicated by an arrow. Lane 2: Nor
mal mouse red blood cells from CBA/H
retired female breeders (10 /A of 2%
RBC in reducing sample buffer). Lane
3: Bromelain-treated mouse ted blood
cells. Lane 4: Bovine carbonic anhyd
rite (5 /rg). Lane 5: Molecular weight
markers. FUB 1 and LPS-serum were
applied at a concentration of 1:10 to
one half of a nitrocellulose sheet that
had been blotted from the same gel.
Control blots treated with PBS instead
of first antibody were negative.
Biotinylated Goal anti-mouse IgM was
used at 1:2500 and strepiavidin-alkaline
phosphatase at 1:2000.

2

FUB 1 (1:10)

1 2 3 , 4 5

3

4

LPS-serum(1:l0)

1 2 3 4 5

5

Reciprocal of FUB 1 Dilution
F igu re 2 Tum i on curvet for FUB 1 in in ELISA wilh nitive and denatured forms of bovine carbonic anhydrite. The wells of a plastic
microcitre plate were coated overnight with 50 /d of a 2.5 mg/ml solution of bovine carbonic anhydrite that had been either left untreated
/ \ (OO), i-e. dissolved in phosphate-buffered saline, or denatured in various ways. The following denaturauon treatments were used: Add treat
ment - 1 mM HQ, pH 2.4 (•>, Heal - heat in phosphate-buffered saline at 60°C for 15 min (■); SDS+Heat - heal in \Q% SDS for 15 min at
60*C (■); Utea - 10 M urea (A): Gu-HCl - 8 M guanidine-HCKA).
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F igu re 3 Competitive inhibition EUSA with untreated or denatured carbonic anhydrase. In control wells (O), FUB 1 was titrated in three
fold ateps tuning at 1 in 3 in 1% BSA and allowed to incubate at room temperature for 90 min, while in test wells FUB was titrated in the
presence of 200/rg/ml carbonic anhydrase in I % BSA (either untreated carbonic anhydrase (•), add-treated carbonic anhydrase (■) or SDSueated carbonic anhydrase (■)).
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Figure 4 A suspension-transfer c-ELISA was used to delect specific inhibition of binding of antibodies against BrMRBC using 500/ig/ml
bovine carbonic anhydrase. FUB 1 did not bind to NMRBC (not shown). Inhibition of FUB 1 binding to BrMRBC could not be demonstrated
when FUB 1 was preincubaied with 500 /¿g/ml bovine carbonic anhydrase ( • ) for 2 hours at room temperature when compared to control
titrations (O) where bovine carbonic anhydrase was not present.

Blots

2

1

5 Western blot of carbonic anhydrase and normal mouse red blood cells and FUB 1. Conditions for electrophoresis and electroblotling were the tame as for Figure 1 except carbonic anhydrase (lane a) and NMRBC (l»ne b) were blotted side-by-tide and the nitrocellulose
wat stored dry before ute. FUB 1 wat preabsorbed extensively by either 20% packed BrMRBC (Blot 1), 20% packed NMRBC (Blot 2) or
unabsorbed (Blot 3) before application to the blots. Preabsorption of FUB 1 with BrMRBC lowers the intensity of binding to carbonic anhyd
rase and the 30 kD bands from mouse erythrocytes, whereas prcabtorbing with NMRBC does not.
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F ig u re o Western blot of carbonic anhydrase and normal mouse red blood cells and LPS-serum. In a separate Western blot experiment with
LPS-terum used at 1:500 against NMRBC (lane a) and carbonic anhydrase (lane b), a similar result to Figure 5 was obtained. LPS-serum was
preabsorbed extensively by either 40% packed BrMRBC (Blot 2), 40% packed NMRBC (Blot 3) or left unabsorbed (Blot 1) before applica
tion to the blots. Blot 4 is the PBS control. Similar results were obtained with LPS-serum at 1:1000 and 1:5000 (not shown).

Laing and co-workers“ have recently demonstrated
with Western blotting experiments that mouse anti-rat
RBC serum, but not mouse anti-BrRat RBC serum, is
capable of detecting rat erythrocyte glycophorins. In

the g a stro in testin a l tract, erythrocytes, the lungs and
the kidneys17. Carbonic anhydrase has been found in

follicle-associated epithelial cells in ileal Peyer s
patches of lambs and goat kids21 and in the gastric pari
contrast, we have shown here that both LPS-serum and etal cells, brush border of the small intestine
the monoclonal anti-BrMRBC antibody, FUB 1, used enterocytes, nephron, glial cells, erythrocytes and adip
in Western blotting experiments (Figures 1, 5 and 61 ose cells of rodents29. The biochemistry and^enetics of
X specifically recognises carbonic anhydrase from mousg) CA has been studied for mouse CA II30" . The two
erythrocytes and bovine carbonic anhydrase. This electrophoretic types of CA II that may be distingu
apparent difference between mouse and rat RBC West ished on cellulose acetate gels (and also found here on
ern blotting experiments may be due to the fact that polyacrylamide gels, Figure 1) are thought to be due to
Laing’s study concentrated on the mouse response to a single nucleotide and subsequent amino acid substitu
rat erythrocyte ghosts whereas we are concerned prim- tion . A number of different isoenzymes of carbonic
x arily with mouse natural autoantibodies that recogri^e anhydrase have been characterised in a range of spe
the antigen revealed when whole mouse erythrocytes cies’4 and the protein sequence is highly conserved
a : have been pretreated with bromelain. Although <£hr- with CA IH displaying some sequence homology to
bonic anhydrase is a transmembrane protein and the ubiquitin, a marker of protein senescence.
a second most abundant erythrocyte protein after haemo
The question arose as to whether carbonic anhydrase
globin, levels of carbonic anhydrase are diminished in was recognised in its native form or had undergone
\ erythrocyte ghost preparations (A.M. Jonusys, un^iQpartial unfolding in the interaction with nitrocellulose.
A fished). This apparent difference between rat ajid) ELISA experiments with bovine carbonic anhydrase
mouse erythrocytes warrants further investigation.
coated plates, together with CA present as a soluble
In immunoblotting experiments (Figures 5 and 6) competitive inhibitor, showed specific binding of FUB
where FUB 1 and LPS-stimulated serum have been 1 to both “native” and denatured carbonic anhydrase
\ preabsorbed extensively with BrMRBC, we have cl(T> (Figures 2 and 3). Thus, this ELISA data suggests that
arly demonstrated that carbonic anhydrase bands in the FUB 1 is binding to an epitope that is present on the
blots have been substantially reduced in staining surface of the CA protein and would suggest a linear
A intensity, suggesting that carbonic anhydrase is part/gf epitope rather than a conformational epitope. Further
the set of BrM-epitopes.
work is in progress to determine the identity of this
Some IgM antibodies in unabsorbed LPS-stimulated epitope.
serum also recognise haemoglobin subunits on blots
A suspension-type ELISA experiment (Figure 4) was
suggesting that some other BrM-specific epitopes, conducted to test if a native or denatured form of car
recognized by other serum IgM antibodies, may be loc bonic anhydrase could inhibit the binding of FUB 1 to
ated on haemoglobin (the faint band in the 12-14 kD BrMRBC, but this could not be demonstrated at the
region, Blot 1 lane a Figure 6). This faint 12-14 kD levels of bovine carbonic anhydrase used. Thus inhibi
band has been augmented in intensity following tion of binding of FUB 1 to antigen coated plates by
absorption of LPS-serum with NMRBC (Blot 3 lane a ELISA can be clearly demonstrated (Figure 2) but not
Figure 6), which may be due to IgM-haemoglobin by cellular ELISA using BrM erythrocytes in suspen
complexes binding to the band.
sion as antigenic targets (Figure 3). This could be due
In a tissue distribution and ontogeny study of the to an effect of intrinsic low affinity of each antigen
BrM antigen, Cunningham and Steele6 found a form of combining site in IgM as well as an effect of avidity
the BrM-antigen at high levels in the stomach and due to the binding of the IgM to a multivalent array of
upper small intestine with some BrM activity present different epitopes on the BrM erythrocyte surface i.e.
in the kidney, liver and salivary glands. Garzelli e t a l 26 FUB 1 preferentially recognising murine carbonic
have confirmed the distribution of the BrM-antigen in anhydrase in the membrane in association with phos
cells of the lamina propria of mouse gastric mucosae, phatidylcholine and other membrane proteins. The
x the cytoplasm of cells in the salivary glands and tl(e) likelihood of multipoint binding may indicate it is dif
lumen of the seminiferous tubules of the testis with an ficult to achieve inhibition in this system using soluble
immunofluorescence study of frozen tissue sections bovine carbonic anhydrase.
and anti-BrMRBC monoclonal autoantibodies.
In other experiments we have reduced and alkylated
The tissue distribution of the in v iv o form of the FUB 1 and shown a greater than 99% loss in binding
BrM-antigen is similar to the distribution of carbonic activity, both for CA in the direct ELISA assay (using
anhydrase II. Carbonic anhydrase (E.C. 4.2.1.1.), a CA-coated plates), and for BrM erythrocytes in the cel30 kD glycoprotein isoenzyme responsible for the lular-ELISA assay. This indicates that the individual
reversible hydration of carbon dioxide required for combining sites are of very low affinity and that the
acid-base balance in mammals, is primarily located in binding avidity of the intact antibody is due entirely to
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Appendix I
Answers to queries raised by Dr. P.L. Ey
Query 1.
Emphasis on one particular antigen (p 37). Possibility o f several?
An erythrocyte may have a large number of potentially antigenic structures, (e.g. blood
group substances, cytoskeletal elements, glycoproteins or glycolipids) that may act as antigens
when injected into different species. However, this thesis specifically deals with one putative
mouse autoantigen, the BrMRBC autoantigen, that has been defined in terms of a structure that
is revealed after proteolytic digestion with bromelain (Cunningham 1974). The exact biological
structure of all of the components of this autoantigen had remained undefined for almost 15
years until carbonic anhydrase was shown to be an in vivo component of the BrMRBC
autoantigen (Jonusys et al. 1991). Some knowledge on the possible natural autoantigenic
ligands has been gained from using a wide variety of compounds, such as phosphatidylcholine
and low density lipoproteins from egg yolk, to inhibit the binding of BrMRBC and specific
IgM natural autoantibodies that bind to BrMRBC (Table 1.3, p.9). Also, anti-BrMRBC
autoantibodies do not bind to normal mouse red blood cells (Chapter 1, 1.4.2), which shows
that potentially autoantigenic structures on the surface of intact red blood cells, such as
cytoskeletal elements or blood group antigens, do not normally act as autoantigens.
In contrast to the lack of specific knowledge on the structure of the BrMRBC
autoantigen, a great deal is known about the structure and genetics of the antibodies that
recognise the BrMRBC autoantigen (Chapter 1, 1.3). For this reason alone it was important to
place emphasis on one particular "antigen" as it is difficult to advance this field of study when
one of the principal components, the target BrMRBC autoantigen, has been so poorly defined
in vivo. This thesis has revealed a previously unrecognised mouse erythrocyte autoantigen, viz.
carbonic anhydrase, and will stimulate further research into the interactions of carbonic
anhydrase and the other main candidate autoantigen, phosphatidylcholine.

Query 2
Seem to assume that all hybridoma-derived anti-BrMRBC antibodies are directed
against the same antigen (eg. p. 38). Evidence that this is so?
In the studies of Pages and Arnaud (1980) and Kawaguchi (1986), in which the
reactivity of anti-BrMRBC antibodies were tested against bromelain-treated RBC and normal red
blood cells from a wide variety of different species, the authors in both papers have attempted to
measure the relative binding hierarchy of anti-BrMRBC antibodies by inhibition of RBC lysis
assays. In these studies it has been assumed that bromelain would have a common action on
RBC, whether they came from a mouse or a frog, and thus reveal a common antigen on all of

these target cells. The exact in vivo identity of the target autoantigen or antigen could not be
defined in these studies, but would have been assumed to be the same for different species'
erythrocytes.
In experiments conducted in this thesis, this problem of what anti-BrMRBC antibodies
bind to on the RBC of different species and whether this antigen was common to a range of
different species was addressed in Western blot and c-ELIS A experiments (Chapter Five, Section
5.5 pl60-166). I found that anti-BrMRBC antibodies recognise carbonic anhydrase from a range
of different species, and the different binding hierarchies found by other authors may perhaps be
explained by the different local topology of different species' erythrocytes after bromelain
treatment in their assay systems. The western blot results obtained here indicate that the
monoclonal antibody, FUB 1, recognises the same antigen, carbonic anhydrase, from the
erthyrocytes of different species.

Query 3
Inhibition o f lysis o f antibody-sensitised BrMRBC (p 43). Any effect on lysis o f
other cells in parallel asays ? (i.e. is inhibition specific fo r antigen, or
interference with c activation?).
These complement-dependent lysis assays, as conducted by Cunningham and Steele
(1981), are specific for the antigen BrMRBC. The inhibition is specific for anti-BrMRBC
antibodies and may not be explained as inhibition of complement components. The relevant
controls were in place for these experiments, viz, erythrocytes and anti-erythrocyte antibodies
from other species (Horse RBC) and anti-HorseRBC antibodies have been used to show that the
lysis of BrMRBC with anti-BrMRBC is specific (Cunningham and Steele 1981).
In experiments where anti-BrM activity was absorbed out of the serum with various
mouse tissues, there was a corresponding lack of absorption of IgM anti-Horse RBC serum
with the same antigens. In different experiments designed to test a range of antigens that may
inhibit the binding of anti-BrMRBC serum to BrMRBC, the same antigens did not inhibit the
lysis of Horse RBC by anti-HRBC serum.Thus the inhibition of lysis described in this study
was due to specific antigen and not interference of complement activation.

Query 4
Can one be certain that it is the protease activity in bromelain that exposes the
BrM RBC antigen(s)? (p.55) Commercial stocks are rather crude and could
contain other enzyme activities , e.g. glycosidases.
This is a valid concern that probably has not been looked at adequately by all researchers
in this area. In a paper by Cunliffe and Cox (1979), the action of bromelain and pronase on

mouse erythocytes was examined, and bromelain, obtained from Sigma and used without further
purification, was found to remove Bands I, II and III as well as some undefined glycoprotein
and protein bands from the membranes of mouse red blood cells. This paper addressed only the
action of bromelain and pronase on mouse RBC membranes and it should be noted that whole
red blood cells, which are the common target cells used in other assay systems, were not
examined.The possible glycosidase activity of bromelain was not examined in this paper nor
was the purity of bromelain available commercially questioned or examined.
Sigma, which is the company that most researchers obtain bromelain from, sells
bromelain on the basis of its proteolytic activity. It is of note that Sigma now markets a more
highly purified product that was not available when I did the work described in this thesis. It
would be of value to test the standard bromelain and the more purified product to determine if it
could be responsible for the removal of carbohydrate.
However, in light of the results obtained with deglycosylated carbonic anhydrase
(Chapter 5, 5.6, Figure 5.15), where it seems apparent that FUB 1 recognises the O-linked
sugars on carbonic anhydrase, bromelain could not be responsible for removing sugars on red
blood cell carbonic anhydrase in situ, otherwise these bands would not be detected on western
blots.

Query 5
Assay volume (p. 57, paragraph 1): Was the final volume 75 or 100pi? It is not
clear whether the 25p i o f rabbit c was included within the 50pl o f diluent, or
added after sample dilution.
On page 57 the volume of the assay described is IO O jlxI; consisting of antibodies serially
diluted in 50jil of buffer and 25jil of rabbit complement and 25jil of a 1% RBC suspension.
The rabbit complement was added after the antibody dilution, so that a constant amount of
complement would be present in all test wells of the assay.

Query 6
AET and periodate treatment (pp. 60, 75). The negative results emphasise the
need to always include positive controls to ensure that the reagents are really
working . Periodate only destroys cis-hydroxy sugars: it does not destroy
carbohydrates generally, nor "deglycosylates"proteins (p.173).
AET and periodate where employed with whole RBC in an attempt to remove
carbohydrates following standard human blood bank techniques (American Association of Blood
Banks 1985) and standard methods to "destroy blood group substances" (Kabat, 1956). It was
perhaps an oversight not to include a standard panel of human RBC, however problems were

encountered with mouse RBC and AET, such as the complete lysis of mouse red blood cells
that are not commonly encountered with human red blood cells. As these experiments were
conducted during the early, unfruitful stages of the project, it would probably be worthwhile to
re-examine these experiments and make changes to the standard human blood protocols with
regard to the concentrations of the reagents used and the times and temperatures of incubation,
such that the assays would be applicable for mouse red blood cells.

Query 7
Coating concentration fo r ELISA (p.73 & elsewhere). Was 2.5 m g/m l really
used? This is a huge overdose and a waste o f purified protein; 5-10 pglml, the
commonly used range, is essentially saturating.
The coating concentration for the carbonic anhydrase ELISA (p73, pl36) was in fact

50jll1 of a 0.25mg/ml stock solution of carbonic anhydrase, which coats each microtitre plate
well with 12.5 |ig of carbonic anhydrase. Any unbound carbonic anhydrase is removed upon
aspiration at the next stage, leaving essentially a saturating level of carbonic anhydrase coating
each well.

Query 8
Poor description o f methodology (p. 74). Was the RBC lysate centrifuged
before treatment with ammonium sulphate? The latter was presumably used at a
fin al saturation o f 45% (w/v?), not 45% o f the volume as described. Was the
redissolved pellet dialysed prior to application to the DEAE column ? (this is not
mentioned). Was a pH gradient employed fo r elution?
Perhaps this section could have been made clearer with a flow diagram, however if the
method described on page 74 (Carter and Parsons 1970) is carefully followed the concerns
raised by the examiner could have been answered. In preparing carbonic anhydrase from
erythrocytes, haemoglobin is removed from the lysate by ammonium sulfate precipitation
(45%w/v) and any membrane constituents are effectively removed by centrifugation at 10,000
rpm for 1 hour. The supernatant (pH 7.2), which contains carbonic anhydrase, is applied to
the DEAE column. The precipitate, containing haemoglobin and RBC membranes, is discarded
and therefore does not have to redissolved or dialysed before being placed in the rubbish bin. A
stepwise pH gradient was employed to elute carbonic anhydrase from the DEAE column.

